Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:adamantinoma'
(id=6825316 ; fe=en:adamantinoma ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=34857 creation date=2017-06-25 touchdate=2025-08-14 00:23:44.000)
≈ 763 relations sortantes

  1. en:adamantinoma -- r_associated #0: 239 / 1 -> médecine
    n1=en:adamantinoma | n2=médecine | rel=r_associated | relid=0 | w=239
  2. en:adamantinoma -- r_associated #0: 68 / 0.285 -> adamantinome
    n1=en:adamantinoma | n2=adamantinome | rel=r_associated | relid=0 | w=68
  3. en:adamantinoma -- r_associated #0: 55 / 0.23 -> processus pathologique
    n1=en:adamantinoma | n2=processus pathologique | rel=r_associated | relid=0 | w=55
  4. en:adamantinoma -- r_associated #0: 50 / 0.209 -> améloblastome malin
    n1=en:adamantinoma | n2=améloblastome malin | rel=r_associated | relid=0 | w=50
  5. en:adamantinoma -- r_associated #0: 50 / 0.209 -> maladies
    n1=en:adamantinoma | n2=maladies | rel=r_associated | relid=0 | w=50
  6. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:ameloblastoma
    n1=en:adamantinoma | n2=en:ameloblastoma | rel=r_associated | relid=0 | w=49
  7. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:ewing sarcoma/peripheral primitive neuroectodermal tumor
    n1=en:adamantinoma | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=49
  8. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:historical aspects qualifier
    n1=en:adamantinoma | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=49
  9. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:maxillary neoplasms
    n1=en:adamantinoma | n2=en:maxillary neoplasms | rel=r_associated | relid=0 | w=49
  10. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:osteoblastoma
    n1=en:adamantinoma | n2=en:osteoblastoma | rel=r_associated | relid=0 | w=49
  11. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:osteogenic/bone tumor, special type
    n1=en:adamantinoma | n2=en:osteogenic/bone tumor, special type | rel=r_associated | relid=0 | w=49
  12. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:pathological aspects
    n1=en:adamantinoma | n2=en:pathological aspects | rel=r_associated | relid=0 | w=49
  13. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:rehabilitation aspects
    n1=en:adamantinoma | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=49
  14. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:skull neoplasm
    n1=en:adamantinoma | n2=en:skull neoplasm | rel=r_associated | relid=0 | w=49
  15. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:sternal neoplasm
    n1=en:adamantinoma | n2=en:sternal neoplasm | rel=r_associated | relid=0 | w=49
  16. en:adamantinoma -- r_associated #0: 49 / 0.205 -> en:therapeutic aspects
    n1=en:adamantinoma | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=49
  17. en:adamantinoma -- r_associated #0: 49 / 0.205 -> épithélioma adamantin
    n1=en:adamantinoma | n2=épithélioma adamantin | rel=r_associated | relid=0 | w=49
  18. en:adamantinoma -- r_associated #0: 48 / 0.201 -> en:complication aspects
    n1=en:adamantinoma | n2=en:complication aspects | rel=r_associated | relid=0 | w=48
  19. en:adamantinoma -- r_associated #0: 48 / 0.201 -> en:exposure as collected domain
    n1=en:adamantinoma | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=48
  20. en:adamantinoma -- r_associated #0: 48 / 0.201 -> en:juvenile ossifying fibroma
    n1=en:adamantinoma | n2=en:juvenile ossifying fibroma | rel=r_associated | relid=0 | w=48
  21. en:adamantinoma -- r_associated #0: 48 / 0.201 -> en:neoplasm of scapula
    n1=en:adamantinoma | n2=en:neoplasm of scapula | rel=r_associated | relid=0 | w=48
  22. en:adamantinoma -- r_associated #0: 48 / 0.201 -> en:neoplasm of uncertain or unknown behaviour: bone and articular cartilage
    n1=en:adamantinoma | n2=en:neoplasm of uncertain or unknown behaviour: bone and articular cartilage | rel=r_associated | relid=0 | w=48
  23. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:chordoma
    n1=en:adamantinoma | n2=en:chordoma | rel=r_associated | relid=0 | w=47
  24. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:congenital mesh qualifier
    n1=en:adamantinoma | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=47
  25. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:diagnosis aspect
    n1=en:adamantinoma | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=47
  26. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:femoral neoplasms
    n1=en:adamantinoma | n2=en:femoral neoplasms | rel=r_associated | relid=0 | w=47
  27. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:intraspinal neoplasm
    n1=en:adamantinoma | n2=en:intraspinal neoplasm | rel=r_associated | relid=0 | w=47
  28. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:neoplasm of bone of upper limb
    n1=en:adamantinoma | n2=en:neoplasm of bone of upper limb | rel=r_associated | relid=0 | w=47
  29. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:neoplasm of uncertain behavior of bone
    n1=en:adamantinoma | n2=en:neoplasm of uncertain behavior of bone | rel=r_associated | relid=0 | w=47
  30. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:notochordal tumor
    n1=en:adamantinoma | n2=en:notochordal tumor | rel=r_associated | relid=0 | w=47
  31. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:ossifying fibroma
    n1=en:adamantinoma | n2=en:ossifying fibroma | rel=r_associated | relid=0 | w=47
  32. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:physiopathological
    n1=en:adamantinoma | n2=en:physiopathological | rel=r_associated | relid=0 | w=47
  33. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:small cell osteosarcoma
    n1=en:adamantinoma | n2=en:small cell osteosarcoma | rel=r_associated | relid=0 | w=47
  34. en:adamantinoma -- r_associated #0: 47 / 0.197 -> en:use of ultrasonography
    n1=en:adamantinoma | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=47
  35. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:cellular secretion
    n1=en:adamantinoma | n2=en:cellular secretion | rel=r_associated | relid=0 | w=46
  36. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:etiology aspects
    n1=en:adamantinoma | n2=en:etiology aspects | rel=r_associated | relid=0 | w=46
  37. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:fibrous dysplasia
    n1=en:adamantinoma | n2=en:fibrous dysplasia | rel=r_associated | relid=0 | w=46
  38. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:giant cell tumor of bone
    n1=en:adamantinoma | n2=en:giant cell tumor of bone | rel=r_associated | relid=0 | w=46
  39. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:immunology aspects
    n1=en:adamantinoma | n2=en:immunology aspects | rel=r_associated | relid=0 | w=46
  40. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:langerhans cell histiocytosis
    n1=en:adamantinoma | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=46
  41. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:neoplasm of bone of face
    n1=en:adamantinoma | n2=en:neoplasm of bone of face | rel=r_associated | relid=0 | w=46
  42. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:osteoid osteoma
    n1=en:adamantinoma | n2=en:osteoid osteoma | rel=r_associated | relid=0 | w=46
  43. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:psychology qualifier
    n1=en:adamantinoma | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=46
  44. en:adamantinoma -- r_associated #0: 46 / 0.192 -> en:vascular bone neoplasm
    n1=en:adamantinoma | n2=en:vascular bone neoplasm | rel=r_associated | relid=0 | w=46
  45. en:adamantinoma -- r_associated #0: 45 / 0.188 -> en:malignant ameloblastoma
    n1=en:adamantinoma | n2=en:malignant ameloblastoma | rel=r_associated | relid=0 | w=45
  46. en:adamantinoma -- r_associated #0: 45 / 0.188 -> en:metastasizing ameloblastoma
    n1=en:adamantinoma | n2=en:metastasizing ameloblastoma | rel=r_associated | relid=0 | w=45
  47. en:adamantinoma -- r_associated #0: 44 / 0.184 -> adamantinome du tibia
    n1=en:adamantinoma | n2=adamantinome du tibia | rel=r_associated | relid=0 | w=44
  48. en:adamantinoma -- r_associated #0: 44 / 0.184 -> en:chemical aspects
    n1=en:adamantinoma | n2=en:chemical aspects | rel=r_associated | relid=0 | w=44
  49. en:adamantinoma -- r_associated #0: 44 / 0.184 -> en:genetic aspects
    n1=en:adamantinoma | n2=en:genetic aspects | rel=r_associated | relid=0 | w=44
  50. en:adamantinoma -- r_associated #0: 44 / 0.184 -> en:neoplasm of clavicle
    n1=en:adamantinoma | n2=en:neoplasm of clavicle | rel=r_associated | relid=0 | w=44
  51. en:adamantinoma -- r_associated #0: 44 / 0.184 -> en:surgical aspects
    n1=en:adamantinoma | n2=en:surgical aspects | rel=r_associated | relid=0 | w=44
  52. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:anaplastic (malignant) meningioma
    n1=en:adamantinoma | n2=en:anaplastic (malignant) meningioma | rel=r_associated | relid=0 | w=43
  53. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:bone epithelioid hemangioendothelioma
    n1=en:adamantinoma | n2=en:bone epithelioid hemangioendothelioma | rel=r_associated | relid=0 | w=43
  54. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:combined small cell lung carcinoma
    n1=en:adamantinoma | n2=en:combined small cell lung carcinoma | rel=r_associated | relid=0 | w=43
  55. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:epithelioid leiomyosarcoma
    n1=en:adamantinoma | n2=en:epithelioid leiomyosarcoma | rel=r_associated | relid=0 | w=43
  56. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:germinoma
    n1=en:adamantinoma | n2=en:germinoma | rel=r_associated | relid=0 | w=43
  57. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:osteosarcoma/malignant fibrous histiocytoma of bone
    n1=en:adamantinoma | n2=en:osteosarcoma/malignant fibrous histiocytoma of bone | rel=r_associated | relid=0 | w=43
  58. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:primary malignant neoplasm of ill-defined site
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=43
  59. en:adamantinoma -- r_associated #0: 43 / 0.18 -> en:transitional cell carcinoma
    n1=en:adamantinoma | n2=en:transitional cell carcinoma | rel=r_associated | relid=0 | w=43
  60. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:aspects of radionuclide imaging
    n1=en:adamantinoma | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=42
  61. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements
    n1=en:adamantinoma | n2=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | rel=r_associated | relid=0 | w=42
  62. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:chemically induced
    n1=en:adamantinoma | n2=en:chemically induced | rel=r_associated | relid=0 | w=42
  63. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:embryologic
    n1=en:adamantinoma | n2=en:embryologic | rel=r_associated | relid=0 | w=42
  64. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:epidemiologic
    n1=en:adamantinoma | n2=en:epidemiologic | rel=r_associated | relid=0 | w=42
  65. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:fibroma
    n1=en:adamantinoma | n2=en:fibroma | rel=r_associated | relid=0 | w=42
  66. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:in blood
    n1=en:adamantinoma | n2=en:in blood | rel=r_associated | relid=0 | w=42
  67. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:in urine
    n1=en:adamantinoma | n2=en:in urine | rel=r_associated | relid=0 | w=42
  68. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:neoplasm of bone of lower limb
    n1=en:adamantinoma | n2=en:neoplasm of bone of lower limb | rel=r_associated | relid=0 | w=42
  69. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:neoplasm of rib
    n1=en:adamantinoma | n2=en:neoplasm of rib | rel=r_associated | relid=0 | w=42
  70. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:nutritional management
    n1=en:adamantinoma | n2=en:nutritional management | rel=r_associated | relid=0 | w=42
  71. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:salivary gland monomorphic adenoma
    n1=en:adamantinoma | n2=en:salivary gland monomorphic adenoma | rel=r_associated | relid=0 | w=42
  72. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:spindle cell sarcoma
    n1=en:adamantinoma | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=42
  73. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:telangiectatic osteosarcoma
    n1=en:adamantinoma | n2=en:telangiectatic osteosarcoma | rel=r_associated | relid=0 | w=42
  74. en:adamantinoma -- r_associated #0: 42 / 0.176 -> en:teratoid medulloepithelioma
    n1=en:adamantinoma | n2=en:teratoid medulloepithelioma | rel=r_associated | relid=0 | w=42
  75. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:adenoma and/or adenocarcinoma
    n1=en:adamantinoma | n2=en:adenoma and/or adenocarcinoma | rel=r_associated | relid=0 | w=41
  76. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:aneurysmal bone cyst
    n1=en:adamantinoma | n2=en:aneurysmal bone cyst | rel=r_associated | relid=0 | w=41
  77. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:askin tumor
    n1=en:adamantinoma | n2=en:askin tumor | rel=r_associated | relid=0 | w=41
  78. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:enostosis
    n1=en:adamantinoma | n2=en:enostosis | rel=r_associated | relid=0 | w=41
  79. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:enzymology
    n1=en:adamantinoma | n2=en:enzymology | rel=r_associated | relid=0 | w=41
  80. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:malignant bone neoplasm
    n1=en:adamantinoma | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=41
  81. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:malignant phyllodes tumor
    n1=en:adamantinoma | n2=en:malignant phyllodes tumor | rel=r_associated | relid=0 | w=41
  82. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:malignant solitary fibrous tumor
    n1=en:adamantinoma | n2=en:malignant solitary fibrous tumor | rel=r_associated | relid=0 | w=41
  83. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:metastatic malignant neoplasm in the bone
    n1=en:adamantinoma | n2=en:metastatic malignant neoplasm in the bone | rel=r_associated | relid=0 | w=41
  84. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:neoplasm of vertebral column
    n1=en:adamantinoma | n2=en:neoplasm of vertebral column | rel=r_associated | relid=0 | w=41
  85. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:osteogenic/bone tumor, nos
    n1=en:adamantinoma | n2=en:osteogenic/bone tumor, nos | rel=r_associated | relid=0 | w=41
  86. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:osteosarcoma
    n1=en:adamantinoma | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=41
  87. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:polygonal cell carcinoma
    n1=en:adamantinoma | n2=en:polygonal cell carcinoma | rel=r_associated | relid=0 | w=41
  88. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:solid papillary carcinoma with invasion
    n1=en:adamantinoma | n2=en:solid papillary carcinoma with invasion | rel=r_associated | relid=0 | w=41
  89. en:adamantinoma -- r_associated #0: 41 / 0.172 -> en:tumor of laryngeal cartilage
    n1=en:adamantinoma | n2=en:tumor of laryngeal cartilage | rel=r_associated | relid=0 | w=41
  90. en:adamantinoma -- r_associated #0: 40 / 0.167 -> en:malignant mast cell neoplasm
    n1=en:adamantinoma | n2=en:malignant mast cell neoplasm | rel=r_associated | relid=0 | w=40
  91. en:adamantinoma -- r_associated #0: 40 / 0.167 -> en:malignant neoplasm of short bones of lower limb
    n1=en:adamantinoma | n2=en:malignant neoplasm of short bones of lower limb | rel=r_associated | relid=0 | w=40
  92. en:adamantinoma -- r_associated #0: 40 / 0.167 -> en:parosteal osteosarcoma
    n1=en:adamantinoma | n2=en:parosteal osteosarcoma | rel=r_associated | relid=0 | w=40
  93. en:adamantinoma -- r_associated #0: 40 / 0.167 -> en:periosteal osteosarcoma
    n1=en:adamantinoma | n2=en:periosteal osteosarcoma | rel=r_associated | relid=0 | w=40
  94. en:adamantinoma -- r_associated #0: 40 / 0.167 -> en:pleomorphic carcinoma
    n1=en:adamantinoma | n2=en:pleomorphic carcinoma | rel=r_associated | relid=0 | w=40
  95. en:adamantinoma -- r_associated #0: 39 / 0.163 -> en:adenocarcinoma in adenomatous polyp
    n1=en:adamantinoma | n2=en:adenocarcinoma in adenomatous polyp | rel=r_associated | relid=0 | w=39
  96. en:adamantinoma -- r_associated #0: 39 / 0.163 -> en:malignant squamous cell neoplasm
    n1=en:adamantinoma | n2=en:malignant squamous cell neoplasm | rel=r_associated | relid=0 | w=39
  97. en:adamantinoma -- r_associated #0: 39 / 0.163 -> en:primary malignant neoplasm of vomer
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of vomer | rel=r_associated | relid=0 | w=39
  98. en:adamantinoma -- r_associated #0: 39 / 0.163 -> en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells
    n1=en:adamantinoma | n2=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=39
  99. en:adamantinoma -- r_associated #0: 39 / 0.163 -> en:undifferentiated sarcoma, not otherwise specified
    n1=en:adamantinoma | n2=en:undifferentiated sarcoma, not otherwise specified | rel=r_associated | relid=0 | w=39
  100. en:adamantinoma -- r_associated #0: 38 / 0.159 -> en:fascial fibrosarcoma
    n1=en:adamantinoma | n2=en:fascial fibrosarcoma | rel=r_associated | relid=0 | w=38
  101. en:adamantinoma -- r_associated #0: 38 / 0.159 -> en:overlapping malignant neoplasm of lip, oral cavity and pharynx
    n1=en:adamantinoma | n2=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=38
  102. en:adamantinoma -- r_associated #0: 38 / 0.159 -> en:small cell carcinoma carcinomatosis
    n1=en:adamantinoma | n2=en:small cell carcinoma carcinomatosis | rel=r_associated | relid=0 | w=38
  103. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:epithelioid malignant peripheral nerve sheath tumor
    n1=en:adamantinoma | n2=en:epithelioid malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=37
  104. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:high risk gastrointestinal stromal tumor
    n1=en:adamantinoma | n2=en:high risk gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=37
  105. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:lymphoma
    n1=en:adamantinoma | n2=en:lymphoma | rel=r_associated | relid=0 | w=37
  106. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:malignant tumor of bone and articular cartilage
    n1=en:adamantinoma | n2=en:malignant tumor of bone and articular cartilage | rel=r_associated | relid=0 | w=37
  107. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:ovarian epithelial tumor
    n1=en:adamantinoma | n2=en:ovarian epithelial tumor | rel=r_associated | relid=0 | w=37
  108. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma
    n1=en:adamantinoma | n2=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | rel=r_associated | relid=0 | w=37
  109. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:primary malignant neoplasm of ribs and/or sternum and/or clavicle
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of ribs and/or sternum and/or clavicle | rel=r_associated | relid=0 | w=37
  110. en:adamantinoma -- r_associated #0: 37 / 0.155 -> en:primary malignant neoplasm of unknown site
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of unknown site | rel=r_associated | relid=0 | w=37
  111. en:adamantinoma -- r_associated #0: 36 / 0.151 -> adamantinome malin (à l'exception des os longs m-92613)
    n1=en:adamantinoma | n2=adamantinome malin (à l'exception des os longs m-92613) | rel=r_associated | relid=0 | w=36
  112. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:eccrine porocarcinoma
    n1=en:adamantinoma | n2=en:eccrine porocarcinoma | rel=r_associated | relid=0 | w=36
  113. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:familial letterer-siwe disease
    n1=en:adamantinoma | n2=en:familial letterer-siwe disease | rel=r_associated | relid=0 | w=36
  114. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:glandular cell neoplasm
    n1=en:adamantinoma | n2=en:glandular cell neoplasm | rel=r_associated | relid=0 | w=36
  115. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:medulloblastoma
    n1=en:adamantinoma | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=36
  116. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:odontoameloblastoma
    n1=en:adamantinoma | n2=en:odontoameloblastoma | rel=r_associated | relid=0 | w=36
  117. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:primary malignant neoplasm of trunk
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of trunk | rel=r_associated | relid=0 | w=36
  118. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:rhabdoid tumor
    n1=en:adamantinoma | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=36
  119. en:adamantinoma -- r_associated #0: 36 / 0.151 -> en:stromal sarcoma
    n1=en:adamantinoma | n2=en:stromal sarcoma | rel=r_associated | relid=0 | w=36
  120. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:adenosquamous carcinoma
    n1=en:adamantinoma | n2=en:adenosquamous carcinoma | rel=r_associated | relid=0 | w=35
  121. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:angiomyosarcoma
    n1=en:adamantinoma | n2=en:angiomyosarcoma | rel=r_associated | relid=0 | w=35
  122. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:aspects of mortality statistics
    n1=en:adamantinoma | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=35
  123. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:benign bone neoplasm
    n1=en:adamantinoma | n2=en:benign bone neoplasm | rel=r_associated | relid=0 | w=35
  124. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:benign muscle neoplasm
    n1=en:adamantinoma | n2=en:benign muscle neoplasm | rel=r_associated | relid=0 | w=35
  125. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:blood supply aspects
    n1=en:adamantinoma | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=35
  126. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:bone neoplasm
    n1=en:adamantinoma | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=35
  127. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:carcinoma in situ
    n1=en:adamantinoma | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=35
  128. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:chief cell adenocarcinoma
    n1=en:adamantinoma | n2=en:chief cell adenocarcinoma | rel=r_associated | relid=0 | w=35
  129. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:clear cell (mesonephroid) neoplasm - category
    n1=en:adamantinoma | n2=en:clear cell (mesonephroid) neoplasm - category | rel=r_associated | relid=0 | w=35
  130. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:diffuse embryoma
    n1=en:adamantinoma | n2=en:diffuse embryoma | rel=r_associated | relid=0 | w=35
  131. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:epithelioid mesothelioma
    n1=en:adamantinoma | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=35
  132. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:epithelioid trophoblastic tumor
    n1=en:adamantinoma | n2=en:epithelioid trophoblastic tumor | rel=r_associated | relid=0 | w=35
  133. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:essential thrombocythemia
    n1=en:adamantinoma | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=35
  134. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:ethnologic
    n1=en:adamantinoma | n2=en:ethnologic | rel=r_associated | relid=0 | w=35
  135. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:ewing sarcoma
    n1=en:adamantinoma | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=35
  136. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:interdigitating dendritic cell sarcoma
    n1=en:adamantinoma | n2=en:interdigitating dendritic cell sarcoma | rel=r_associated | relid=0 | w=35
  137. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:intraductal papillary adenocarcinoma with invasion
    n1=en:adamantinoma | n2=en:intraductal papillary adenocarcinoma with invasion | rel=r_associated | relid=0 | w=35
  138. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:invasive ductal and lobular carcinoma in situ
    n1=en:adamantinoma | n2=en:invasive ductal and lobular carcinoma in situ | rel=r_associated | relid=0 | w=35
  139. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:liposarcoma of connective tissue
    n1=en:adamantinoma | n2=en:liposarcoma of connective tissue | rel=r_associated | relid=0 | w=35
  140. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:long bone
    n1=en:adamantinoma | n2=en:long bone | rel=r_associated | relid=0 | w=35
  141. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:lymphosarcoma of lymph nodes of head, face and neck
    n1=en:adamantinoma | n2=en:lymphosarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=35
  142. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignancy in giant cell tumor of bone
    n1=en:adamantinoma | n2=en:malignancy in giant cell tumor of bone | rel=r_associated | relid=0 | w=35
  143. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant adrenal gland pheochromocytoma
    n1=en:adamantinoma | n2=en:malignant adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=35
  144. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant chest wall bone neoplasm
    n1=en:adamantinoma | n2=en:malignant chest wall bone neoplasm | rel=r_associated | relid=0 | w=35
  145. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant mesothelioma
    n1=en:adamantinoma | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=35
  146. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant mixed tumor, chondrosarcomatous type
    n1=en:adamantinoma | n2=en:malignant mixed tumor, chondrosarcomatous type | rel=r_associated | relid=0 | w=35
  147. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant neoplasm of ribs, sternum and clavicle
    n1=en:adamantinoma | n2=en:malignant neoplasm of ribs, sternum and clavicle | rel=r_associated | relid=0 | w=35
  148. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant odontogenic ghost cell tumor
    n1=en:adamantinoma | n2=en:malignant odontogenic ghost cell tumor | rel=r_associated | relid=0 | w=35
  149. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant peripheral nerve sheath tumor with perineurial differentiation
    n1=en:adamantinoma | n2=en:malignant peripheral nerve sheath tumor with perineurial differentiation | rel=r_associated | relid=0 | w=35
  150. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant sacral teratoma
    n1=en:adamantinoma | n2=en:malignant sacral teratoma | rel=r_associated | relid=0 | w=35
  151. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant type a thymoma
    n1=en:adamantinoma | n2=en:malignant type a thymoma | rel=r_associated | relid=0 | w=35
  152. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:malignant type b2 thymoma
    n1=en:adamantinoma | n2=en:malignant type b2 thymoma | rel=r_associated | relid=0 | w=35
  153. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:medulloepithelioma
    n1=en:adamantinoma | n2=en:medulloepithelioma | rel=r_associated | relid=0 | w=35
  154. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:miscellaneous bone tumors
    n1=en:adamantinoma | n2=en:miscellaneous bone tumors | rel=r_associated | relid=0 | w=35
  155. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:mixed mesodermal (mullerian) tumor
    n1=en:adamantinoma | n2=en:mixed mesodermal (mullerian) tumor | rel=r_associated | relid=0 | w=35
  156. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:mucosal lentiginous melanoma
    n1=en:adamantinoma | n2=en:mucosal lentiginous melanoma | rel=r_associated | relid=0 | w=35
  157. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:neoplasm of pelvic bone
    n1=en:adamantinoma | n2=en:neoplasm of pelvic bone | rel=r_associated | relid=0 | w=35
  158. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:non-keratinizing sinonasal squamous cell carcinoma
    n1=en:adamantinoma | n2=en:non-keratinizing sinonasal squamous cell carcinoma | rel=r_associated | relid=0 | w=35
  159. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:osteoclastic giant cell-rich tumor of bone
    n1=en:adamantinoma | n2=en:osteoclastic giant cell-rich tumor of bone | rel=r_associated | relid=0 | w=35
  160. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:oxyphilic adenocarcinoma
    n1=en:adamantinoma | n2=en:oxyphilic adenocarcinoma | rel=r_associated | relid=0 | w=35
  161. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:papillary meningioma
    n1=en:adamantinoma | n2=en:papillary meningioma | rel=r_associated | relid=0 | w=35
  162. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:papilloma
    n1=en:adamantinoma | n2=en:papilloma | rel=r_associated | relid=0 | w=35
  163. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:primary malignant neoplasm of articular cartilage
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of articular cartilage | rel=r_associated | relid=0 | w=35
  164. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:primary malignant neoplasm of bone of skull
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of bone of skull | rel=r_associated | relid=0 | w=35
  165. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:primary malignant neoplasm of paraganglion
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of paraganglion | rel=r_associated | relid=0 | w=35
  166. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:primary malignant neoplasm of pelvic bone
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of pelvic bone | rel=r_associated | relid=0 | w=35
  167. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:primary malignant neoplasm of vertebral column
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of vertebral column | rel=r_associated | relid=0 | w=35
  168. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:refractory anemia
    n1=en:adamantinoma | n2=en:refractory anemia | rel=r_associated | relid=0 | w=35
  169. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:regressing melanoma
    n1=en:adamantinoma | n2=en:regressing melanoma | rel=r_associated | relid=0 | w=35
  170. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:skin adenoid basal cell carcinoma
    n1=en:adamantinoma | n2=en:skin adenoid basal cell carcinoma | rel=r_associated | relid=0 | w=35
  171. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:skin basal cell carcinoma
    n1=en:adamantinoma | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=35
  172. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:spindle cell melanoma
    n1=en:adamantinoma | n2=en:spindle cell melanoma | rel=r_associated | relid=0 | w=35
  173. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:stage iv bone cancer
    n1=en:adamantinoma | n2=en:stage iv bone cancer | rel=r_associated | relid=0 | w=35
  174. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:superficial spreading melanoma
    n1=en:adamantinoma | n2=en:superficial spreading melanoma | rel=r_associated | relid=0 | w=35
  175. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:sweat gland adenocarcinoma
    n1=en:adamantinoma | n2=en:sweat gland adenocarcinoma | rel=r_associated | relid=0 | w=35
  176. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:thymus epithelial neoplasm
    n1=en:adamantinoma | n2=en:thymus epithelial neoplasm | rel=r_associated | relid=0 | w=35
  177. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:transitional cell neoplasm
    n1=en:adamantinoma | n2=en:transitional cell neoplasm | rel=r_associated | relid=0 | w=35
  178. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:undifferentiated pleomorphic sarcoma
    n1=en:adamantinoma | n2=en:undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=35
  179. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:well differentiated liposarcoma
    n1=en:adamantinoma | n2=en:well differentiated liposarcoma | rel=r_associated | relid=0 | w=35
  180. en:adamantinoma -- r_associated #0: 35 / 0.146 -> en:wolffian adnexal tumor
    n1=en:adamantinoma | n2=en:wolffian adnexal tumor | rel=r_associated | relid=0 | w=35
  181. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:adenomyoepithelioma with carcinoma
    n1=en:adamantinoma | n2=en:adenomyoepithelioma with carcinoma | rel=r_associated | relid=0 | w=34
  182. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:ameloblastic odontosarcoma
    n1=en:adamantinoma | n2=en:ameloblastic odontosarcoma | rel=r_associated | relid=0 | w=34
  183. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:burkitt leukemia
    n1=en:adamantinoma | n2=en:burkitt leukemia | rel=r_associated | relid=0 | w=34
  184. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:carcinoma ex pleomorphic adenoma
    n1=en:adamantinoma | n2=en:carcinoma ex pleomorphic adenoma | rel=r_associated | relid=0 | w=34
  185. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:chondrosarcoma
    n1=en:adamantinoma | n2=en:chondrosarcoma | rel=r_associated | relid=0 | w=34
  186. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:dedifferentiated chordoma
    n1=en:adamantinoma | n2=en:dedifferentiated chordoma | rel=r_associated | relid=0 | w=34
  187. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:desmoplastic melanoma
    n1=en:adamantinoma | n2=en:desmoplastic melanoma | rel=r_associated | relid=0 | w=34
  188. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:gain of chromosome 8
    n1=en:adamantinoma | n2=en:gain of chromosome 8 | rel=r_associated | relid=0 | w=34
  189. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:glassy cell carcinoma
    n1=en:adamantinoma | n2=en:glassy cell carcinoma | rel=r_associated | relid=0 | w=34
  190. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:high grade serous carcinoma
    n1=en:adamantinoma | n2=en:high grade serous carcinoma | rel=r_associated | relid=0 | w=34
  191. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:lobular breast carcinoma
    n1=en:adamantinoma | n2=en:lobular breast carcinoma | rel=r_associated | relid=0 | w=34
  192. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant epithelioma
    n1=en:adamantinoma | n2=en:malignant epithelioma | rel=r_associated | relid=0 | w=34
  193. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant granular cell tumor
    n1=en:adamantinoma | n2=en:malignant granular cell tumor | rel=r_associated | relid=0 | w=34
  194. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant immunoproliferative neoplasm
    n1=en:adamantinoma | n2=en:malignant immunoproliferative neoplasm | rel=r_associated | relid=0 | w=34
  195. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant mixed tumor, osteosarcomatous type
    n1=en:adamantinoma | n2=en:malignant mixed tumor, osteosarcomatous type | rel=r_associated | relid=0 | w=34
  196. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant neoplasm of laryngeal cartilage
    n1=en:adamantinoma | n2=en:malignant neoplasm of laryngeal cartilage | rel=r_associated | relid=0 | w=34
  197. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant neoplasm of scapula and long bones of upper limb
    n1=en:adamantinoma | n2=en:malignant neoplasm of scapula and long bones of upper limb | rel=r_associated | relid=0 | w=34
  198. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant neuroendocrine neoplasm, epithelial
    n1=en:adamantinoma | n2=en:malignant neuroendocrine neoplasm, epithelial | rel=r_associated | relid=0 | w=34
  199. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant osteoclastic giant cell-rich tumor of bone
    n1=en:adamantinoma | n2=en:malignant osteoclastic giant cell-rich tumor of bone | rel=r_associated | relid=0 | w=34
  200. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:malignant struma ovarii
    n1=en:adamantinoma | n2=en:malignant struma ovarii | rel=r_associated | relid=0 | w=34
  201. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:mesenchymoma
    n1=en:adamantinoma | n2=en:mesenchymoma | rel=r_associated | relid=0 | w=34
  202. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:mesonephric neoplasm
    n1=en:adamantinoma | n2=en:mesonephric neoplasm | rel=r_associated | relid=0 | w=34
  203. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:mixed liposarcoma
    n1=en:adamantinoma | n2=en:mixed liposarcoma | rel=r_associated | relid=0 | w=34
  204. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:mucoepidermoid carcinoma
    n1=en:adamantinoma | n2=en:mucoepidermoid carcinoma | rel=r_associated | relid=0 | w=34
  205. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:neuroepithelioma
    n1=en:adamantinoma | n2=en:neuroepithelioma | rel=r_associated | relid=0 | w=34
  206. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:olfactory neurogenic tumor
    n1=en:adamantinoma | n2=en:olfactory neurogenic tumor | rel=r_associated | relid=0 | w=34
  207. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:overlapping malignant melanoma of skin
    n1=en:adamantinoma | n2=en:overlapping malignant melanoma of skin | rel=r_associated | relid=0 | w=34
  208. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:paget's disease and infiltrating duct carcinoma of breast
    n1=en:adamantinoma | n2=en:paget's disease and infiltrating duct carcinoma of breast | rel=r_associated | relid=0 | w=34
  209. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:periosteal fibrosarcoma
    n1=en:adamantinoma | n2=en:periosteal fibrosarcoma | rel=r_associated | relid=0 | w=34
  210. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:polycythemia vera
    n1=en:adamantinoma | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=34
  211. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:primary malignant adenomatous neoplasm
    n1=en:adamantinoma | n2=en:primary malignant adenomatous neoplasm | rel=r_associated | relid=0 | w=34
  212. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:primary malignant neoplasm of bone of lower limb
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of bone of lower limb | rel=r_associated | relid=0 | w=34
  213. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:pseudoglandular squamous cell carcinoma
    n1=en:adamantinoma | n2=en:pseudoglandular squamous cell carcinoma | rel=r_associated | relid=0 | w=34
  214. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:refractory cytopenia with multilineage dysplasia
    n1=en:adamantinoma | n2=en:refractory cytopenia with multilineage dysplasia | rel=r_associated | relid=0 | w=34
  215. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:refractory cytopenia with multilineage dysplasia and ring sideroblasts
    n1=en:adamantinoma | n2=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | rel=r_associated | relid=0 | w=34
  216. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:secretory breast carcinoma
    n1=en:adamantinoma | n2=en:secretory breast carcinoma | rel=r_associated | relid=0 | w=34
  217. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:sertoli cell carcinoma
    n1=en:adamantinoma | n2=en:sertoli cell carcinoma | rel=r_associated | relid=0 | w=34
  218. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:skin metatypical carcinoma
    n1=en:adamantinoma | n2=en:skin metatypical carcinoma | rel=r_associated | relid=0 | w=34
  219. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:tibia
    n1=en:adamantinoma | n2=en:tibia | rel=r_associated | relid=0 | w=34
  220. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:undifferentiated carcinoma
    n1=en:adamantinoma | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=34
  221. en:adamantinoma -- r_associated #0: 34 / 0.142 -> en:warthin tumor
    n1=en:adamantinoma | n2=en:warthin tumor | rel=r_associated | relid=0 | w=34
  222. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:ameloblastic fibrosarcoma
    n1=en:adamantinoma | n2=en:ameloblastic fibrosarcoma | rel=r_associated | relid=0 | w=32
  223. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:bone osteosarcoma
    n1=en:adamantinoma | n2=en:bone osteosarcoma | rel=r_associated | relid=0 | w=32
  224. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:carcinosarcoma, embryonal
    n1=en:adamantinoma | n2=en:carcinosarcoma, embryonal | rel=r_associated | relid=0 | w=32
  225. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:chondroma
    n1=en:adamantinoma | n2=en:chondroma | rel=r_associated | relid=0 | w=32
  226. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:choriocarcinoma combined with other germ cell elements
    n1=en:adamantinoma | n2=en:choriocarcinoma combined with other germ cell elements | rel=r_associated | relid=0 | w=32
  227. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:complex epithelial neoplasm
    n1=en:adamantinoma | n2=en:complex epithelial neoplasm | rel=r_associated | relid=0 | w=32
  228. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:dysgerminoma
    n1=en:adamantinoma | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=32
  229. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:epithelial cell
    n1=en:adamantinoma | n2=en:epithelial cell | rel=r_associated | relid=0 | w=32
  230. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:epithelial tissue
    n1=en:adamantinoma | n2=en:epithelial tissue | rel=r_associated | relid=0 | w=32
  231. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone
    n1=en:adamantinoma | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=32
  232. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:fibroblastic liposarcoma
    n1=en:adamantinoma | n2=en:fibroblastic liposarcoma | rel=r_associated | relid=0 | w=32
  233. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:giant cell carcinoma
    n1=en:adamantinoma | n2=en:giant cell carcinoma | rel=r_associated | relid=0 | w=32
  234. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:invasive micropapillary breast carcinoma
    n1=en:adamantinoma | n2=en:invasive micropapillary breast carcinoma | rel=r_associated | relid=0 | w=32
  235. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:kidney wilms tumor
    n1=en:adamantinoma | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=32
  236. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:low grade myofibroblastic sarcoma
    n1=en:adamantinoma | n2=en:low grade myofibroblastic sarcoma | rel=r_associated | relid=0 | w=32
  237. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant aortic body tumor
    n1=en:adamantinoma | n2=en:malignant aortic body tumor | rel=r_associated | relid=0 | w=32
  238. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant melanoma in giant pigmented nevus
    n1=en:adamantinoma | n2=en:malignant melanoma in giant pigmented nevus | rel=r_associated | relid=0 | w=32
  239. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant mesenchymoma
    n1=en:adamantinoma | n2=en:malignant mesenchymoma | rel=r_associated | relid=0 | w=32
  240. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant mixed neoplasm
    n1=en:adamantinoma | n2=en:malignant mixed neoplasm | rel=r_associated | relid=0 | w=32
  241. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant neoplasm of bones of skull and face, except mandible
    n1=en:adamantinoma | n2=en:malignant neoplasm of bones of skull and face, except mandible | rel=r_associated | relid=0 | w=32
  242. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant neoplasm of short bones of upper limb
    n1=en:adamantinoma | n2=en:malignant neoplasm of short bones of upper limb | rel=r_associated | relid=0 | w=32
  243. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant neoplasm of xiphoid process
    n1=en:adamantinoma | n2=en:malignant neoplasm of xiphoid process | rel=r_associated | relid=0 | w=32
  244. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:malignant ovarian thecoma
    n1=en:adamantinoma | n2=en:malignant ovarian thecoma | rel=r_associated | relid=0 | w=32
  245. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:meningeal sarcomatosis
    n1=en:adamantinoma | n2=en:meningeal sarcomatosis | rel=r_associated | relid=0 | w=32
  246. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:microcystic adnexal carcinoma
    n1=en:adamantinoma | n2=en:microcystic adnexal carcinoma | rel=r_associated | relid=0 | w=32
  247. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:minimal deviation malignant melanoma
    n1=en:adamantinoma | n2=en:minimal deviation malignant melanoma | rel=r_associated | relid=0 | w=32
  248. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:mixed acinar-ductal carcinoma
    n1=en:adamantinoma | n2=en:mixed acinar-ductal carcinoma | rel=r_associated | relid=0 | w=32
  249. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:mixed germ cell tumor
    n1=en:adamantinoma | n2=en:mixed germ cell tumor | rel=r_associated | relid=0 | w=32
  250. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:mixed tumor, mesodermal
    n1=en:adamantinoma | n2=en:mixed tumor, mesodermal | rel=r_associated | relid=0 | w=32
  251. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:pancreatic acinar cell cystadenocarcinoma
    n1=en:adamantinoma | n2=en:pancreatic acinar cell cystadenocarcinoma | rel=r_associated | relid=0 | w=32
  252. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:pancreatic intraepithelial neoplasia
    n1=en:adamantinoma | n2=en:pancreatic intraepithelial neoplasia | rel=r_associated | relid=0 | w=32
  253. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:primary malignant neoplasm of muscle
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of muscle | rel=r_associated | relid=0 | w=32
  254. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:primary malignant neoplasm of respiratory tract
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of respiratory tract | rel=r_associated | relid=0 | w=32
  255. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:primary malignant neoplasm of unspecified site (clinical)
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of unspecified site (clinical) | rel=r_associated | relid=0 | w=32
  256. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:refractory anemia with excess blasts
    n1=en:adamantinoma | n2=en:refractory anemia with excess blasts | rel=r_associated | relid=0 | w=32
  257. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:seromucinous carcinoma
    n1=en:adamantinoma | n2=en:seromucinous carcinoma | rel=r_associated | relid=0 | w=32
  258. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:sertoli-leydig cell tumor, poorly differentiated
    n1=en:adamantinoma | n2=en:sertoli-leydig cell tumor, poorly differentiated | rel=r_associated | relid=0 | w=32
  259. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:small cell carcinoma, fusiform cell type
    n1=en:adamantinoma | n2=en:small cell carcinoma, fusiform cell type | rel=r_associated | relid=0 | w=32
  260. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:solitary osseous plasmacytoma
    n1=en:adamantinoma | n2=en:solitary osseous plasmacytoma | rel=r_associated | relid=0 | w=32
  261. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:squamous cell neoplasm
    n1=en:adamantinoma | n2=en:squamous cell neoplasm | rel=r_associated | relid=0 | w=32
  262. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:testicular spermatocytic seminoma
    n1=en:adamantinoma | n2=en:testicular spermatocytic seminoma | rel=r_associated | relid=0 | w=32
  263. en:adamantinoma -- r_associated #0: 32 / 0.134 -> en:thymoma type b3
    n1=en:adamantinoma | n2=en:thymoma type b3 | rel=r_associated | relid=0 | w=32
  264. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:adenosarcoma
    n1=en:adamantinoma | n2=en:adenosarcoma | rel=r_associated | relid=0 | w=31
  265. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:atypical teratoid/rhabdoid tumor
    n1=en:adamantinoma | n2=en:atypical teratoid/rhabdoid tumor | rel=r_associated | relid=0 | w=31
  266. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:carcinoma
    n1=en:adamantinoma | n2=en:carcinoma | rel=r_associated | relid=0 | w=31
  267. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:chondroid chordoma
    n1=en:adamantinoma | n2=en:chondroid chordoma | rel=r_associated | relid=0 | w=31
  268. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:choroid plexus neoplasm
    n1=en:adamantinoma | n2=en:choroid plexus neoplasm | rel=r_associated | relid=0 | w=31
  269. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:clear cell sarcoma of soft tissue
    n1=en:adamantinoma | n2=en:clear cell sarcoma of soft tissue | rel=r_associated | relid=0 | w=31
  270. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:dedifferentiated liposarcoma
    n1=en:adamantinoma | n2=en:dedifferentiated liposarcoma | rel=r_associated | relid=0 | w=31
  271. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:eccrine adenocarcinoma
    n1=en:adamantinoma | n2=en:eccrine adenocarcinoma | rel=r_associated | relid=0 | w=31
  272. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:extraskeletal osteosarcoma
    n1=en:adamantinoma | n2=en:extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=31
  273. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:heavy chain disease
    n1=en:adamantinoma | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=31
  274. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:hepatoblastoma
    n1=en:adamantinoma | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=31
  275. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:hepatoid adenocarcinoma
    n1=en:adamantinoma | n2=en:hepatoid adenocarcinoma | rel=r_associated | relid=0 | w=31
  276. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:langerhans cell sarcoma
    n1=en:adamantinoma | n2=en:langerhans cell sarcoma | rel=r_associated | relid=0 | w=31
  277. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:large cell neuroendocrine carcinoma
    n1=en:adamantinoma | n2=en:large cell neuroendocrine carcinoma | rel=r_associated | relid=0 | w=31
  278. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:liposarcoma
    n1=en:adamantinoma | n2=en:liposarcoma | rel=r_associated | relid=0 | w=31
  279. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:malignant giant cell neoplasm
    n1=en:adamantinoma | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=31
  280. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:malignant neoplasm of carpal bones
    n1=en:adamantinoma | n2=en:malignant neoplasm of carpal bones | rel=r_associated | relid=0 | w=31
  281. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:malignant neoplasm of pelvic bones, sacrum and coccyx
    n1=en:adamantinoma | n2=en:malignant neoplasm of pelvic bones, sacrum and coccyx | rel=r_associated | relid=0 | w=31
  282. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:malignant neoplasm of upper limb bones and scapula
    n1=en:adamantinoma | n2=en:malignant neoplasm of upper limb bones and scapula | rel=r_associated | relid=0 | w=31
  283. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:malignant neuroendocrine tumor
    n1=en:adamantinoma | n2=en:malignant neuroendocrine tumor | rel=r_associated | relid=0 | w=31
  284. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:metastatic carcinoma in the bone
    n1=en:adamantinoma | n2=en:metastatic carcinoma in the bone | rel=r_associated | relid=0 | w=31
  285. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:micropapillary transitional cell carcinoma
    n1=en:adamantinoma | n2=en:micropapillary transitional cell carcinoma | rel=r_associated | relid=0 | w=31
  286. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:myxoid chondrosarcoma
    n1=en:adamantinoma | n2=en:myxoid chondrosarcoma | rel=r_associated | relid=0 | w=31
  287. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:myxoid liposarcoma
    n1=en:adamantinoma | n2=en:myxoid liposarcoma | rel=r_associated | relid=0 | w=31
  288. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:paget disease and intraductal carcinoma of the breast
    n1=en:adamantinoma | n2=en:paget disease and intraductal carcinoma of the breast | rel=r_associated | relid=0 | w=31
  289. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:periosteal chondrosarcoma
    n1=en:adamantinoma | n2=en:periosteal chondrosarcoma | rel=r_associated | relid=0 | w=31
  290. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:pleomorphic rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=31
  291. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:primary lymphoma of bone
    n1=en:adamantinoma | n2=en:primary lymphoma of bone | rel=r_associated | relid=0 | w=31
  292. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:primary malignant neoplasm of gastrointestinal tract
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=31
  293. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:primary malignant neoplasm of independent multiple sites
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of independent multiple sites | rel=r_associated | relid=0 | w=31
  294. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:primary malignant neoplasm of laryngeal cartilage
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of laryngeal cartilage | rel=r_associated | relid=0 | w=31
  295. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:primary undifferentiated large cell carcinoma
    n1=en:adamantinoma | n2=en:primary undifferentiated large cell carcinoma | rel=r_associated | relid=0 | w=31
  296. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=31
  297. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:sarcomatoid mesothelioma
    n1=en:adamantinoma | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=31
  298. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:sarcomatoid transitional cell carcinoma
    n1=en:adamantinoma | n2=en:sarcomatoid transitional cell carcinoma | rel=r_associated | relid=0 | w=31
  299. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:secondary osteosarcoma
    n1=en:adamantinoma | n2=en:secondary osteosarcoma | rel=r_associated | relid=0 | w=31
  300. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements
    n1=en:adamantinoma | n2=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | rel=r_associated | relid=0 | w=31
  301. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:small cell carcinoma
    n1=en:adamantinoma | n2=en:small cell carcinoma | rel=r_associated | relid=0 | w=31
  302. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:thyroid gland spindle cell tumor with thymus-like differentiation
    n1=en:adamantinoma | n2=en:thyroid gland spindle cell tumor with thymus-like differentiation | rel=r_associated | relid=0 | w=31
  303. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:type b spindle cell melanoma
    n1=en:adamantinoma | n2=en:type b spindle cell melanoma | rel=r_associated | relid=0 | w=31
  304. en:adamantinoma -- r_associated #0: 31 / 0.13 -> en:verrucous carcinoma
    n1=en:adamantinoma | n2=en:verrucous carcinoma | rel=r_associated | relid=0 | w=31
  305. en:adamantinoma -- r_associated #0: 30 / 0.126 -> adamantinome des os longs
    n1=en:adamantinoma | n2=adamantinome des os longs | rel=r_associated | relid=0 | w=30
  306. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:basaloid carcinoma
    n1=en:adamantinoma | n2=en:basaloid carcinoma | rel=r_associated | relid=0 | w=30
  307. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:biphasic mesothelioma
    n1=en:adamantinoma | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=30
  308. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:bone glomus tumor
    n1=en:adamantinoma | n2=en:bone glomus tumor | rel=r_associated | relid=0 | w=30
  309. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:carcinoid tumor
    n1=en:adamantinoma | n2=en:carcinoid tumor | rel=r_associated | relid=0 | w=30
  310. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:carcinoma of lip, oral cavity and pharynx
    n1=en:adamantinoma | n2=en:carcinoma of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=30
  311. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:clinical data interchange standards consortium terminology
    n1=en:adamantinoma | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=30
  312. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:encapsulated papillary carcinoma with invasion
    n1=en:adamantinoma | n2=en:encapsulated papillary carcinoma with invasion | rel=r_associated | relid=0 | w=30
  313. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:epithelioid cell melanoma
    n1=en:adamantinoma | n2=en:epithelioid cell melanoma | rel=r_associated | relid=0 | w=30
  314. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:fibrosarcoma of connective tissue
    n1=en:adamantinoma | n2=en:fibrosarcoma of connective tissue | rel=r_associated | relid=0 | w=30
  315. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:gain of chromosome 19
    n1=en:adamantinoma | n2=en:gain of chromosome 19 | rel=r_associated | relid=0 | w=30
  316. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:idiopathic hypereosinophilic syndrome
    n1=en:adamantinoma | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=30
  317. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:in cerebrospinal fluid
    n1=en:adamantinoma | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=30
  318. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:indolent clinical course
    n1=en:adamantinoma | n2=en:indolent clinical course | rel=r_associated | relid=0 | w=30
  319. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:intermediate bone neoplasm
    n1=en:adamantinoma | n2=en:intermediate bone neoplasm | rel=r_associated | relid=0 | w=30
  320. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:large cell carcinoma
    n1=en:adamantinoma | n2=en:large cell carcinoma | rel=r_associated | relid=0 | w=30
  321. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:large cell lung carcinoma with rhabdoid phenotype
    n1=en:adamantinoma | n2=en:large cell lung carcinoma with rhabdoid phenotype | rel=r_associated | relid=0 | w=30
  322. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:leiomyosarcoma
    n1=en:adamantinoma | n2=en:leiomyosarcoma | rel=r_associated | relid=0 | w=30
  323. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:lymphangiosarcoma
    n1=en:adamantinoma | n2=en:lymphangiosarcoma | rel=r_associated | relid=0 | w=30
  324. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant epithelial neoplasm - category
    n1=en:adamantinoma | n2=en:malignant epithelial neoplasm - category | rel=r_associated | relid=0 | w=30
  325. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant glomus tumor
    n1=en:adamantinoma | n2=en:malignant glomus tumor | rel=r_associated | relid=0 | w=30
  326. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant immunoproliferative disease (clinical)
    n1=en:adamantinoma | n2=en:malignant immunoproliferative disease (clinical) | rel=r_associated | relid=0 | w=30
  327. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant neoplasm of hand bones
    n1=en:adamantinoma | n2=en:malignant neoplasm of hand bones | rel=r_associated | relid=0 | w=30
  328. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant neuroendocrine neoplasm, neural
    n1=en:adamantinoma | n2=en:malignant neuroendocrine neoplasm, neural | rel=r_associated | relid=0 | w=30
  329. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant odontogenic neoplasm
    n1=en:adamantinoma | n2=en:malignant odontogenic neoplasm | rel=r_associated | relid=0 | w=30
  330. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant sertoli cell tumor
    n1=en:adamantinoma | n2=en:malignant sertoli cell tumor | rel=r_associated | relid=0 | w=30
  331. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant spindle cell neoplasm
    n1=en:adamantinoma | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=30
  332. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:malignant thymoma
    n1=en:adamantinoma | n2=en:malignant thymoma | rel=r_associated | relid=0 | w=30
  333. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:mesenchymal chondrosarcoma
    n1=en:adamantinoma | n2=en:mesenchymal chondrosarcoma | rel=r_associated | relid=0 | w=30
  334. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:mesonephric adenocarcinoma
    n1=en:adamantinoma | n2=en:mesonephric adenocarcinoma | rel=r_associated | relid=0 | w=30
  335. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:metabolic aspects
    n1=en:adamantinoma | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=30
  336. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:metastasis to lymph node from squamous cell carcinoma
    n1=en:adamantinoma | n2=en:metastasis to lymph node from squamous cell carcinoma | rel=r_associated | relid=0 | w=30
  337. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:microbiological
    n1=en:adamantinoma | n2=en:microbiological | rel=r_associated | relid=0 | w=30
  338. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:mixed epithelioid and spindle cell melanoma
    n1=en:adamantinoma | n2=en:mixed epithelioid and spindle cell melanoma | rel=r_associated | relid=0 | w=30
  339. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:neoplastic smooth muscle cell
    n1=en:adamantinoma | n2=en:neoplastic smooth muscle cell | rel=r_associated | relid=0 | w=30
  340. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:non-hodgkin's lymphoma of bone
    n1=en:adamantinoma | n2=en:non-hodgkin's lymphoma of bone | rel=r_associated | relid=0 | w=30
  341. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:oligodendroglioma
    n1=en:adamantinoma | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=30
  342. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:osteofibrous dysplasia
    n1=en:adamantinoma | n2=en:osteofibrous dysplasia | rel=r_associated | relid=0 | w=30
  343. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:osteogenic/miscellaneous bone tumors (all subtypes)
    n1=en:adamantinoma | n2=en:osteogenic/miscellaneous bone tumors (all subtypes) | rel=r_associated | relid=0 | w=30
  344. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:osteoma
    n1=en:adamantinoma | n2=en:osteoma | rel=r_associated | relid=0 | w=30
  345. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:papillary transitional cell carcinoma
    n1=en:adamantinoma | n2=en:papillary transitional cell carcinoma | rel=r_associated | relid=0 | w=30
  346. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:primary malignant neoplasm of back
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of back | rel=r_associated | relid=0 | w=30
  347. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:primary malignant neoplasm of bone of upper limb
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of bone of upper limb | rel=r_associated | relid=0 | w=30
  348. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:primary malignant neoplasm of endocrine gland
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of endocrine gland | rel=r_associated | relid=0 | w=30
  349. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:primary malignant neoplasm of lower limb
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=30
  350. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:primitive neuroectodermal tumor
    n1=en:adamantinoma | n2=en:primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=30
  351. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:prolymphocytic lymphosarcoma
    n1=en:adamantinoma | n2=en:prolymphocytic lymphosarcoma | rel=r_associated | relid=0 | w=30
  352. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:refractory anemia with ring sideroblasts
    n1=en:adamantinoma | n2=en:refractory anemia with ring sideroblasts | rel=r_associated | relid=0 | w=30
  353. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:small cell intermediate cell carcinoma
    n1=en:adamantinoma | n2=en:small cell intermediate cell carcinoma | rel=r_associated | relid=0 | w=30
  354. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:small cell sarcoma
    n1=en:adamantinoma | n2=en:small cell sarcoma | rel=r_associated | relid=0 | w=30
  355. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:stage i bone cancer
    n1=en:adamantinoma | n2=en:stage i bone cancer | rel=r_associated | relid=0 | w=30
  356. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:stage iii bone cancer
    n1=en:adamantinoma | n2=en:stage iii bone cancer | rel=r_associated | relid=0 | w=30
  357. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:swelling
    n1=en:adamantinoma | n2=en:swelling | rel=r_associated | relid=0 | w=30
  358. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:t lymphoblastic leukemia/lymphoma
    n1=en:adamantinoma | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=30
  359. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:thyroid gland carcinoma showing thymus-like differentiation
    n1=en:adamantinoma | n2=en:thyroid gland carcinoma showing thymus-like differentiation | rel=r_associated | relid=0 | w=30
  360. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:tibial adamantinoma
    n1=en:adamantinoma | n2=en:tibial adamantinoma | rel=r_associated | relid=0 | w=30
  361. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:vaccine-induced fibrosarcoma
    n1=en:adamantinoma | n2=en:vaccine-induced fibrosarcoma | rel=r_associated | relid=0 | w=30
  362. en:adamantinoma -- r_associated #0: 30 / 0.126 -> en:viruses
    n1=en:adamantinoma | n2=en:viruses | rel=r_associated | relid=0 | w=30
  363. en:adamantinoma -- r_associated #0: 30 / 0.126 -> pathologie du système ostéoarticulaire
    n1=en:adamantinoma | n2=pathologie du système ostéoarticulaire | rel=r_associated | relid=0 | w=30
  364. en:adamantinoma -- r_associated #0: 29 / 0.121 -> améloblastome, sai
    n1=en:adamantinoma | n2=améloblastome, sai | rel=r_associated | relid=0 | w=29
  365. en:adamantinoma -- r_associated #0: 29 / 0.121 -> cellule épithéliale
    n1=en:adamantinoma | n2=cellule épithéliale | rel=r_associated | relid=0 | w=29
  366. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:acinar cell carcinoma
    n1=en:adamantinoma | n2=en:acinar cell carcinoma | rel=r_associated | relid=0 | w=29
  367. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:adenoma
    n1=en:adamantinoma | n2=en:adenoma | rel=r_associated | relid=0 | w=29
  368. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:adnexal carcinoma
    n1=en:adamantinoma | n2=en:adnexal carcinoma | rel=r_associated | relid=0 | w=29
  369. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:alpha heavy chain disease
    n1=en:adamantinoma | n2=en:alpha heavy chain disease | rel=r_associated | relid=0 | w=29
  370. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:anaplastic ganglioglioma
    n1=en:adamantinoma | n2=en:anaplastic ganglioglioma | rel=r_associated | relid=0 | w=29
  371. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:atypical medullary carcinoma
    n1=en:adamantinoma | n2=en:atypical medullary carcinoma | rel=r_associated | relid=0 | w=29
  372. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:chondroblastoma, malignant
    n1=en:adamantinoma | n2=en:chondroblastoma, malignant | rel=r_associated | relid=0 | w=29
  373. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:chronic myelomonocytic leukemia
    n1=en:adamantinoma | n2=en:chronic myelomonocytic leukemia | rel=r_associated | relid=0 | w=29
  374. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:clear cell chondrosarcoma
    n1=en:adamantinoma | n2=en:clear cell chondrosarcoma | rel=r_associated | relid=0 | w=29
  375. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:composite hodgkin and non-hodgkin lymphoma
    n1=en:adamantinoma | n2=en:composite hodgkin and non-hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  376. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:endometrioid tumor
    n1=en:adamantinoma | n2=en:endometrioid tumor | rel=r_associated | relid=0 | w=29
  377. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:epithelial component present
    n1=en:adamantinoma | n2=en:epithelial component present | rel=r_associated | relid=0 | w=29
  378. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:ganglioneuroblastoma
    n1=en:adamantinoma | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=29
  379. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:giant cell and spindle cell carcinoma
    n1=en:adamantinoma | n2=en:giant cell and spindle cell carcinoma | rel=r_associated | relid=0 | w=29
  380. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:giant cell sarcoma (except of bone, m-92503)
    n1=en:adamantinoma | n2=en:giant cell sarcoma (except of bone, m-92503) | rel=r_associated | relid=0 | w=29
  381. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:granulocytic sarcoma
    n1=en:adamantinoma | n2=en:granulocytic sarcoma | rel=r_associated | relid=0 | w=29
  382. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:hodgkin lymphoma
    n1=en:adamantinoma | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=29
  383. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:infiltrating duct mixed with other types of carcinoma
    n1=en:adamantinoma | n2=en:infiltrating duct mixed with other types of carcinoma | rel=r_associated | relid=0 | w=29
  384. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:infiltrating lobular mixed with other types of carcinoma
    n1=en:adamantinoma | n2=en:infiltrating lobular mixed with other types of carcinoma | rel=r_associated | relid=0 | w=29
  385. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:leiomyoma
    n1=en:adamantinoma | n2=en:leiomyoma | rel=r_associated | relid=0 | w=29
  386. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant blood vessel neoplasm
    n1=en:adamantinoma | n2=en:malignant blood vessel neoplasm | rel=r_associated | relid=0 | w=29
  387. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant bone marrow neoplasm
    n1=en:adamantinoma | n2=en:malignant bone marrow neoplasm | rel=r_associated | relid=0 | w=29
  388. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant carotid body paraganglioma
    n1=en:adamantinoma | n2=en:malignant carotid body paraganglioma | rel=r_associated | relid=0 | w=29
  389. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant neoplasm of bone of lower limb
    n1=en:adamantinoma | n2=en:malignant neoplasm of bone of lower limb | rel=r_associated | relid=0 | w=29
  390. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant neoplasm of long bones of lower limb
    n1=en:adamantinoma | n2=en:malignant neoplasm of long bones of lower limb | rel=r_associated | relid=0 | w=29
  391. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant neoplasm of vertebral column, excluding sacrum and coccyx
    n1=en:adamantinoma | n2=en:malignant neoplasm of vertebral column, excluding sacrum and coccyx | rel=r_associated | relid=0 | w=29
  392. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant ossifying fibromyxoid tumor
    n1=en:adamantinoma | n2=en:malignant ossifying fibromyxoid tumor | rel=r_associated | relid=0 | w=29
  393. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant peripheral nerve sheath tumor
    n1=en:adamantinoma | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=29
  394. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant triton tumor
    n1=en:adamantinoma | n2=en:malignant triton tumor | rel=r_associated | relid=0 | w=29
  395. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant trophoblastic teratoma
    n1=en:adamantinoma | n2=en:malignant trophoblastic teratoma | rel=r_associated | relid=0 | w=29
  396. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:malignant type b1 thymoma
    n1=en:adamantinoma | n2=en:malignant type b1 thymoma | rel=r_associated | relid=0 | w=29
  397. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:melanoma arising from blue nevus
    n1=en:adamantinoma | n2=en:melanoma arising from blue nevus | rel=r_associated | relid=0 | w=29
  398. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:meningeal melanomatosis
    n1=en:adamantinoma | n2=en:meningeal melanomatosis | rel=r_associated | relid=0 | w=29
  399. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:mucin-producing adenocarcinoma
    n1=en:adamantinoma | n2=en:mucin-producing adenocarcinoma | rel=r_associated | relid=0 | w=29
  400. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:myelodysplastic syndrome with isolated del(5q)
    n1=en:adamantinoma | n2=en:myelodysplastic syndrome with isolated del(5q) | rel=r_associated | relid=0 | w=29
  401. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:myelodysplastic syndrome, no icd-o subtype
    n1=en:adamantinoma | n2=en:myelodysplastic syndrome, no icd-o subtype | rel=r_associated | relid=0 | w=29
  402. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:myosarcoma
    n1=en:adamantinoma | n2=en:myosarcoma | rel=r_associated | relid=0 | w=29
  403. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:neoplastic sex cord-stromal cell
    n1=en:adamantinoma | n2=en:neoplastic sex cord-stromal cell | rel=r_associated | relid=0 | w=29
  404. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:neuroblastoma
    n1=en:adamantinoma | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=29
  405. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:nodular melanoma
    n1=en:adamantinoma | n2=en:nodular melanoma | rel=r_associated | relid=0 | w=29
  406. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:overlapping malignant neoplasm of bone and articular cartilage of limbs
    n1=en:adamantinoma | n2=en:overlapping malignant neoplasm of bone and articular cartilage of limbs | rel=r_associated | relid=0 | w=29
  407. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:peripheral primitive neuroectodermal tumor
    n1=en:adamantinoma | n2=en:peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=29
  408. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:pilomatrical carcinoma
    n1=en:adamantinoma | n2=en:pilomatrical carcinoma | rel=r_associated | relid=0 | w=29
  409. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:polyembryoma
    n1=en:adamantinoma | n2=en:polyembryoma | rel=r_associated | relid=0 | w=29
  410. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:poorly differentiated carcinoma
    n1=en:adamantinoma | n2=en:poorly differentiated carcinoma | rel=r_associated | relid=0 | w=29
  411. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:primary malignant neoplasm of ear, nose and/or throat
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of ear, nose and/or throat | rel=r_associated | relid=0 | w=29
  412. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:primary malignant neoplasm of sweat gland
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of sweat gland | rel=r_associated | relid=0 | w=29
  413. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:primary malignant neoplasm of upper limb (disorder)
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of upper limb (disorder) | rel=r_associated | relid=0 | w=29
  414. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:primary myelofibrosis
    n1=en:adamantinoma | n2=en:primary myelofibrosis | rel=r_associated | relid=0 | w=29
  415. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:reactive immunoproliferative disease
    n1=en:adamantinoma | n2=en:reactive immunoproliferative disease | rel=r_associated | relid=0 | w=29
  416. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:skin nodular basal cell carcinoma
    n1=en:adamantinoma | n2=en:skin nodular basal cell carcinoma | rel=r_associated | relid=0 | w=29
  417. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:spiradenocarcinoma
    n1=en:adamantinoma | n2=en:spiradenocarcinoma | rel=r_associated | relid=0 | w=29
  418. en:adamantinoma -- r_associated #0: 29 / 0.121 -> en:synovial sarcoma - category
    n1=en:adamantinoma | n2=en:synovial sarcoma - category | rel=r_associated | relid=0 | w=29
  419. en:adamantinoma -- r_associated #0: 29 / 0.121 -> ostéo-fibrodysplasie de Campanacci
    n1=en:adamantinoma | n2=ostéo-fibrodysplasie de Campanacci | rel=r_associated | relid=0 | w=29
  420. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:adamantinoma of long bone of lower limb
    n1=en:adamantinoma | n2=en:adamantinoma of long bone of lower limb | rel=r_associated | relid=0 | w=28
  421. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:alveolar rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:alveolar rhabdomyosarcoma | rel=r_associated | relid=0 | w=28
  422. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:anal canal cloacogenic carcinoma
    n1=en:adamantinoma | n2=en:anal canal cloacogenic carcinoma | rel=r_associated | relid=0 | w=28
  423. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:balloon cell melanoma
    n1=en:adamantinoma | n2=en:balloon cell melanoma | rel=r_associated | relid=0 | w=28
  424. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:bone sarcoma
    n1=en:adamantinoma | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=28
  425. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:carcinoma with osteoclast-like giant cells
    n1=en:adamantinoma | n2=en:carcinoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=28
  426. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:carcinomatosis
    n1=en:adamantinoma | n2=en:carcinomatosis | rel=r_associated | relid=0 | w=28
  427. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:conventional osteosarcoma
    n1=en:adamantinoma | n2=en:conventional osteosarcoma | rel=r_associated | relid=0 | w=28
  428. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:dedifferentiated chondrosarcoma
    n1=en:adamantinoma | n2=en:dedifferentiated chondrosarcoma | rel=r_associated | relid=0 | w=28
  429. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:digital papillary eccrine carcinoma
    n1=en:adamantinoma | n2=en:digital papillary eccrine carcinoma | rel=r_associated | relid=0 | w=28
  430. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:duct carcinoma, desmoplastic type
    n1=en:adamantinoma | n2=en:duct carcinoma, desmoplastic type | rel=r_associated | relid=0 | w=28
  431. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:embryonal rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:embryonal rhabdomyosarcoma | rel=r_associated | relid=0 | w=28
  432. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:epithelial skin neoplasm
    n1=en:adamantinoma | n2=en:epithelial skin neoplasm | rel=r_associated | relid=0 | w=28
  433. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:esthesioneurocytoma
    n1=en:adamantinoma | n2=en:esthesioneurocytoma | rel=r_associated | relid=0 | w=28
  434. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:follicular dendritic cell sarcoma
    n1=en:adamantinoma | n2=en:follicular dendritic cell sarcoma | rel=r_associated | relid=0 | w=28
  435. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:gain of chromosome 7
    n1=en:adamantinoma | n2=en:gain of chromosome 7 | rel=r_associated | relid=0 | w=28
  436. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:glioblastoma
    n1=en:adamantinoma | n2=en:glioblastoma | rel=r_associated | relid=0 | w=28
  437. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:high grade surface osteosarcoma
    n1=en:adamantinoma | n2=en:high grade surface osteosarcoma | rel=r_associated | relid=0 | w=28
  438. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:hypereosinophilic syndrome
    n1=en:adamantinoma | n2=en:hypereosinophilic syndrome | rel=r_associated | relid=0 | w=28
  439. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:infiltrating carcinoma with ductal and lobular features
    n1=en:adamantinoma | n2=en:infiltrating carcinoma with ductal and lobular features | rel=r_associated | relid=0 | w=28
  440. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:intraepithelial neoplasia
    n1=en:adamantinoma | n2=en:intraepithelial neoplasia | rel=r_associated | relid=0 | w=28
  441. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:invasive ductal carcinoma, not otherwise specified
    n1=en:adamantinoma | n2=en:invasive ductal carcinoma, not otherwise specified | rel=r_associated | relid=0 | w=28
  442. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:lentigo maligna melanoma
    n1=en:adamantinoma | n2=en:lentigo maligna melanoma | rel=r_associated | relid=0 | w=28
  443. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:leukemia
    n1=en:adamantinoma | n2=en:leukemia | rel=r_associated | relid=0 | w=28
  444. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:leukemia (category)
    n1=en:adamantinoma | n2=en:leukemia (category) | rel=r_associated | relid=0 | w=28
  445. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant cell
    n1=en:adamantinoma | n2=en:malignant cell | rel=r_associated | relid=0 | w=28
  446. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant granulosa cell tumor
    n1=en:adamantinoma | n2=en:malignant granulosa cell tumor | rel=r_associated | relid=0 | w=28
  447. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant mixed tumor, carcinomatous type
    n1=en:adamantinoma | n2=en:malignant mixed tumor, carcinomatous type | rel=r_associated | relid=0 | w=28
  448. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant neoplasm of lower jaw bone
    n1=en:adamantinoma | n2=en:malignant neoplasm of lower jaw bone | rel=r_associated | relid=0 | w=28
  449. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant neoplasm of nail apparatus
    n1=en:adamantinoma | n2=en:malignant neoplasm of nail apparatus | rel=r_associated | relid=0 | w=28
  450. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant neoplasm, overlapping lesion of digestive system
    n1=en:adamantinoma | n2=en:malignant neoplasm, overlapping lesion of digestive system | rel=r_associated | relid=0 | w=28
  451. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant ovarian brenner tumor
    n1=en:adamantinoma | n2=en:malignant ovarian brenner tumor | rel=r_associated | relid=0 | w=28
  452. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:malignant pecoma
    n1=en:adamantinoma | n2=en:malignant pecoma | rel=r_associated | relid=0 | w=28
  453. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:mast cell malignancy
    n1=en:adamantinoma | n2=en:mast cell malignancy | rel=r_associated | relid=0 | w=28
  454. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:medullary carcinoma with lymphoid stroma
    n1=en:adamantinoma | n2=en:medullary carcinoma with lymphoid stroma | rel=r_associated | relid=0 | w=28
  455. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:melanoma
    n1=en:adamantinoma | n2=en:melanoma | rel=r_associated | relid=0 | w=28
  456. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:metastasis to lymph node from adenocarcinoma
    n1=en:adamantinoma | n2=en:metastasis to lymph node from adenocarcinoma | rel=r_associated | relid=0 | w=28
  457. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:metastatic carcinoma
    n1=en:adamantinoma | n2=en:metastatic carcinoma | rel=r_associated | relid=0 | w=28
  458. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:mixed type rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:mixed type rhabdomyosarcoma | rel=r_associated | relid=0 | w=28
  459. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:myeloproliferative neoplasm
    n1=en:adamantinoma | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=28
  460. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:nonseminomatous germ cell tumor
    n1=en:adamantinoma | n2=en:nonseminomatous germ cell tumor | rel=r_associated | relid=0 | w=28
  461. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:overlapping malignant neoplasm of ill-defined site
    n1=en:adamantinoma | n2=en:overlapping malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=28
  462. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:plasma cell myeloma/plasmacytoma
    n1=en:adamantinoma | n2=en:plasma cell myeloma/plasmacytoma | rel=r_associated | relid=0 | w=28
  463. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:pleuropulmonary blastoma
    n1=en:adamantinoma | n2=en:pleuropulmonary blastoma | rel=r_associated | relid=0 | w=28
  464. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:primary malignant neoplasm of sacrum
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of sacrum | rel=r_associated | relid=0 | w=28
  465. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:primary malignant neoplasm of scapula (disorder)
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of scapula (disorder) | rel=r_associated | relid=0 | w=28
  466. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:primary malignant neoplasm of soft tissues
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=28
  467. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:sarcomatoid carcinoma
    n1=en:adamantinoma | n2=en:sarcomatoid carcinoma | rel=r_associated | relid=0 | w=28
  468. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:sarcomatoid squamous cell carcinoma
    n1=en:adamantinoma | n2=en:sarcomatoid squamous cell carcinoma | rel=r_associated | relid=0 | w=28
  469. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:skin basosquamous cell carcinoma
    n1=en:adamantinoma | n2=en:skin basosquamous cell carcinoma | rel=r_associated | relid=0 | w=28
  470. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:solid pseudopapillary carcinoma
    n1=en:adamantinoma | n2=en:solid pseudopapillary carcinoma | rel=r_associated | relid=0 | w=28
  471. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:spindle cell rhabdomyosarcoma
    n1=en:adamantinoma | n2=en:spindle cell rhabdomyosarcoma | rel=r_associated | relid=0 | w=28
  472. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:spongioneuroblastoma
    n1=en:adamantinoma | n2=en:spongioneuroblastoma | rel=r_associated | relid=0 | w=28
  473. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:thymic carcinoma
    n1=en:adamantinoma | n2=en:thymic carcinoma | rel=r_associated | relid=0 | w=28
  474. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:thymoma
    n1=en:adamantinoma | n2=en:thymoma | rel=r_associated | relid=0 | w=28
  475. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:tumorlet
    n1=en:adamantinoma | n2=en:tumorlet | rel=r_associated | relid=0 | w=28
  476. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:type a spindle cell melanoma
    n1=en:adamantinoma | n2=en:type a spindle cell melanoma | rel=r_associated | relid=0 | w=28
  477. en:adamantinoma -- r_associated #0: 28 / 0.117 -> en:undifferentiated (embryonal) sarcoma
    n1=en:adamantinoma | n2=en:undifferentiated (embryonal) sarcoma | rel=r_associated | relid=0 | w=28
  478. en:adamantinoma -- r_associated #0: 27 / 0.113 -> améloblastome à cellules granuleuses
    n1=en:adamantinoma | n2=améloblastome à cellules granuleuses | rel=r_associated | relid=0 | w=27
  479. en:adamantinoma -- r_associated #0: 27 / 0.113 -> cancer
    n1=en:adamantinoma | n2=cancer | rel=r_associated | relid=0 | w=27
  480. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:acral lentiginous melanoma
    n1=en:adamantinoma | n2=en:acral lentiginous melanoma | rel=r_associated | relid=0 | w=27
  481. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:adamantinoma of femur
    n1=en:adamantinoma | n2=en:adamantinoma of femur | rel=r_associated | relid=0 | w=27
  482. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:alveolar soft part sarcoma
    n1=en:adamantinoma | n2=en:alveolar soft part sarcoma | rel=r_associated | relid=0 | w=27
  483. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:amelanotic melanoma
    n1=en:adamantinoma | n2=en:amelanotic melanoma | rel=r_associated | relid=0 | w=27
  484. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:benign epithelial neoplasm
    n1=en:adamantinoma | n2=en:benign epithelial neoplasm | rel=r_associated | relid=0 | w=27
  485. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:benign epithelial neoplasm - category
    n1=en:adamantinoma | n2=en:benign epithelial neoplasm - category | rel=r_associated | relid=0 | w=27
  486. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:carcinofibroma
    n1=en:adamantinoma | n2=en:carcinofibroma | rel=r_associated | relid=0 | w=27
  487. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:carcinoma of bone, connective tissue, skin and breast
    n1=en:adamantinoma | n2=en:carcinoma of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=27
  488. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:cdisc send terminology
    n1=en:adamantinoma | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=27
  489. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:clear cell sarcoma of the kidney
    n1=en:adamantinoma | n2=en:clear cell sarcoma of the kidney | rel=r_associated | relid=0 | w=27
  490. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:cystic partially differentiated nephroblastoma
    n1=en:adamantinoma | n2=en:cystic partially differentiated nephroblastoma | rel=r_associated | relid=0 | w=27
  491. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:ectomesenchymoma
    n1=en:adamantinoma | n2=en:ectomesenchymoma | rel=r_associated | relid=0 | w=27
  492. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:endocrine neoplasm
    n1=en:adamantinoma | n2=en:endocrine neoplasm | rel=r_associated | relid=0 | w=27
  493. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:endolymphatic sac tumor
    n1=en:adamantinoma | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=27
  494. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:epithelioid sarcoma
    n1=en:adamantinoma | n2=en:epithelioid sarcoma | rel=r_associated | relid=0 | w=27
  495. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:extramammary paget disease
    n1=en:adamantinoma | n2=en:extramammary paget disease | rel=r_associated | relid=0 | w=27
  496. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:follicular dendritic sarcoma of lymph nodes of multiple sites
    n1=en:adamantinoma | n2=en:follicular dendritic sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=27
  497. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:gain of chromosome 12
    n1=en:adamantinoma | n2=en:gain of chromosome 12 | rel=r_associated | relid=0 | w=27
  498. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:histiocytoma
    n1=en:adamantinoma | n2=en:histiocytoma | rel=r_associated | relid=0 | w=27
  499. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:infantile fibrosarcoma
    n1=en:adamantinoma | n2=en:infantile fibrosarcoma | rel=r_associated | relid=0 | w=27
  500. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:local recurrence of malignant tumor of bone
    n1=en:adamantinoma | n2=en:local recurrence of malignant tumor of bone | rel=r_associated | relid=0 | w=27
  501. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant extra-adrenal paraganglioma
    n1=en:adamantinoma | n2=en:malignant extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=27
  502. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant glioma
    n1=en:adamantinoma | n2=en:malignant glioma | rel=r_associated | relid=0 | w=27
  503. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant histiocytosis
    n1=en:adamantinoma | n2=en:malignant histiocytosis | rel=r_associated | relid=0 | w=27
  504. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant leydig cell tumor
    n1=en:adamantinoma | n2=en:malignant leydig cell tumor | rel=r_associated | relid=0 | w=27
  505. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant melanoma in precancerous melanosis
    n1=en:adamantinoma | n2=en:malignant melanoma in precancerous melanosis | rel=r_associated | relid=0 | w=27
  506. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant neoplasm of bones of skull and face
    n1=en:adamantinoma | n2=en:malignant neoplasm of bones of skull and face | rel=r_associated | relid=0 | w=27
  507. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant tenosynovial giant cell tumor
    n1=en:adamantinoma | n2=en:malignant tenosynovial giant cell tumor | rel=r_associated | relid=0 | w=27
  508. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant tumor, small cell type
    n1=en:adamantinoma | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=27
  509. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:malignant type ab thymoma
    n1=en:adamantinoma | n2=en:malignant type ab thymoma | rel=r_associated | relid=0 | w=27
  510. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:mesothelioma (malignant, clinical disorder) (disorder)
    n1=en:adamantinoma | n2=en:mesothelioma (malignant, clinical disorder) (disorder) | rel=r_associated | relid=0 | w=27
  511. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:metaplastic carcinoma
    n1=en:adamantinoma | n2=en:metaplastic carcinoma | rel=r_associated | relid=0 | w=27
  512. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:mixed glioma
    n1=en:adamantinoma | n2=en:mixed glioma | rel=r_associated | relid=0 | w=27
  513. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:myxosarcoma
    n1=en:adamantinoma | n2=en:myxosarcoma | rel=r_associated | relid=0 | w=27
  514. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:ncit neoplasm core terminology
    n1=en:adamantinoma | n2=en:ncit neoplasm core terminology | rel=r_associated | relid=0 | w=27
  515. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:neoplastic epithelial cell
    n1=en:adamantinoma | n2=en:neoplastic epithelial cell | rel=r_associated | relid=0 | w=27
  516. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:non-small cell carcinoma
    n1=en:adamantinoma | n2=en:non-small cell carcinoma | rel=r_associated | relid=0 | w=27
  517. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:overlapping malignant neoplasm of gastrointestinal tract
    n1=en:adamantinoma | n2=en:overlapping malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=27
  518. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:pancreatoblastoma
    n1=en:adamantinoma | n2=en:pancreatoblastoma | rel=r_associated | relid=0 | w=27
  519. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:papillary epithelial neoplasm
    n1=en:adamantinoma | n2=en:papillary epithelial neoplasm | rel=r_associated | relid=0 | w=27
  520. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:polymorphous low grade adenocarcinoma
    n1=en:adamantinoma | n2=en:polymorphous low grade adenocarcinoma | rel=r_associated | relid=0 | w=27
  521. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:primary malignant neoplasm of bone
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of bone | rel=r_associated | relid=0 | w=27
  522. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:primary malignant neoplasm of maxilla (disorder)
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of maxilla (disorder) | rel=r_associated | relid=0 | w=27
  523. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:primary malignant neoplasm of nervous system
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of nervous system | rel=r_associated | relid=0 | w=27
  524. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:refractory anemia with excess blasts in transformation
    n1=en:adamantinoma | n2=en:refractory anemia with excess blasts in transformation | rel=r_associated | relid=0 | w=27
  525. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:sarcoma
    n1=en:adamantinoma | n2=en:sarcoma | rel=r_associated | relid=0 | w=27
  526. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:second primary malignant neoplasm
    n1=en:adamantinoma | n2=en:second primary malignant neoplasm | rel=r_associated | relid=0 | w=27
  527. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:signet ring cell carcinoma
    n1=en:adamantinoma | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=27
  528. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:stage ii bone cancer
    n1=en:adamantinoma | n2=en:stage ii bone cancer | rel=r_associated | relid=0 | w=27
  529. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:steroid cell tumor, malignant
    n1=en:adamantinoma | n2=en:steroid cell tumor, malignant | rel=r_associated | relid=0 | w=27
  530. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:superficial multifocal basal cell carcinoma
    n1=en:adamantinoma | n2=en:superficial multifocal basal cell carcinoma | rel=r_associated | relid=0 | w=27
  531. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:therapy-related myelodysplastic syndrome
    n1=en:adamantinoma | n2=en:therapy-related myelodysplastic syndrome | rel=r_associated | relid=0 | w=27
  532. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:thyroid gland diffuse sclerosing papillary carcinoma
    n1=en:adamantinoma | n2=en:thyroid gland diffuse sclerosing papillary carcinoma | rel=r_associated | relid=0 | w=27
  533. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:tp53 gene inactivation
    n1=en:adamantinoma | n2=en:tp53 gene inactivation | rel=r_associated | relid=0 | w=27
  534. en:adamantinoma -- r_associated #0: 27 / 0.113 -> en:trichilemmocarcinoma
    n1=en:adamantinoma | n2=en:trichilemmocarcinoma | rel=r_associated | relid=0 | w=27
  535. en:adamantinoma -- r_associated #0: 27 / 0.113 -> pathologie ostéo-articulaire
    n1=en:adamantinoma | n2=pathologie ostéo-articulaire | rel=r_associated | relid=0 | w=27
  536. en:adamantinoma -- r_associated #0: 26 / 0.109 -> améloblastomes
    n1=en:adamantinoma | n2=améloblastomes | rel=r_associated | relid=0 | w=26
  537. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:adamantinoma of long bones
    n1=en:adamantinoma | n2=en:adamantinoma of long bones | rel=r_associated | relid=0 | w=26
  538. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:adenocarcinoma in villous adenoma
    n1=en:adamantinoma | n2=en:adenocarcinoma in villous adenoma | rel=r_associated | relid=0 | w=26
  539. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:angiomyoliposarcoma
    n1=en:adamantinoma | n2=en:angiomyoliposarcoma | rel=r_associated | relid=0 | w=26
  540. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:basal cell neoplasm
    n1=en:adamantinoma | n2=en:basal cell neoplasm | rel=r_associated | relid=0 | w=26
  541. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:bone
    n1=en:adamantinoma | n2=en:bone | rel=r_associated | relid=0 | w=26
  542. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:cdisc send tumor findings results terminology
    n1=en:adamantinoma | n2=en:cdisc send tumor findings results terminology | rel=r_associated | relid=0 | w=26
  543. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:chondroblastic osteosarcoma
    n1=en:adamantinoma | n2=en:chondroblastic osteosarcoma | rel=r_associated | relid=0 | w=26
  544. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:desmoplastic small round cell tumor
    n1=en:adamantinoma | n2=en:desmoplastic small round cell tumor | rel=r_associated | relid=0 | w=26
  545. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:ductal carcinoma
    n1=en:adamantinoma | n2=en:ductal carcinoma | rel=r_associated | relid=0 | w=26
  546. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:embryonal tumor with multilayered rosettes, c19mc-altered
    n1=en:adamantinoma | n2=en:embryonal tumor with multilayered rosettes, c19mc-altered | rel=r_associated | relid=0 | w=26
  547. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:endometrial stromal sarcoma - category
    n1=en:adamantinoma | n2=en:endometrial stromal sarcoma - category | rel=r_associated | relid=0 | w=26
  548. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:epithelial-myoepithelial carcinoma
    n1=en:adamantinoma | n2=en:epithelial-myoepithelial carcinoma | rel=r_associated | relid=0 | w=26
  549. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:ewing sarcoma of bone
    n1=en:adamantinoma | n2=en:ewing sarcoma of bone | rel=r_associated | relid=0 | w=26
  550. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:extrarenal rhabdoid tumor
    n1=en:adamantinoma | n2=en:extrarenal rhabdoid tumor | rel=r_associated | relid=0 | w=26
  551. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:fibroblastic osteosarcoma
    n1=en:adamantinoma | n2=en:fibroblastic osteosarcoma | rel=r_associated | relid=0 | w=26
  552. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:fibrosarcoma
    n1=en:adamantinoma | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=26
  553. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:histiocytic sarcoma
    n1=en:adamantinoma | n2=en:histiocytic sarcoma | rel=r_associated | relid=0 | w=26
  554. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:indolent systemic mastocytosis
    n1=en:adamantinoma | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=26
  555. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:low grade central osteosarcoma
    n1=en:adamantinoma | n2=en:low grade central osteosarcoma | rel=r_associated | relid=0 | w=26
  556. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:low grade serous carcinoma
    n1=en:adamantinoma | n2=en:low grade serous carcinoma | rel=r_associated | relid=0 | w=26
  557. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:lymphosarcoma of lymph nodes of multiple sites
    n1=en:adamantinoma | n2=en:lymphosarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=26
  558. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:malignant neoplasm of scapula and long bones of upper arm
    n1=en:adamantinoma | n2=en:malignant neoplasm of scapula and long bones of upper arm | rel=r_associated | relid=0 | w=26
  559. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:malignant neoplasm of vertebral column
    n1=en:adamantinoma | n2=en:malignant neoplasm of vertebral column | rel=r_associated | relid=0 | w=26
  560. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:malignant sebaceous neoplasm
    n1=en:adamantinoma | n2=en:malignant sebaceous neoplasm | rel=r_associated | relid=0 | w=26
  561. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:malignant tumor, clear cell type
    n1=en:adamantinoma | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=26
  562. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:melanoma in junctional nevus
    n1=en:adamantinoma | n2=en:melanoma in junctional nevus | rel=r_associated | relid=0 | w=26
  563. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:myeloliposarcoma
    n1=en:adamantinoma | n2=en:myeloliposarcoma | rel=r_associated | relid=0 | w=26
  564. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:myxoid leiomyosarcoma
    n1=en:adamantinoma | n2=en:myxoid leiomyosarcoma | rel=r_associated | relid=0 | w=26
  565. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:neoplastic cell
    n1=en:adamantinoma | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=26
  566. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:non-hodgkin lymphoma
    n1=en:adamantinoma | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=26
  567. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:pleomorphic liposarcoma
    n1=en:adamantinoma | n2=en:pleomorphic liposarcoma | rel=r_associated | relid=0 | w=26
  568. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:primary malignant neoplasm of head
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of head | rel=r_associated | relid=0 | w=26
  569. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:primary malignant neoplasm of neck
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of neck | rel=r_associated | relid=0 | w=26
  570. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:regressed germ cell tumor
    n1=en:adamantinoma | n2=en:regressed germ cell tumor | rel=r_associated | relid=0 | w=26
  571. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:rhabdomyoma
    n1=en:adamantinoma | n2=en:rhabdomyoma | rel=r_associated | relid=0 | w=26
  572. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:skin fibroepithelial basal cell carcinoma
    n1=en:adamantinoma | n2=en:skin fibroepithelial basal cell carcinoma | rel=r_associated | relid=0 | w=26
  573. en:adamantinoma -- r_associated #0: 26 / 0.109 -> en:skin infiltrating basal cell carcinoma
    n1=en:adamantinoma | n2=en:skin infiltrating basal cell carcinoma | rel=r_associated | relid=0 | w=26
  574. en:adamantinoma -- r_associated #0: 26 / 0.109 -> Médecine
    n1=en:adamantinoma | n2=Médecine | rel=r_associated | relid=0 | w=26
  575. en:adamantinoma -- r_associated #0: 26 / 0.109 -> médecine
    (science)
    n1=en:adamantinoma | n2=médecine
    (science)
    | rel=r_associated | relid=0 | w=26
  576. en:adamantinoma -- r_associated #0: 25 / 0.105 -> cancérologie
    n1=en:adamantinoma | n2=cancérologie | rel=r_associated | relid=0 | w=25
  577. en:adamantinoma -- r_associated #0: 25 / 0.105 -> carcinologie
    n1=en:adamantinoma | n2=carcinologie | rel=r_associated | relid=0 | w=25
  578. en:adamantinoma -- r_associated #0: 25 / 0.105 -> médecine spécialisée
    n1=en:adamantinoma | n2=médecine spécialisée | rel=r_associated | relid=0 | w=25
  579. en:adamantinoma -- r_associated #0: 25 / 0.105 -> oncologie
    n1=en:adamantinoma | n2=oncologie | rel=r_associated | relid=0 | w=25
  580. en:adamantinoma -- r_associated #0: 25 / 0.105 -> spécialités médicales
    n1=en:adamantinoma | n2=spécialités médicales | rel=r_associated | relid=0 | w=25
  581. en:adamantinoma -- r_associated #0: 25 / 0.105 -> tumeurs
    n1=en:adamantinoma | n2=tumeurs | rel=r_associated | relid=0 | w=25
  582. en:adamantinoma -- r_associated #0: 24 / 0.1 -> kyste odontogène granuleux
    n1=en:adamantinoma | n2=kyste odontogène granuleux | rel=r_associated | relid=0 | w=24
  583. en:adamantinoma -- r_associated #0: 24 / 0.1 -> tumeur odontogène maligne
    n1=en:adamantinoma | n2=tumeur odontogène maligne | rel=r_associated | relid=0 | w=24
  584. en:adamantinoma -- r_associated #0: 23 / 0.096 -> adamantinome, sai (à l'exception des os longs, m-92613)
    n1=en:adamantinoma | n2=adamantinome, sai (à l'exception des os longs, m-92613) | rel=r_associated | relid=0 | w=23
  585. en:adamantinoma -- r_associated #0: 23 / 0.096 -> améloblastome
    n1=en:adamantinoma | n2=améloblastome | rel=r_associated | relid=0 | w=23
  586. en:adamantinoma -- r_associated #0: 23 / 0.096 -> améloblastome unikystique
    n1=en:adamantinoma | n2=améloblastome unikystique | rel=r_associated | relid=0 | w=23
  587. en:adamantinoma -- r_associated #0: 23 / 0.096 -> en:pharmacotherapeutic
    n1=en:adamantinoma | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=23
  588. en:adamantinoma -- r_associated #0: 22 / 0.092 -> en:roentgenographic
    n1=en:adamantinoma | n2=en:roentgenographic | rel=r_associated | relid=0 | w=22
  589. en:adamantinoma -- r_associated #0: 22 / 0.092 -> maladie
    n1=en:adamantinoma | n2=maladie | rel=r_associated | relid=0 | w=22
  590. en:adamantinoma -- r_associated #0: 22 / 0.092 -> pathologie du système ostéo-articulaire
    n1=en:adamantinoma | n2=pathologie du système ostéo-articulaire | rel=r_associated | relid=0 | w=22
  591. en:adamantinoma -- r_associated #0: 21 / 0.088 -> en:connective and soft tissue
    n1=en:adamantinoma | n2=en:connective and soft tissue | rel=r_associated | relid=0 | w=21
  592. en:adamantinoma -- r_associated #0: 21 / 0.088 -> en:parasitology
    n1=en:adamantinoma | n2=en:parasitology | rel=r_associated | relid=0 | w=21
  593. en:adamantinoma -- r_associated #0: 20 / 0.084 -> acral lentiginous melanoma
    n1=en:adamantinoma | n2=acral lentiginous melanoma | rel=r_associated | relid=0 | w=20
  594. en:adamantinoma -- r_associated #0: 20 / 0.084 -> adénocarcinome eccrine
    n1=en:adamantinoma | n2=adénocarcinome eccrine | rel=r_associated | relid=0 | w=20
  595. en:adamantinoma -- r_associated #0: 20 / 0.084 -> adénocarcinome sudoripare
    n1=en:adamantinoma | n2=adénocarcinome sudoripare | rel=r_associated | relid=0 | w=20
  596. en:adamantinoma -- r_associated #0: 20 / 0.084 -> adénome
    n1=en:adamantinoma | n2=adénome | rel=r_associated | relid=0 | w=20
  597. en:adamantinoma -- r_associated #0: 20 / 0.084 -> androblastome malin
    n1=en:adamantinoma | n2=androblastome malin | rel=r_associated | relid=0 | w=20
  598. en:adamantinoma -- r_associated #0: 20 / 0.084 -> arrhénoblastome malin
    n1=en:adamantinoma | n2=arrhénoblastome malin | rel=r_associated | relid=0 | w=20
  599. en:adamantinoma -- r_associated #0: 20 / 0.084 -> balloon cell melanoma
    n1=en:adamantinoma | n2=balloon cell melanoma | rel=r_associated | relid=0 | w=20
  600. en:adamantinoma -- r_associated #0: 20 / 0.084 -> bone
    n1=en:adamantinoma | n2=bone | rel=r_associated | relid=0 | w=20
  601. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cancer des os
    n1=en:adamantinoma | n2=cancer des os | rel=r_associated | relid=0 | w=20
  602. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cancer du sang
    n1=en:adamantinoma | n2=cancer du sang | rel=r_associated | relid=0 | w=20
  603. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cancer épithélial
    n1=en:adamantinoma | n2=cancer épithélial | rel=r_associated | relid=0 | w=20
  604. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cancer in situ
    n1=en:adamantinoma | n2=cancer in situ | rel=r_associated | relid=0 | w=20
  605. en:adamantinoma -- r_associated #0: 20 / 0.084 -> Cancer osseux
    n1=en:adamantinoma | n2=Cancer osseux | rel=r_associated | relid=0 | w=20
  606. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cancer osseux
    n1=en:adamantinoma | n2=cancer osseux | rel=r_associated | relid=0 | w=20
  607. en:adamantinoma -- r_associated #0: 20 / 0.084 -> carcinoma
    n1=en:adamantinoma | n2=carcinoma | rel=r_associated | relid=0 | w=20
  608. en:adamantinoma -- r_associated #0: 20 / 0.084 -> carcinomatose
    n1=en:adamantinoma | n2=carcinomatose | rel=r_associated | relid=0 | w=20
  609. en:adamantinoma -- r_associated #0: 20 / 0.084 -> carcinome
    n1=en:adamantinoma | n2=carcinome | rel=r_associated | relid=0 | w=20
  610. en:adamantinoma -- r_associated #0: 20 / 0.084 -> carcinôme
    n1=en:adamantinoma | n2=carcinôme | rel=r_associated | relid=0 | w=20
  611. en:adamantinoma -- r_associated #0: 20 / 0.084 -> carcinome intra-épithélial
    n1=en:adamantinoma | n2=carcinome intra-épithélial | rel=r_associated | relid=0 | w=20
  612. en:adamantinoma -- r_associated #0: 20 / 0.084 -> cellule tumorale
    n1=en:adamantinoma | n2=cellule tumorale | rel=r_associated | relid=0 | w=20
  613. en:adamantinoma -- r_associated #0: 20 / 0.084 -> chondrome
    n1=en:adamantinoma | n2=chondrome | rel=r_associated | relid=0 | w=20
  614. en:adamantinoma -- r_associated #0: 20 / 0.084 -> chondrosarcome
    n1=en:adamantinoma | n2=chondrosarcome | rel=r_associated | relid=0 | w=20
  615. en:adamantinoma -- r_associated #0: 20 / 0.084 -> chordome
    n1=en:adamantinoma | n2=chordome | rel=r_associated | relid=0 | w=20
  616. en:adamantinoma -- r_associated #0: 20 / 0.084 -> dysgerminome
    n1=en:adamantinoma | n2=dysgerminome | rel=r_associated | relid=0 | w=20
  617. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:« osteogenic » sarcoma
    n1=en:adamantinoma | n2=en:« osteogenic » sarcoma | rel=r_associated | relid=0 | w=20
  618. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:anevrysmal bone cyst
    n1=en:adamantinoma | n2=en:anevrysmal bone cyst | rel=r_associated | relid=0 | w=20
  619. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:bone cancer by ajcc v8 stage
    n1=en:adamantinoma | n2=en:bone cancer by ajcc v8 stage | rel=r_associated | relid=0 | w=20
  620. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:carcinomatosa
    n1=en:adamantinoma | n2=en:carcinomatosa | rel=r_associated | relid=0 | w=20
  621. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:corneal rodent ulcer
    n1=en:adamantinoma | n2=en:corneal rodent ulcer | rel=r_associated | relid=0 | w=20
  622. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:enchondrosarcoma
    n1=en:adamantinoma | n2=en:enchondrosarcoma | rel=r_associated | relid=0 | w=20
  623. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:epithelial carcinoma
    n1=en:adamantinoma | n2=en:epithelial carcinoma | rel=r_associated | relid=0 | w=20
  624. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:fibrocellular tumor
    n1=en:adamantinoma | n2=en:fibrocellular tumor | rel=r_associated | relid=0 | w=20
  625. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:fibroid tumor
    n1=en:adamantinoma | n2=en:fibroid tumor | rel=r_associated | relid=0 | w=20
  626. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:giant-cell tumor
    n1=en:adamantinoma | n2=en:giant-cell tumor | rel=r_associated | relid=0 | w=20
  627. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:heavy chains disease
    n1=en:adamantinoma | n2=en:heavy chains disease | rel=r_associated | relid=0 | w=20
  628. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:in situ cancer
    n1=en:adamantinoma | n2=en:in situ cancer | rel=r_associated | relid=0 | w=20
  629. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:lelomyosarcoma
    n1=en:adamantinoma | n2=en:lelomyosarcoma | rel=r_associated | relid=0 | w=20
  630. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:leucemia
    n1=en:adamantinoma | n2=en:leucemia | rel=r_associated | relid=0 | w=20
  631. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:leukaemia
    n1=en:adamantinoma | n2=en:leukaemia | rel=r_associated | relid=0 | w=20
  632. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:leukocythemia
    n1=en:adamantinoma | n2=en:leukocythemia | rel=r_associated | relid=0 | w=20
  633. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:low grade lesion
    n1=en:adamantinoma | n2=en:low grade lesion | rel=r_associated | relid=0 | w=20
  634. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:lytic bone lesion
    n1=en:adamantinoma | n2=en:lytic bone lesion | rel=r_associated | relid=0 | w=20
  635. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:malignant fibrous histiocytoma
    n1=en:adamantinoma | n2=en:malignant fibrous histiocytoma | rel=r_associated | relid=0 | w=20
  636. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:malignant histiocytoma
    n1=en:adamantinoma | n2=en:malignant histiocytoma | rel=r_associated | relid=0 | w=20
  637. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:malignant neoplasm of mandible
    n1=en:adamantinoma | n2=en:malignant neoplasm of mandible | rel=r_associated | relid=0 | w=20
  638. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:meduloepithelioma
    n1=en:adamantinoma | n2=en:meduloepithelioma | rel=r_associated | relid=0 | w=20
  639. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:metastatic qualifier
    n1=en:adamantinoma | n2=en:metastatic qualifier | rel=r_associated | relid=0 | w=20
  640. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:myeloplaxoma
    n1=en:adamantinoma | n2=en:myeloplaxoma | rel=r_associated | relid=0 | w=20
  641. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:osteoclastoma
    n1=en:adamantinoma | n2=en:osteoclastoma | rel=r_associated | relid=0 | w=20
  642. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:osteoporosis-pseudoglioma syndrome
    n1=en:adamantinoma | n2=en:osteoporosis-pseudoglioma syndrome | rel=r_associated | relid=0 | w=20
  643. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:pain
    n1=en:adamantinoma | n2=en:pain | rel=r_associated | relid=0 | w=20
  644. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:primary malignant neoplasm of mandible
    n1=en:adamantinoma | n2=en:primary malignant neoplasm of mandible | rel=r_associated | relid=0 | w=20
  645. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:sea-blue histiocyte disease
    n1=en:adamantinoma | n2=en:sea-blue histiocyte disease | rel=r_associated | relid=0 | w=20
  646. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:tumentia
    n1=en:adamantinoma | n2=en:tumentia | rel=r_associated | relid=0 | w=20
  647. en:adamantinoma -- r_associated #0: 20 / 0.084 -> en:tumor cell
    n1=en:adamantinoma | n2=en:tumor cell | rel=r_associated | relid=0 | w=20
  648. en:adamantinoma -- r_associated #0: 20 / 0.084 -> enchondrome
    n1=en:adamantinoma | n2=enchondrome | rel=r_associated | relid=0 | w=20
  649. en:adamantinoma -- r_associated #0: 20 / 0.084 -> enflé
    n1=en:adamantinoma | n2=enflé | rel=r_associated | relid=0 | w=20
  650. en:adamantinoma -- r_associated #0: 20 / 0.084 -> enzymologie
    n1=en:adamantinoma | n2=enzymologie | rel=r_associated | relid=0 | w=20
  651. en:adamantinoma -- r_associated #0: 20 / 0.084 -> enzymology
    n1=en:adamantinoma | n2=enzymology | rel=r_associated | relid=0 | w=20
  652. en:adamantinoma -- r_associated #0: 20 / 0.084 -> épidémiologique
    n1=en:adamantinoma | n2=épidémiologique | rel=r_associated | relid=0 | w=20
  653. en:adamantinoma -- r_associated #0: 20 / 0.084 -> épithélioma malin
    n1=en:adamantinoma | n2=épithélioma malin | rel=r_associated | relid=0 | w=20
  654. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ethnologique
    n1=en:adamantinoma | n2=ethnologique | rel=r_associated | relid=0 | w=20
  655. en:adamantinoma -- r_associated #0: 20 / 0.084 -> fibrome
    n1=en:adamantinoma | n2=fibrome | rel=r_associated | relid=0 | w=20
  656. en:adamantinoma -- r_associated #0: 20 / 0.084 -> fibrome ossifiant
    n1=en:adamantinoma | n2=fibrome ossifiant | rel=r_associated | relid=0 | w=20
  657. en:adamantinoma -- r_associated #0: 20 / 0.084 -> fibrosarcome
    n1=en:adamantinoma | n2=fibrosarcome | rel=r_associated | relid=0 | w=20
  658. en:adamantinoma -- r_associated #0: 20 / 0.084 -> fibrosarcome améloblastique
    n1=en:adamantinoma | n2=fibrosarcome améloblastique | rel=r_associated | relid=0 | w=20
  659. en:adamantinoma -- r_associated #0: 20 / 0.084 -> fibroxanthome malin
    n1=en:adamantinoma | n2=fibroxanthome malin | rel=r_associated | relid=0 | w=20
  660. en:adamantinoma -- r_associated #0: 20 / 0.084 -> germinome
    n1=en:adamantinoma | n2=germinome | rel=r_associated | relid=0 | w=20
  661. en:adamantinoma -- r_associated #0: 20 / 0.084 -> gonflement
    n1=en:adamantinoma | n2=gonflement | rel=r_associated | relid=0 | w=20
  662. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytes bleu de mer (maladie des)
    n1=en:adamantinoma | n2=histiocytes bleu de mer (maladie des) | rel=r_associated | relid=0 | w=20
  663. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytofibrome
    n1=en:adamantinoma | n2=histiocytofibrome | rel=r_associated | relid=0 | w=20
  664. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytofibrome malin
    n1=en:adamantinoma | n2=histiocytofibrome malin | rel=r_associated | relid=0 | w=20
  665. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytome
    n1=en:adamantinoma | n2=histiocytome | rel=r_associated | relid=0 | w=20
  666. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytome fibreux malin
    n1=en:adamantinoma | n2=histiocytome fibreux malin | rel=r_associated | relid=0 | w=20
  667. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytome fibreux malin stade non spécifié
    n1=en:adamantinoma | n2=histiocytome fibreux malin stade non spécifié | rel=r_associated | relid=0 | w=20
  668. en:adamantinoma -- r_associated #0: 20 / 0.084 -> histiocytome malin
    n1=en:adamantinoma | n2=histiocytome malin | rel=r_associated | relid=0 | w=20
  669. en:adamantinoma -- r_associated #0: 20 / 0.084 -> hyperéosinophile sanguine idiopathique
    n1=en:adamantinoma | n2=hyperéosinophile sanguine idiopathique | rel=r_associated | relid=0 | w=20
  670. en:adamantinoma -- r_associated #0: 20 / 0.084 -> intumescence
    n1=en:adamantinoma | n2=intumescence | rel=r_associated | relid=0 | w=20
  671. en:adamantinoma -- r_associated #0: 20 / 0.084 -> kyste anévrismal
    n1=en:adamantinoma | n2=kyste anévrismal | rel=r_associated | relid=0 | w=20
  672. en:adamantinoma -- r_associated #0: 20 / 0.084 -> kyste anévrismal des os
    n1=en:adamantinoma | n2=kyste anévrismal des os | rel=r_associated | relid=0 | w=20
  673. en:adamantinoma -- r_associated #0: 20 / 0.084 -> léiomyosarcome
    n1=en:adamantinoma | n2=léiomyosarcome | rel=r_associated | relid=0 | w=20
  674. en:adamantinoma -- r_associated #0: 20 / 0.084 -> leiomyosarcome
    n1=en:adamantinoma | n2=leiomyosarcome | rel=r_associated | relid=0 | w=20
  675. en:adamantinoma -- r_associated #0: 20 / 0.084 -> leucémie
    n1=en:adamantinoma | n2=leucémie | rel=r_associated | relid=0 | w=20
  676. en:adamantinoma -- r_associated #0: 20 / 0.084 -> leucose
    n1=en:adamantinoma | n2=leucose | rel=r_associated | relid=0 | w=20
  677. en:adamantinoma -- r_associated #0: 20 / 0.084 -> lipomyxosarcome
    n1=en:adamantinoma | n2=lipomyxosarcome | rel=r_associated | relid=0 | w=20
  678. en:adamantinoma -- r_associated #0: 20 / 0.084 -> liposarcome
    n1=en:adamantinoma | n2=liposarcome | rel=r_associated | relid=0 | w=20
  679. en:adamantinoma -- r_associated #0: 20 / 0.084 -> liposarcome pléomorphe
    n1=en:adamantinoma | n2=liposarcome pléomorphe | rel=r_associated | relid=0 | w=20
  680. en:adamantinoma -- r_associated #0: 20 / 0.084 -> lymphangio-sarcome
    n1=en:adamantinoma | n2=lymphangio-sarcome | rel=r_associated | relid=0 | w=20
  681. en:adamantinoma -- r_associated #0: 20 / 0.084 -> maladie de vaquez
    n1=en:adamantinoma | n2=maladie de vaquez | rel=r_associated | relid=0 | w=20
  682. en:adamantinoma -- r_associated #0: 20 / 0.084 -> maladie de Vaquez
    n1=en:adamantinoma | n2=maladie de Vaquez | rel=r_associated | relid=0 | w=20
  683. en:adamantinoma -- r_associated #0: 20 / 0.084 -> maladie des chaînes lourdes
    n1=en:adamantinoma | n2=maladie des chaînes lourdes | rel=r_associated | relid=0 | w=20
  684. en:adamantinoma -- r_associated #0: 20 / 0.084 -> médulloépithéliome
    n1=en:adamantinoma | n2=médulloépithéliome | rel=r_associated | relid=0 | w=20
  685. en:adamantinoma -- r_associated #0: 20 / 0.084 -> médulloépithéliome tératoïde
    n1=en:adamantinoma | n2=médulloépithéliome tératoïde | rel=r_associated | relid=0 | w=20
  686. en:adamantinoma -- r_associated #0: 20 / 0.084 -> melanoma
    n1=en:adamantinoma | n2=melanoma | rel=r_associated | relid=0 | w=20
  687. en:adamantinoma -- r_associated #0: 20 / 0.084 -> melanomalignom
    n1=en:adamantinoma | n2=melanomalignom | rel=r_associated | relid=0 | w=20
  688. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome
    n1=en:adamantinoma | n2=mélanome | rel=r_associated | relid=0 | w=20
  689. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome à cellules ballonnisantes
    n1=en:adamantinoma | n2=mélanome à cellules ballonnisantes | rel=r_associated | relid=0 | w=20
  690. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome à cellules fusiformes
    n1=en:adamantinoma | n2=mélanome à cellules fusiformes | rel=r_associated | relid=0 | w=20
  691. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome à cellules fusiformes de type b
    n1=en:adamantinoma | n2=mélanome à cellules fusiformes de type b | rel=r_associated | relid=0 | w=20
  692. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome achromique
    n1=en:adamantinoma | n2=mélanome achromique | rel=r_associated | relid=0 | w=20
  693. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome desmoplastique
    n1=en:adamantinoma | n2=mélanome desmoplastique | rel=r_associated | relid=0 | w=20
  694. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome lentigineux acral
    n1=en:adamantinoma | n2=mélanome lentigineux acral | rel=r_associated | relid=0 | w=20
  695. en:adamantinoma -- r_associated #0: 20 / 0.084 -> mélanome superficiel extensif
    n1=en:adamantinoma | n2=mélanome superficiel extensif | rel=r_associated | relid=0 | w=20
  696. en:adamantinoma -- r_associated #0: 20 / 0.084 -> microbiologique
    n1=en:adamantinoma | n2=microbiologique | rel=r_associated | relid=0 | w=20
  697. en:adamantinoma -- r_associated #0: 20 / 0.084 -> myélofibrose primaire
    n1=en:adamantinoma | n2=myélofibrose primaire | rel=r_associated | relid=0 | w=20
  698. en:adamantinoma -- r_associated #0: 20 / 0.084 -> myélofibrose primitive
    n1=en:adamantinoma | n2=myélofibrose primitive | rel=r_associated | relid=0 | w=20
  699. en:adamantinoma -- r_associated #0: 20 / 0.084 -> myxosarcome
    n1=en:adamantinoma | n2=myxosarcome | rel=r_associated | relid=0 | w=20
  700. en:adamantinoma -- r_associated #0: 20 / 0.084 -> naevocarcinome à cellules fusiformes
    n1=en:adamantinoma | n2=naevocarcinome à cellules fusiformes | rel=r_associated | relid=0 | w=20
  701. en:adamantinoma -- r_associated #0: 20 / 0.084 -> naevocarcinome à cellules fusiformes de type b
    n1=en:adamantinoma | n2=naevocarcinome à cellules fusiformes de type b | rel=r_associated | relid=0 | w=20
  702. en:adamantinoma -- r_associated #0: 20 / 0.084 -> neuro-épithéliome
    n1=en:adamantinoma | n2=neuro-épithéliome | rel=r_associated | relid=0 | w=20
  703. en:adamantinoma -- r_associated #0: 20 / 0.084 -> neuroépithéliome
    n1=en:adamantinoma | n2=neuroépithéliome | rel=r_associated | relid=0 | w=20
  704. en:adamantinoma -- r_associated #0: 20 / 0.084 -> odontosarcome améloblastique
    n1=en:adamantinoma | n2=odontosarcome améloblastique | rel=r_associated | relid=0 | w=20
  705. en:adamantinoma -- r_associated #0: 20 / 0.084 -> oligodendrogliome
    n1=en:adamantinoma | n2=oligodendrogliome | rel=r_associated | relid=0 | w=20
  706. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéoblastome
    n1=en:adamantinoma | n2=ostéoblastome | rel=r_associated | relid=0 | w=20
  707. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéoclastome
    n1=en:adamantinoma | n2=ostéoclastome | rel=r_associated | relid=0 | w=20
  708. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéoporose-pseudogliome (syndrome)
    n1=en:adamantinoma | n2=ostéoporose-pseudogliome (syndrome) | rel=r_associated | relid=0 | w=20
  709. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome
    n1=en:adamantinoma | n2=ostéosarcome | rel=r_associated | relid=0 | w=20
  710. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome à petites cellules
    n1=en:adamantinoma | n2=ostéosarcome à petites cellules | rel=r_associated | relid=0 | w=20
  711. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome juxta-cortical
    n1=en:adamantinoma | n2=ostéosarcome juxta-cortical | rel=r_associated | relid=0 | w=20
  712. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome juxtacortical
    n1=en:adamantinoma | n2=ostéosarcome juxtacortical | rel=r_associated | relid=0 | w=20
  713. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome périosté
    n1=en:adamantinoma | n2=ostéosarcome périosté | rel=r_associated | relid=0 | w=20
  714. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ostéosarcome télangiectasique
    n1=en:adamantinoma | n2=ostéosarcome télangiectasique | rel=r_associated | relid=0 | w=20
  715. en:adamantinoma -- r_associated #0: 20 / 0.084 -> parasitologie
    n1=en:adamantinoma | n2=parasitologie | rel=r_associated | relid=0 | w=20
  716. en:adamantinoma -- r_associated #0: 20 / 0.084 -> polycythemia vera
    n1=en:adamantinoma | n2=polycythemia vera | rel=r_associated | relid=0 | w=20
  717. en:adamantinoma -- r_associated #0: 20 / 0.084 -> polyembryome
    n1=en:adamantinoma | n2=polyembryome | rel=r_associated | relid=0 | w=20
  718. en:adamantinoma -- r_associated #0: 20 / 0.084 -> polyglobulie essentielle
    n1=en:adamantinoma | n2=polyglobulie essentielle | rel=r_associated | relid=0 | w=20
  719. en:adamantinoma -- r_associated #0: 20 / 0.084 -> polyglobulie vraie
    n1=en:adamantinoma | n2=polyglobulie vraie | rel=r_associated | relid=0 | w=20
  720. en:adamantinoma -- r_associated #0: 20 / 0.084 -> porocarcinome
    n1=en:adamantinoma | n2=porocarcinome | rel=r_associated | relid=0 | w=20
  721. en:adamantinoma -- r_associated #0: 20 / 0.084 -> rhabdomyosarcome
    n1=en:adamantinoma | n2=rhabdomyosarcome | rel=r_associated | relid=0 | w=20
  722. en:adamantinoma -- r_associated #0: 20 / 0.084 -> rhabdomyosarcomes
    n1=en:adamantinoma | n2=rhabdomyosarcomes | rel=r_associated | relid=0 | w=20
  723. en:adamantinoma -- r_associated #0: 20 / 0.084 -> sarcome
    n1=en:adamantinoma | n2=sarcome | rel=r_associated | relid=0 | w=20
  724. en:adamantinoma -- r_associated #0: 20 / 0.084 -> sarcome a petites cellules
    n1=en:adamantinoma | n2=sarcome a petites cellules | rel=r_associated | relid=0 | w=20
  725. en:adamantinoma -- r_associated #0: 20 / 0.084 -> sarcome à petites cellules
    n1=en:adamantinoma | n2=sarcome à petites cellules | rel=r_associated | relid=0 | w=20
  726. en:adamantinoma -- r_associated #0: 20 / 0.084 -> sarcome épithélioïde
    n1=en:adamantinoma | n2=sarcome épithélioïde | rel=r_associated | relid=0 | w=20
  727. en:adamantinoma -- r_associated #0: 20 / 0.084 -> sarcome granulocytaire
    n1=en:adamantinoma | n2=sarcome granulocytaire | rel=r_associated | relid=0 | w=20
  728. en:adamantinoma -- r_associated #0: 20 / 0.084 -> séminome
    n1=en:adamantinoma | n2=séminome | rel=r_associated | relid=0 | w=20
  729. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tératome à prédominance médulloépithéliale
    n1=en:adamantinoma | n2=tératome à prédominance médulloépithéliale | rel=r_associated | relid=0 | w=20
  730. en:adamantinoma -- r_associated #0: 20 / 0.084 -> thymome
    n1=en:adamantinoma | n2=thymome | rel=r_associated | relid=0 | w=20
  731. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tibia
    n1=en:adamantinoma | n2=tibia | rel=r_associated | relid=0 | w=20
  732. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tissu épithélial
    n1=en:adamantinoma | n2=tissu épithélial | rel=r_associated | relid=0 | w=20
  733. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tuméfaction
    n1=en:adamantinoma | n2=tuméfaction | rel=r_associated | relid=0 | w=20
  734. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tuméfié
    n1=en:adamantinoma | n2=tuméfié | rel=r_associated | relid=0 | w=20
  735. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumescence
    n1=en:adamantinoma | n2=tumescence | rel=r_associated | relid=0 | w=20
  736. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur à cellules géantes de l'os
    n1=en:adamantinoma | n2=tumeur à cellules géantes de l'os | rel=r_associated | relid=0 | w=20
  737. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur à cellules géantes des os
    n1=en:adamantinoma | n2=tumeur à cellules géantes des os | rel=r_associated | relid=0 | w=20
  738. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur à myéloplaxes
    n1=en:adamantinoma | n2=tumeur à myéloplaxes | rel=r_associated | relid=0 | w=20
  739. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur cancéreuse
    n1=en:adamantinoma | n2=tumeur cancéreuse | rel=r_associated | relid=0 | w=20
  740. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur des cellules squameuses
    n1=en:adamantinoma | n2=tumeur des cellules squameuses | rel=r_associated | relid=0 | w=20
  741. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne d'Abrikossof
    n1=en:adamantinoma | n2=tumeur maligne d'Abrikossof | rel=r_associated | relid=0 | w=20
  742. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne de la mâchoire inférieure
    n1=en:adamantinoma | n2=tumeur maligne de la mâchoire inférieure | rel=r_associated | relid=0 | w=20
  743. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne de la mandibule
    n1=en:adamantinoma | n2=tumeur maligne de la mandibule | rel=r_associated | relid=0 | w=20
  744. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne des os
    n1=en:adamantinoma | n2=tumeur maligne des os | rel=r_associated | relid=0 | w=20
  745. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne du maxillaire inférieur
    n1=en:adamantinoma | n2=tumeur maligne du maxillaire inférieur | rel=r_associated | relid=0 | w=20
  746. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne mandibulaire
    n1=en:adamantinoma | n2=tumeur maligne mandibulaire | rel=r_associated | relid=0 | w=20
  747. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur maligne osseuse
    n1=en:adamantinoma | n2=tumeur maligne osseuse | rel=r_associated | relid=0 | w=20
  748. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur neuro-ectodermique primitive
    n1=en:adamantinoma | n2=tumeur neuro-ectodermique primitive | rel=r_associated | relid=0 | w=20
  749. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur neuroectodermique périphérique primitive
    n1=en:adamantinoma | n2=tumeur neuroectodermique périphérique primitive | rel=r_associated | relid=0 | w=20
  750. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur neuroectodermique primitive
    n1=en:adamantinoma | n2=tumeur neuroectodermique primitive | rel=r_associated | relid=0 | w=20
  751. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur osseuse à cellules géantes
    n1=en:adamantinoma | n2=tumeur osseuse à cellules géantes | rel=r_associated | relid=0 | w=20
  752. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeur primitive neuroectodermique
    n1=en:adamantinoma | n2=tumeur primitive neuroectodermique | rel=r_associated | relid=0 | w=20
  753. en:adamantinoma -- r_associated #0: 20 / 0.084 -> tumeurs neuroectodermiques périphériques primitives
    n1=en:adamantinoma | n2=tumeurs neuroectodermiques périphériques primitives | rel=r_associated | relid=0 | w=20
  754. en:adamantinoma -- r_associated #0: 20 / 0.084 -> ulcus rodens
    n1=en:adamantinoma | n2=ulcus rodens | rel=r_associated | relid=0 | w=20
  755. en:adamantinoma -- r_associated #0: 15 / 0.063 -> Adamantiades (maladie d')
    n1=en:adamantinoma | n2=Adamantiades (maladie d') | rel=r_associated | relid=0 | w=15
  756. en:adamantinoma -- r_associated #0: 10 / 0.042 -> Adamantiades
    n1=en:adamantinoma | n2=Adamantiades | rel=r_associated | relid=0 | w=10
  757. en:adamantinoma -- r_associated #0: 10 / 0.042 -> adamantin
    n1=en:adamantinoma | n2=adamantin | rel=r_associated | relid=0 | w=10
  758. en:adamantinoma -- r_associated #0: 10 / 0.042 -> adamantoblaste
    n1=en:adamantinoma | n2=adamantoblaste | rel=r_associated | relid=0 | w=10
  759. en:adamantinoma -- r_associated #0: 10 / 0.042 -> maladie d'Adamantiades
    n1=en:adamantinoma | n2=maladie d'Adamantiades | rel=r_associated | relid=0 | w=10
  760. en:adamantinoma -- r_associated #0: 2 / 0.008 -> maladie
    (médecine)
    n1=en:adamantinoma | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=2
  761. en:adamantinoma -- r_associated #0: 2 / 0.008 -> pathologie
    n1=en:adamantinoma | n2=pathologie | rel=r_associated | relid=0 | w=2
  762. en:adamantinoma -- r_associated #0: 1 / 0.004 -> épithélioma
    n1=en:adamantinoma | n2=épithélioma | rel=r_associated | relid=0 | w=1
  763. en:adamantinoma -- r_associated #0: 1 / 0.004 -> processus
    n1=en:adamantinoma | n2=processus | rel=r_associated | relid=0 | w=1
≈ 930 relations entrantes

  1. en:epithelial cell --- r_associated #0: 502 --> en:adamantinoma
    n1=en:epithelial cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=502
  2. cellule épithéliale --- r_associated #0: 501 --> en:adamantinoma
    n1=cellule épithéliale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=501
  3. Cancer osseux --- r_associated #0: 231 --> en:adamantinoma
    n1=Cancer osseux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=231
  4. en:sarcoma --- r_associated #0: 228 --> en:adamantinoma
    n1=en:sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=228
  5. en:malignant bone neoplasm --- r_associated #0: 224 --> en:adamantinoma
    n1=en:malignant bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=224
  6. sarcome --- r_associated #0: 224 --> en:adamantinoma
    n1=sarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=224
  7. tumeur maligne osseuse --- r_associated #0: 220 --> en:adamantinoma
    n1=tumeur maligne osseuse | n2=en:adamantinoma | rel=r_associated | relid=0 | w=220
  8. tumeur maligne des os --- r_associated #0: 215 --> en:adamantinoma
    n1=tumeur maligne des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=215
  9. en:malignant odontogenic neoplasm --- r_associated #0: 211 --> en:adamantinoma
    n1=en:malignant odontogenic neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=211
  10. tumeur odontogène maligne --- r_associated #0: 208 --> en:adamantinoma
    n1=tumeur odontogène maligne | n2=en:adamantinoma | rel=r_associated | relid=0 | w=208
  11. cancer osseux --- r_associated #0: 206 --> en:adamantinoma
    n1=cancer osseux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=206
  12. cancer des os --- r_associated #0: 205 --> en:adamantinoma
    n1=cancer des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=205
  13. en:enzymology --- r_associated #0: 203 --> en:adamantinoma
    n1=en:enzymology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=203
  14. médecine --- r_associated #0: 202 --> en:adamantinoma
    n1=médecine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=202
  15. en:granulocytic sarcoma --- r_associated #0: 200 --> en:adamantinoma
    n1=en:granulocytic sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=200
  16. enzymologie --- r_associated #0: 200 --> en:adamantinoma
    n1=enzymologie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=200
  17. sarcome granulocytaire --- r_associated #0: 198 --> en:adamantinoma
    n1=sarcome granulocytaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=198
  18. leucémie --- r_associated #0: 176 --> en:adamantinoma
    n1=leucémie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=176
  19. rhabdomyosarcome --- r_associated #0: 175 --> en:adamantinoma
    n1=rhabdomyosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=175
  20. en:leukemia --- r_associated #0: 173 --> en:adamantinoma
    n1=en:leukemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=173
  21. en:rhabdomyosarcoma --- r_associated #0: 171 --> en:adamantinoma
    n1=en:rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=171
  22. enzymology --- r_associated #0: 160 --> en:adamantinoma
    n1=enzymology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=160
  23. en:malignant neoplasm of lower jaw bone --- r_associated #0: 138 --> en:adamantinoma
    n1=en:malignant neoplasm of lower jaw bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=138
  24. médulloépithéliome --- r_associated #0: 136 --> en:adamantinoma
    n1=médulloépithéliome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=136
  25. en:malignant neoplasm of mandible --- r_associated #0: 135 --> en:adamantinoma
    n1=en:malignant neoplasm of mandible | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  26. en:medulloepithelioma --- r_associated #0: 135 --> en:adamantinoma
    n1=en:medulloepithelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  27. mélanome à cellules fusiformes --- r_associated #0: 135 --> en:adamantinoma
    n1=mélanome à cellules fusiformes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  28. tumeur maligne de la mandibule --- r_associated #0: 135 --> en:adamantinoma
    n1=tumeur maligne de la mandibule | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  29. tumeur maligne de la mâchoire inférieure --- r_associated #0: 135 --> en:adamantinoma
    n1=tumeur maligne de la mâchoire inférieure | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  30. tumeur maligne du maxillaire inférieur --- r_associated #0: 135 --> en:adamantinoma
    n1=tumeur maligne du maxillaire inférieur | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  31. tumeur maligne mandibulaire --- r_associated #0: 135 --> en:adamantinoma
    n1=tumeur maligne mandibulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=135
  32. en:spindle cell melanoma --- r_associated #0: 134 --> en:adamantinoma
    n1=en:spindle cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=134
  33. arrhénoblastome malin --- r_associated #0: 132 --> en:adamantinoma
    n1=arrhénoblastome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=132
  34. en:ameloblastic fibrosarcoma --- r_associated #0: 130 --> en:adamantinoma
    n1=en:ameloblastic fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=130
  35. en:malignant sertoli cell tumor --- r_associated #0: 130 --> en:adamantinoma
    n1=en:malignant sertoli cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=130
  36. naevocarcinome à cellules fusiformes --- r_associated #0: 130 --> en:adamantinoma
    n1=naevocarcinome à cellules fusiformes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=130
  37. neuro-épithéliome --- r_associated #0: 130 --> en:adamantinoma
    n1=neuro-épithéliome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=130
  38. polyembryome --- r_associated #0: 130 --> en:adamantinoma
    n1=polyembryome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=130
  39. en:neuroepithelioma --- r_associated #0: 128 --> en:adamantinoma
    n1=en:neuroepithelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=128
  40. tumeur neuroectodermique périphérique primitive --- r_associated #0: 128 --> en:adamantinoma
    n1=tumeur neuroectodermique périphérique primitive | n2=en:adamantinoma | rel=r_associated | relid=0 | w=128
  41. en:polyembryoma --- r_associated #0: 126 --> en:adamantinoma
    n1=en:polyembryoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=126
  42. fibrosarcome améloblastique --- r_associated #0: 126 --> en:adamantinoma
    n1=fibrosarcome améloblastique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=126
  43. neuroépithéliome --- r_associated #0: 126 --> en:adamantinoma
    n1=neuroépithéliome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=126
  44. en:primary malignant neoplasm of mandible --- r_associated #0: 125 --> en:adamantinoma
    n1=en:primary malignant neoplasm of mandible | n2=en:adamantinoma | rel=r_associated | relid=0 | w=125
  45. rhabdomyosarcomes --- r_associated #0: 125 --> en:adamantinoma
    n1=rhabdomyosarcomes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=125
  46. ulcus rodens --- r_associated #0: 125 --> en:adamantinoma
    n1=ulcus rodens | n2=en:adamantinoma | rel=r_associated | relid=0 | w=125
  47. en:chondroma --- r_associated #0: 121 --> en:adamantinoma
    n1=en:chondroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=121
  48. chondrome --- r_associated #0: 120 --> en:adamantinoma
    n1=chondrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=120
  49. en:type b spindle cell melanoma --- r_associated #0: 119 --> en:adamantinoma
    n1=en:type b spindle cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=119
  50. fibroxanthome malin --- r_associated #0: 116 --> en:adamantinoma
    n1=fibroxanthome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=116
  51. naevocarcinome à cellules fusiformes de type b --- r_associated #0: 116 --> en:adamantinoma
    n1=naevocarcinome à cellules fusiformes de type b | n2=en:adamantinoma | rel=r_associated | relid=0 | w=116
  52. histiocytome fibreux malin stade non spécifié --- r_associated #0: 115 --> en:adamantinoma
    n1=histiocytome fibreux malin stade non spécifié | n2=en:adamantinoma | rel=r_associated | relid=0 | w=115
  53. histiocytome malin --- r_associated #0: 111 --> en:adamantinoma
    n1=histiocytome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=111
  54. médulloépithéliome tératoïde --- r_associated #0: 111 --> en:adamantinoma
    n1=médulloépithéliome tératoïde | n2=en:adamantinoma | rel=r_associated | relid=0 | w=111
  55. en:undifferentiated pleomorphic sarcoma --- r_associated #0: 110 --> en:adamantinoma
    n1=en:undifferentiated pleomorphic sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=110
  56. tumeur neuro-ectodermique primitive --- r_associated #0: 110 --> en:adamantinoma
    n1=tumeur neuro-ectodermique primitive | n2=en:adamantinoma | rel=r_associated | relid=0 | w=110
  57. tumeur primitive neuroectodermique --- r_associated #0: 110 --> en:adamantinoma
    n1=tumeur primitive neuroectodermique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=110
  58. tumeur à cellules géantes de l'os --- r_associated #0: 110 --> en:adamantinoma
    n1=tumeur à cellules géantes de l'os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=110
  59. en:teratoid medulloepithelioma --- r_associated #0: 108 --> en:adamantinoma
    n1=en:teratoid medulloepithelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=108
  60. tumeur neuroectodermique primitive --- r_associated #0: 108 --> en:adamantinoma
    n1=tumeur neuroectodermique primitive | n2=en:adamantinoma | rel=r_associated | relid=0 | w=108
  61. en:giant cell tumor of bone --- r_associated #0: 106 --> en:adamantinoma
    n1=en:giant cell tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=106
  62. myélofibrose primitive --- r_associated #0: 106 --> en:adamantinoma
    n1=myélofibrose primitive | n2=en:adamantinoma | rel=r_associated | relid=0 | w=106
  63. en:primitive neuroectodermal tumor --- r_associated #0: 105 --> en:adamantinoma
    n1=en:primitive neuroectodermal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=105
  64. myélofibrose primaire --- r_associated #0: 105 --> en:adamantinoma
    n1=myélofibrose primaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=105
  65. ostéoclastome --- r_associated #0: 105 --> en:adamantinoma
    n1=ostéoclastome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=105
  66. sarcome à petites cellules --- r_associated #0: 105 --> en:adamantinoma
    n1=sarcome à petites cellules | n2=en:adamantinoma | rel=r_associated | relid=0 | w=105
  67. tumeur à myéloplaxes --- r_associated #0: 105 --> en:adamantinoma
    n1=tumeur à myéloplaxes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=105
  68. mélanome à cellules fusiformes de type b --- r_associated #0: 104 --> en:adamantinoma
    n1=mélanome à cellules fusiformes de type b | n2=en:adamantinoma | rel=r_associated | relid=0 | w=104
  69. sarcome a petites cellules --- r_associated #0: 103 --> en:adamantinoma
    n1=sarcome a petites cellules | n2=en:adamantinoma | rel=r_associated | relid=0 | w=103
  70. en:small cell sarcoma --- r_associated #0: 102 --> en:adamantinoma
    n1=en:small cell sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=102
  71. en:squamous cell neoplasm --- r_associated #0: 102 --> en:adamantinoma
    n1=en:squamous cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=102
  72. histiocytofibrome malin --- r_associated #0: 101 --> en:adamantinoma
    n1=histiocytofibrome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=101
  73. en:leukaemia --- r_associated #0: 100 --> en:adamantinoma
    n1=en:leukaemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=100
  74. en:primary myelofibrosis --- r_associated #0: 100 --> en:adamantinoma
    n1=en:primary myelofibrosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=100
  75. tumeur des cellules squameuses --- r_associated #0: 100 --> en:adamantinoma
    n1=tumeur des cellules squameuses | n2=en:adamantinoma | rel=r_associated | relid=0 | w=100
  76. tumeur osseuse à cellules géantes --- r_associated #0: 100 --> en:adamantinoma
    n1=tumeur osseuse à cellules géantes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=100
  77. tumeur cancéreuse --- r_associated #0: 95 --> en:adamantinoma
    n1=tumeur cancéreuse | n2=en:adamantinoma | rel=r_associated | relid=0 | w=95
  78. en:carcinoma --- r_associated #0: 91 --> en:adamantinoma
    n1=en:carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=91
  79. histiocytome fibreux malin --- r_associated #0: 91 --> en:adamantinoma
    n1=histiocytome fibreux malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=91
  80. cancer du sang --- r_associated #0: 90 --> en:adamantinoma
    n1=cancer du sang | n2=en:adamantinoma | rel=r_associated | relid=0 | w=90
  81. léiomyosarcome --- r_associated #0: 84 --> en:adamantinoma
    n1=léiomyosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=84
  82. acral lentiginous melanoma --- r_associated #0: 82 --> en:adamantinoma
    n1=acral lentiginous melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=82
  83. en:leiomyosarcoma --- r_associated #0: 81 --> en:adamantinoma
    n1=en:leiomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=81
  84. en:balloon cell melanoma --- r_associated #0: 80 --> en:adamantinoma
    n1=en:balloon cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=80
  85. en:acral lentiginous melanoma --- r_associated #0: 78 --> en:adamantinoma
    n1=en:acral lentiginous melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=78
  86. balloon cell melanoma --- r_associated #0: 76 --> en:adamantinoma
    n1=balloon cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=76
  87. en:tibia --- r_associated #0: 76 --> en:adamantinoma
    n1=en:tibia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=76
  88. leiomyosarcome --- r_associated #0: 76 --> en:adamantinoma
    n1=leiomyosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=76
  89. Cellule épithéliale --- r_associated #0: 75 --> en:adamantinoma
    n1=Cellule épithéliale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=75
  90. tibia --- r_associated #0: 73 --> en:adamantinoma
    n1=tibia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=73
  91. melanomalignom --- r_associated #0: 70 --> en:adamantinoma
    n1=melanomalignom | n2=en:adamantinoma | rel=r_associated | relid=0 | w=70
  92. carcinome intra-épithélial --- r_associated #0: 67 --> en:adamantinoma
    n1=carcinome intra-épithélial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=67
  93. en:leucemia --- r_associated #0: 67 --> en:adamantinoma
    n1=en:leucemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=67
  94. en:malignant fibrous histiocytoma --- r_associated #0: 66 --> en:adamantinoma
    n1=en:malignant fibrous histiocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=66
  95. en:carcinoma in situ --- r_associated #0: 65 --> en:adamantinoma
    n1=en:carcinoma in situ | n2=en:adamantinoma | rel=r_associated | relid=0 | w=65
  96. en:in situ cancer --- r_associated #0: 65 --> en:adamantinoma
    n1=en:in situ cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=65
  97. mélanome superficiel extensif --- r_associated #0: 65 --> en:adamantinoma
    n1=mélanome superficiel extensif | n2=en:adamantinoma | rel=r_associated | relid=0 | w=65
  98. cancer in situ --- r_associated #0: 64 --> en:adamantinoma
    n1=cancer in situ | n2=en:adamantinoma | rel=r_associated | relid=0 | w=64
  99. en:superficial spreading melanoma --- r_associated #0: 64 --> en:adamantinoma
    n1=en:superficial spreading melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=64
  100. mélanome --- r_associated #0: 63 --> en:adamantinoma
    n1=mélanome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=63
  101. carcinoma --- r_associated #0: 62 --> en:adamantinoma
    n1=carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=62
  102. en:leukocythemia --- r_associated #0: 62 --> en:adamantinoma
    n1=en:leukocythemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=62
  103. en:melanoma --- r_associated #0: 62 --> en:adamantinoma
    n1=en:melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=62
  104. en:osteoclastoma --- r_associated #0: 62 --> en:adamantinoma
    n1=en:osteoclastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=62
  105. en:giant-cell tumor --- r_associated #0: 61 --> en:adamantinoma
    n1=en:giant-cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=61
  106. androblastome malin --- r_associated #0: 60 --> en:adamantinoma
    n1=androblastome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=60
  107. histiocytes bleu de mer (maladie des) --- r_associated #0: 59 --> en:adamantinoma
    n1=histiocytes bleu de mer (maladie des) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=59
  108. tératome à prédominance médulloépithéliale --- r_associated #0: 59 --> en:adamantinoma
    n1=tératome à prédominance médulloépithéliale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=59
  109. bone --- r_associated #0: 58 --> en:adamantinoma
    n1=bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=58
  110. en:epithelial tissue --- r_associated #0: 57 --> en:adamantinoma
    n1=en:epithelial tissue | n2=en:adamantinoma | rel=r_associated | relid=0 | w=57
  111. tissu épithélial --- r_associated #0: 57 --> en:adamantinoma
    n1=tissu épithélial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=57
  112. en:bone --- r_associated #0: 56 --> en:adamantinoma
    n1=en:bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=56
  113. maladie des chaînes lourdes --- r_associated #0: 55 --> en:adamantinoma
    n1=maladie des chaînes lourdes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=55
  114. dysgerminome --- r_associated #0: 54 --> en:adamantinoma
    n1=dysgerminome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=54
  115. en:myeloplaxoma --- r_associated #0: 54 --> en:adamantinoma
    n1=en:myeloplaxoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=54
  116. cellule tumorale --- r_associated #0: 53 --> en:adamantinoma
    n1=cellule tumorale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=53
  117. en:neoplastic cell --- r_associated #0: 53 --> en:adamantinoma
    n1=en:neoplastic cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=53
  118. en:heavy chain disease --- r_associated #0: 52 --> en:adamantinoma
    n1=en:heavy chain disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=52
  119. tumeur à cellules géantes des os --- r_associated #0: 52 --> en:adamantinoma
    n1=tumeur à cellules géantes des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=52
  120. épithélioma malin --- r_associated #0: 51 --> en:adamantinoma
    n1=épithélioma malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=51
  121. en:dysgerminoma --- r_associated #0: 50 --> en:adamantinoma
    n1=en:dysgerminoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=50
  122. en:tumor cell --- r_associated #0: 50 --> en:adamantinoma
    n1=en:tumor cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=50
  123. kyste anévrismal des os --- r_associated #0: 50 --> en:adamantinoma
    n1=kyste anévrismal des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=50
  124. cancer épithélial --- r_associated #0: 49 --> en:adamantinoma
    n1=cancer épithélial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=49
  125. en:malignant epithelioma --- r_associated #0: 49 --> en:adamantinoma
    n1=en:malignant epithelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=49
  126. en:aneurysmal bone cyst --- r_associated #0: 47 --> en:adamantinoma
    n1=en:aneurysmal bone cyst | n2=en:adamantinoma | rel=r_associated | relid=0 | w=47
  127. melanoma --- r_associated #0: 46 --> en:adamantinoma
    n1=melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=46
  128. carcinôme --- r_associated #0: 45 --> en:adamantinoma
    n1=carcinôme | n2=en:adamantinoma | rel=r_associated | relid=0 | w=45
  129. en:lelomyosarcoma --- r_associated #0: 45 --> en:adamantinoma
    n1=en:lelomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=45
  130. histiocytofibrome --- r_associated #0: 45 --> en:adamantinoma
    n1=histiocytofibrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=45
  131. tumeur maligne d'Abrikossof --- r_associated #0: 45 --> en:adamantinoma
    n1=tumeur maligne d'Abrikossof | n2=en:adamantinoma | rel=r_associated | relid=0 | w=45
  132. carcinome --- r_associated #0: 44 --> en:adamantinoma
    n1=carcinome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=44
  133. lymphangio-sarcome --- r_associated #0: 44 --> en:adamantinoma
    n1=lymphangio-sarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=44
  134. maladie de Vaquez --- r_associated #0: 44 --> en:adamantinoma
    n1=maladie de Vaquez | n2=en:adamantinoma | rel=r_associated | relid=0 | w=44
  135. ostéosarcome --- r_associated #0: 44 --> en:adamantinoma
    n1=ostéosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=44
  136. en:histiocytoma --- r_associated #0: 43 --> en:adamantinoma
    n1=en:histiocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  137. en:malignant granular cell tumor --- r_associated #0: 43 --> en:adamantinoma
    n1=en:malignant granular cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  138. en:malignant mast cell neoplasm --- r_associated #0: 43 --> en:adamantinoma
    n1=en:malignant mast cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  139. en:malignant type ab thymoma --- r_associated #0: 43 --> en:adamantinoma
    n1=en:malignant type ab thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  140. en:mixed tumor, mesodermal --- r_associated #0: 43 --> en:adamantinoma
    n1=en:mixed tumor, mesodermal | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  141. en:type a spindle cell melanoma --- r_associated #0: 43 --> en:adamantinoma
    n1=en:type a spindle cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=43
  142. en:eccrine adenocarcinoma --- r_associated #0: 42 --> en:adamantinoma
    n1=en:eccrine adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=42
  143. en:endometrioid tumor --- r_associated #0: 42 --> en:adamantinoma
    n1=en:endometrioid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=42
  144. en:neoplasm of bone of face --- r_associated #0: 42 --> en:adamantinoma
    n1=en:neoplasm of bone of face | n2=en:adamantinoma | rel=r_associated | relid=0 | w=42
  145. en:osteosarcoma --- r_associated #0: 42 --> en:adamantinoma
    n1=en:osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=42
  146. en:solitary osseous plasmacytoma --- r_associated #0: 42 --> en:adamantinoma
    n1=en:solitary osseous plasmacytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=42
  147. adénome --- r_associated #0: 41 --> en:adamantinoma
    n1=adénome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  148. chordome --- r_associated #0: 41 --> en:adamantinoma
    n1=chordome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  149. en:malignant solitary fibrous tumor --- r_associated #0: 41 --> en:adamantinoma
    n1=en:malignant solitary fibrous tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  150. en:periosteal fibrosarcoma --- r_associated #0: 41 --> en:adamantinoma
    n1=en:periosteal fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  151. en:primary malignant neoplasm of back --- r_associated #0: 41 --> en:adamantinoma
    n1=en:primary malignant neoplasm of back | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  152. en:small cell carcinoma, fusiform cell type --- r_associated #0: 41 --> en:adamantinoma
    n1=en:small cell carcinoma, fusiform cell type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  153. en:small cell osteosarcoma --- r_associated #0: 41 --> en:adamantinoma
    n1=en:small cell osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  154. fibrosarcome --- r_associated #0: 41 --> en:adamantinoma
    n1=fibrosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  155. liposarcome pléomorphe --- r_associated #0: 41 --> en:adamantinoma
    n1=liposarcome pléomorphe | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  156. porocarcinome --- r_associated #0: 41 --> en:adamantinoma
    n1=porocarcinome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=41
  157. en:chordoma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:chordoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  158. en:eccrine porocarcinoma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:eccrine porocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  159. en:fibrosarcoma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  160. en:in cerebrospinal fluid --- r_associated #0: 40 --> en:adamantinoma
    n1=en:in cerebrospinal fluid | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  161. en:lymphangiosarcoma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:lymphangiosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  162. en:malignant histiocytoma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:malignant histiocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  163. en:malignant sebaceous neoplasm --- r_associated #0: 40 --> en:adamantinoma
    n1=en:malignant sebaceous neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  164. en:medullary carcinoma with lymphoid stroma --- r_associated #0: 40 --> en:adamantinoma
    n1=en:medullary carcinoma with lymphoid stroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  165. en:polycythemia vera --- r_associated #0: 40 --> en:adamantinoma
    n1=en:polycythemia vera | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  166. hyperéosinophile sanguine idiopathique --- r_associated #0: 40 --> en:adamantinoma
    n1=hyperéosinophile sanguine idiopathique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  167. polycythemia vera --- r_associated #0: 40 --> en:adamantinoma
    n1=polycythemia vera | n2=en:adamantinoma | rel=r_associated | relid=0 | w=40
  168. en:anevrysmal bone cyst --- r_associated #0: 39 --> en:adamantinoma
    n1=en:anevrysmal bone cyst | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  169. en:basaloid carcinoma --- r_associated #0: 39 --> en:adamantinoma
    n1=en:basaloid carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  170. en:chondroblastic osteosarcoma --- r_associated #0: 39 --> en:adamantinoma
    n1=en:chondroblastic osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  171. en:diffuse embryoma --- r_associated #0: 39 --> en:adamantinoma
    n1=en:diffuse embryoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  172. en:non-small cell carcinoma --- r_associated #0: 39 --> en:adamantinoma
    n1=en:non-small cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  173. en:vascular bone neoplasm --- r_associated #0: 39 --> en:adamantinoma
    n1=en:vascular bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  174. mélanome à cellules ballonnisantes --- r_associated #0: 39 --> en:adamantinoma
    n1=mélanome à cellules ballonnisantes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  175. ostéoblastome --- r_associated #0: 39 --> en:adamantinoma
    n1=ostéoblastome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  176. épidémiologique --- r_associated #0: 39 --> en:adamantinoma
    n1=épidémiologique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=39
  177. en:adenoma --- r_associated #0: 38 --> en:adamantinoma
    n1=en:adenoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  178. en:conventional osteosarcoma --- r_associated #0: 38 --> en:adamantinoma
    n1=en:conventional osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  179. en:heavy chains disease --- r_associated #0: 38 --> en:adamantinoma
    n1=en:heavy chains disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  180. en:poorly differentiated carcinoma --- r_associated #0: 38 --> en:adamantinoma
    n1=en:poorly differentiated carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  181. histiocytome --- r_associated #0: 38 --> en:adamantinoma
    n1=histiocytome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  182. polyglobulie essentielle --- r_associated #0: 38 --> en:adamantinoma
    n1=polyglobulie essentielle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=38
  183. en:benign epithelial neoplasm --- r_associated #0: 37 --> en:adamantinoma
    n1=en:benign epithelial neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  184. en:idiopathic hypereosinophilic syndrome --- r_associated #0: 37 --> en:adamantinoma
    n1=en:idiopathic hypereosinophilic syndrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  185. en:meduloepithelioma --- r_associated #0: 37 --> en:adamantinoma
    n1=en:meduloepithelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  186. en:osteoblastoma --- r_associated #0: 37 --> en:adamantinoma
    n1=en:osteoblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  187. en:pleomorphic liposarcoma --- r_associated #0: 37 --> en:adamantinoma
    n1=en:pleomorphic liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  188. myxosarcome --- r_associated #0: 37 --> en:adamantinoma
    n1=myxosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=37
  189. en:adamantinoma of femur --- r_associated #0: 36 --> en:adamantinoma
    n1=en:adamantinoma of femur | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  190. en:malignant mixed tumor, carcinomatous type --- r_associated #0: 36 --> en:adamantinoma
    n1=en:malignant mixed tumor, carcinomatous type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  191. en:metaplastic carcinoma --- r_associated #0: 36 --> en:adamantinoma
    n1=en:metaplastic carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  192. en:non-keratinizing sinonasal squamous cell carcinoma --- r_associated #0: 36 --> en:adamantinoma
    n1=en:non-keratinizing sinonasal squamous cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  193. en:spindle cell sarcoma --- r_associated #0: 36 --> en:adamantinoma
    n1=en:spindle cell sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  194. liposarcome --- r_associated #0: 36 --> en:adamantinoma
    n1=liposarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  195. ostéosarcome juxta-cortical --- r_associated #0: 36 --> en:adamantinoma
    n1=ostéosarcome juxta-cortical | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  196. ostéosarcome juxtacortical --- r_associated #0: 36 --> en:adamantinoma
    n1=ostéosarcome juxtacortical | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  197. ostéosarcome à petites cellules --- r_associated #0: 36 --> en:adamantinoma
    n1=ostéosarcome à petites cellules | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  198. polyglobulie vraie --- r_associated #0: 36 --> en:adamantinoma
    n1=polyglobulie vraie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  199. sarcome épithélioïde --- r_associated #0: 36 --> en:adamantinoma
    n1=sarcome épithélioïde | n2=en:adamantinoma | rel=r_associated | relid=0 | w=36
  200. adamantinome --- r_associated #0: 35 --> en:adamantinoma
    n1=adamantinome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  201. en:amelanotic melanoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:amelanotic melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  202. en:angiomyosarcoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:angiomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  203. en:aspects of mortality statistics --- r_associated #0: 35 --> en:adamantinoma
    n1=en:aspects of mortality statistics | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  204. en:benign bone neoplasm --- r_associated #0: 35 --> en:adamantinoma
    n1=en:benign bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  205. en:bone neoplasm --- r_associated #0: 35 --> en:adamantinoma
    n1=en:bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  206. en:carcinofibroma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:carcinofibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  207. en:chondroblastoma, malignant --- r_associated #0: 35 --> en:adamantinoma
    n1=en:chondroblastoma, malignant | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  208. en:epidemiologic --- r_associated #0: 35 --> en:adamantinoma
    n1=en:epidemiologic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  209. en:extrarenal rhabdoid tumor --- r_associated #0: 35 --> en:adamantinoma
    n1=en:extrarenal rhabdoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  210. en:fibroblastic liposarcoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:fibroblastic liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  211. en:fibroblastic osteosarcoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:fibroblastic osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  212. en:hodgkin lymphoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:hodgkin lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  213. en:infiltrating carcinoma with ductal and lobular features --- r_associated #0: 35 --> en:adamantinoma
    n1=en:infiltrating carcinoma with ductal and lobular features | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  214. en:leukemia (category) --- r_associated #0: 35 --> en:adamantinoma
    n1=en:leukemia (category) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  215. en:liposarcoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  216. en:local recurrence of malignant tumor of bone --- r_associated #0: 35 --> en:adamantinoma
    n1=en:local recurrence of malignant tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  217. en:malignant immunoproliferative disease (clinical) --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant immunoproliferative disease (clinical) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  218. en:malignant mixed neoplasm --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant mixed neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  219. en:malignant mixed tumor, osteosarcomatous type --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant mixed tumor, osteosarcomatous type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  220. en:malignant neoplasm of bones of skull and face, except mandible --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant neoplasm of bones of skull and face, except mandible | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  221. en:malignant neoplasm of vertebral column, excluding sacrum and coccyx --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant neoplasm of vertebral column, excluding sacrum and coccyx | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  222. en:malignant neuroendocrine neoplasm, neural --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant neuroendocrine neoplasm, neural | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  223. en:malignant osteoclastic giant cell-rich tumor of bone --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant osteoclastic giant cell-rich tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  224. en:malignant pecoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant pecoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  225. en:malignant phyllodes tumor --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant phyllodes tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  226. en:malignant type a thymoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:malignant type a thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  227. en:meningeal melanomatosis --- r_associated #0: 35 --> en:adamantinoma
    n1=en:meningeal melanomatosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  228. en:mucosal lentiginous melanoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:mucosal lentiginous melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  229. en:notochordal tumor --- r_associated #0: 35 --> en:adamantinoma
    n1=en:notochordal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  230. en:osteoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:osteoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  231. en:overlapping malignant melanoma of skin --- r_associated #0: 35 --> en:adamantinoma
    n1=en:overlapping malignant melanoma of skin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  232. en:overlapping malignant neoplasm of gastrointestinal tract --- r_associated #0: 35 --> en:adamantinoma
    n1=en:overlapping malignant neoplasm of gastrointestinal tract | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  233. en:oxyphilic adenocarcinoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:oxyphilic adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  234. en:papillary meningioma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:papillary meningioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  235. en:parasitology --- r_associated #0: 35 --> en:adamantinoma
    n1=en:parasitology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  236. en:periosteal chondrosarcoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:periosteal chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  237. en:primary malignant neoplasm of head --- r_associated #0: 35 --> en:adamantinoma
    n1=en:primary malignant neoplasm of head | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  238. en:primary malignant neoplasm of sacrum --- r_associated #0: 35 --> en:adamantinoma
    n1=en:primary malignant neoplasm of sacrum | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  239. en:salivary gland monomorphic adenoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:salivary gland monomorphic adenoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  240. en:sarcomatoid transitional cell carcinoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:sarcomatoid transitional cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  241. en:sweat gland adenocarcinoma --- r_associated #0: 35 --> en:adamantinoma
    n1=en:sweat gland adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  242. en:tumor of laryngeal cartilage --- r_associated #0: 35 --> en:adamantinoma
    n1=en:tumor of laryngeal cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  243. mélanome achromique --- r_associated #0: 35 --> en:adamantinoma
    n1=mélanome achromique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  244. parasitologie --- r_associated #0: 35 --> en:adamantinoma
    n1=parasitologie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=35
  245. en:alveolar soft part sarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:alveolar soft part sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  246. en:atypical teratoid/rhabdoid tumor --- r_associated #0: 34 --> en:adamantinoma
    n1=en:atypical teratoid/rhabdoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  247. en:biphasic mesothelioma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:biphasic mesothelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  248. en:bone osteosarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:bone osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  249. en:bone sarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:bone sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  250. en:cdisc send terminology --- r_associated #0: 34 --> en:adamantinoma
    n1=en:cdisc send terminology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  251. en:choriocarcinoma combined with other germ cell elements --- r_associated #0: 34 --> en:adamantinoma
    n1=en:choriocarcinoma combined with other germ cell elements | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  252. en:choroid plexus neoplasm --- r_associated #0: 34 --> en:adamantinoma
    n1=en:choroid plexus neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  253. en:clear cell sarcoma of the kidney --- r_associated #0: 34 --> en:adamantinoma
    n1=en:clear cell sarcoma of the kidney | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  254. en:encapsulated papillary carcinoma with invasion --- r_associated #0: 34 --> en:adamantinoma
    n1=en:encapsulated papillary carcinoma with invasion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  255. en:epithelioid leiomyosarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:epithelioid leiomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  256. en:fascial fibrosarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:fascial fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  257. en:high grade surface osteosarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:high grade surface osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  258. en:in urine --- r_associated #0: 34 --> en:adamantinoma
    n1=en:in urine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  259. en:lymphosarcoma of lymph nodes of multiple sites --- r_associated #0: 34 --> en:adamantinoma
    n1=en:lymphosarcoma of lymph nodes of multiple sites | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  260. en:malignant granulosa cell tumor --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant granulosa cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  261. en:malignant neoplasm of hand bones --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant neoplasm of hand bones | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  262. en:malignant neoplasm of upper limb bones and scapula --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant neoplasm of upper limb bones and scapula | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  263. en:malignant neuroendocrine neoplasm, epithelial --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant neuroendocrine neoplasm, epithelial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  264. en:malignant neuroendocrine tumor --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant neuroendocrine tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  265. en:malignant peripheral nerve sheath tumor --- r_associated #0: 34 --> en:adamantinoma
    n1=en:malignant peripheral nerve sheath tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  266. en:myeloproliferative neoplasm --- r_associated #0: 34 --> en:adamantinoma
    n1=en:myeloproliferative neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  267. en:paget disease and intraductal carcinoma of the breast --- r_associated #0: 34 --> en:adamantinoma
    n1=en:paget disease and intraductal carcinoma of the breast | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  268. en:primary malignant neoplasm of bone of lower limb --- r_associated #0: 34 --> en:adamantinoma
    n1=en:primary malignant neoplasm of bone of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  269. en:primary malignant neoplasm of paraganglion --- r_associated #0: 34 --> en:adamantinoma
    n1=en:primary malignant neoplasm of paraganglion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  270. en:primary malignant neoplasm of unspecified site (clinical) --- r_associated #0: 34 --> en:adamantinoma
    n1=en:primary malignant neoplasm of unspecified site (clinical) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  271. en:refractory anemia with excess blasts --- r_associated #0: 34 --> en:adamantinoma
    n1=en:refractory anemia with excess blasts | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  272. en:regressing melanoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:regressing melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  273. en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements --- r_associated #0: 34 --> en:adamantinoma
    n1=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  274. en:stromal sarcoma --- r_associated #0: 34 --> en:adamantinoma
    n1=en:stromal sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  275. en:thyroid gland spindle cell tumor with thymus-like differentiation --- r_associated #0: 34 --> en:adamantinoma
    n1=en:thyroid gland spindle cell tumor with thymus-like differentiation | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  276. en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells --- r_associated #0: 34 --> en:adamantinoma
    n1=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  277. fibrome --- r_associated #0: 34 --> en:adamantinoma
    n1=fibrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=34
  278. en:myxosarcoma --- r_associated #0: 33 --> en:adamantinoma
    n1=en:myxosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=33
  279. en:adenocarcinoma in villous adenoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:adenocarcinoma in villous adenoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  280. en:angiomyoliposarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:angiomyoliposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  281. en:atypical medullary carcinoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:atypical medullary carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  282. en:basal cell neoplasm --- r_associated #0: 32 --> en:adamantinoma
    n1=en:basal cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  283. en:benign epithelial neoplasm - category --- r_associated #0: 32 --> en:adamantinoma
    n1=en:benign epithelial neoplasm - category | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  284. en:burkitt leukemia --- r_associated #0: 32 --> en:adamantinoma
    n1=en:burkitt leukemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  285. en:connective and soft tissue --- r_associated #0: 32 --> en:adamantinoma
    n1=en:connective and soft tissue | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  286. en:dedifferentiated chondrosarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:dedifferentiated chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  287. en:epithelioid sarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:epithelioid sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  288. en:ethnologic --- r_associated #0: 32 --> en:adamantinoma
    n1=en:ethnologic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  289. en:exposure as collected domain --- r_associated #0: 32 --> en:adamantinoma
    n1=en:exposure as collected domain | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  290. en:fibrocellular tumor --- r_associated #0: 32 --> en:adamantinoma
    n1=en:fibrocellular tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  291. en:gain of chromosome 8 --- r_associated #0: 32 --> en:adamantinoma
    n1=en:gain of chromosome 8 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  292. en:genetic aspects --- r_associated #0: 32 --> en:adamantinoma
    n1=en:genetic aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  293. en:invasive ductal carcinoma, not otherwise specified --- r_associated #0: 32 --> en:adamantinoma
    n1=en:invasive ductal carcinoma, not otherwise specified | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  294. en:invasive micropapillary breast carcinoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:invasive micropapillary breast carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  295. en:langerhans cell sarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:langerhans cell sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  296. en:large cell carcinoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:large cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  297. en:low grade myofibroblastic sarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:low grade myofibroblastic sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  298. en:malignant struma ovarii --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant struma ovarii | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  299. en:malignant triton tumor --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant triton tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  300. en:malignant tumor of bone and articular cartilage --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant tumor of bone and articular cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  301. en:malignant tumor, clear cell type --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant tumor, clear cell type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  302. en:malignant type b1 thymoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant type b1 thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  303. en:malignant type b2 thymoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:malignant type b2 thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  304. en:meningeal sarcomatosis --- r_associated #0: 32 --> en:adamantinoma
    n1=en:meningeal sarcomatosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  305. en:mesothelioma (malignant, clinical disorder) (disorder) --- r_associated #0: 32 --> en:adamantinoma
    n1=en:mesothelioma (malignant, clinical disorder) (disorder) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  306. en:neoplastic smooth muscle cell --- r_associated #0: 32 --> en:adamantinoma
    n1=en:neoplastic smooth muscle cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  307. en:overlapping malignant neoplasm of ill-defined site --- r_associated #0: 32 --> en:adamantinoma
    n1=en:overlapping malignant neoplasm of ill-defined site | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  308. en:parosteal osteosarcoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:parosteal osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  309. en:primary malignant neoplasm of laryngeal cartilage --- r_associated #0: 32 --> en:adamantinoma
    n1=en:primary malignant neoplasm of laryngeal cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  310. en:refractory anemia with ring sideroblasts --- r_associated #0: 32 --> en:adamantinoma
    n1=en:refractory anemia with ring sideroblasts | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  311. en:sarcomatoid carcinoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:sarcomatoid carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  312. en:skin infiltrating basal cell carcinoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:skin infiltrating basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  313. en:spongioneuroblastoma --- r_associated #0: 32 --> en:adamantinoma
    n1=en:spongioneuroblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  314. en:therapeutic aspects --- r_associated #0: 32 --> en:adamantinoma
    n1=en:therapeutic aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  315. en:therapy-related myelodysplastic syndrome --- r_associated #0: 32 --> en:adamantinoma
    n1=en:therapy-related myelodysplastic syndrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  316. kyste anévrismal --- r_associated #0: 32 --> en:adamantinoma
    n1=kyste anévrismal | n2=en:adamantinoma | rel=r_associated | relid=0 | w=32
  317. adamantinome du tibia --- r_associated #0: 31 --> en:adamantinoma
    n1=adamantinome du tibia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  318. en:adenocarcinoma in adenomatous polyp --- r_associated #0: 31 --> en:adamantinoma
    n1=en:adenocarcinoma in adenomatous polyp | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  319. en:anaplastic ganglioglioma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:anaplastic ganglioglioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  320. en:clear cell sarcoma of soft tissue --- r_associated #0: 31 --> en:adamantinoma
    n1=en:clear cell sarcoma of soft tissue | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  321. en:dedifferentiated chordoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:dedifferentiated chordoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  322. en:digital papillary eccrine carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:digital papillary eccrine carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  323. en:endolymphatic sac tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:endolymphatic sac tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  324. en:epithelial component present --- r_associated #0: 31 --> en:adamantinoma
    n1=en:epithelial component present | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  325. en:epithelioid malignant peripheral nerve sheath tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:epithelioid malignant peripheral nerve sheath tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  326. en:epithelioid trophoblastic tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:epithelioid trophoblastic tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  327. en:follicular dendritic sarcoma of lymph nodes of multiple sites --- r_associated #0: 31 --> en:adamantinoma
    n1=en:follicular dendritic sarcoma of lymph nodes of multiple sites | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  328. en:germinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:germinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  329. en:glassy cell carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:glassy cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  330. en:hepatoid adenocarcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:hepatoid adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  331. en:histiocytic sarcoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:histiocytic sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  332. en:infiltrating lobular mixed with other types of carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:infiltrating lobular mixed with other types of carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  333. en:invasive ductal and lobular carcinoma in situ --- r_associated #0: 31 --> en:adamantinoma
    n1=en:invasive ductal and lobular carcinoma in situ | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  334. en:malignant aortic body tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:malignant aortic body tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  335. en:malignant neoplasm of long bones of lower limb --- r_associated #0: 31 --> en:adamantinoma
    n1=en:malignant neoplasm of long bones of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  336. en:malignant neoplasm of vertebral column --- r_associated #0: 31 --> en:adamantinoma
    n1=en:malignant neoplasm of vertebral column | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  337. en:malignant neoplasm of xiphoid process --- r_associated #0: 31 --> en:adamantinoma
    n1=en:malignant neoplasm of xiphoid process | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  338. en:malignant neoplasm, overlapping lesion of digestive system --- r_associated #0: 31 --> en:adamantinoma
    n1=en:malignant neoplasm, overlapping lesion of digestive system | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  339. en:melanoma in junctional nevus --- r_associated #0: 31 --> en:adamantinoma
    n1=en:melanoma in junctional nevus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  340. en:metastasis to lymph node from squamous cell carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:metastasis to lymph node from squamous cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  341. en:metastatic qualifier --- r_associated #0: 31 --> en:adamantinoma
    n1=en:metastatic qualifier | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  342. en:micropapillary transitional cell carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:micropapillary transitional cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  343. en:mixed epithelioid and spindle cell melanoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:mixed epithelioid and spindle cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  344. en:neoplasm of bone of upper limb --- r_associated #0: 31 --> en:adamantinoma
    n1=en:neoplasm of bone of upper limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  345. en:neoplasm of uncertain or unknown behaviour: bone and articular cartilage --- r_associated #0: 31 --> en:adamantinoma
    n1=en:neoplasm of uncertain or unknown behaviour: bone and articular cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  346. en:neoplasm of vertebral column --- r_associated #0: 31 --> en:adamantinoma
    n1=en:neoplasm of vertebral column | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  347. en:nonseminomatous germ cell tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:nonseminomatous germ cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  348. en:ossifying fibroma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:ossifying fibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  349. en:paget's disease and infiltrating duct carcinoma of breast --- r_associated #0: 31 --> en:adamantinoma
    n1=en:paget's disease and infiltrating duct carcinoma of breast | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  350. en:primary malignant neoplasm of bone of upper limb --- r_associated #0: 31 --> en:adamantinoma
    n1=en:primary malignant neoplasm of bone of upper limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  351. en:primary malignant neoplasm of gastrointestinal tract --- r_associated #0: 31 --> en:adamantinoma
    n1=en:primary malignant neoplasm of gastrointestinal tract | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  352. en:primary malignant neoplasm of ill-defined site --- r_associated #0: 31 --> en:adamantinoma
    n1=en:primary malignant neoplasm of ill-defined site | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  353. en:primary malignant neoplasm of scapula (disorder) --- r_associated #0: 31 --> en:adamantinoma
    n1=en:primary malignant neoplasm of scapula (disorder) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  354. en:regressed germ cell tumor --- r_associated #0: 31 --> en:adamantinoma
    n1=en:regressed germ cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  355. en:second primary malignant neoplasm --- r_associated #0: 31 --> en:adamantinoma
    n1=en:second primary malignant neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  356. en:superficial multifocal basal cell carcinoma --- r_associated #0: 31 --> en:adamantinoma
    n1=en:superficial multifocal basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  357. en:thyroid gland carcinoma showing thymus-like differentiation --- r_associated #0: 31 --> en:adamantinoma
    n1=en:thyroid gland carcinoma showing thymus-like differentiation | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  358. enchondrome --- r_associated #0: 31 --> en:adamantinoma
    n1=enchondrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  359. fibrome ossifiant --- r_associated #0: 31 --> en:adamantinoma
    n1=fibrome ossifiant | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  360. germinome --- r_associated #0: 31 --> en:adamantinoma
    n1=germinome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  361. mélanome lentigineux acral --- r_associated #0: 31 --> en:adamantinoma
    n1=mélanome lentigineux acral | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  362. ostéosarcome télangiectasique --- r_associated #0: 31 --> en:adamantinoma
    n1=ostéosarcome télangiectasique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  363. tumescence --- r_associated #0: 31 --> en:adamantinoma
    n1=tumescence | n2=en:adamantinoma | rel=r_associated | relid=0 | w=31
  364. carcinomatose --- r_associated #0: 30 --> en:adamantinoma
    n1=carcinomatose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  365. chondrosarcome --- r_associated #0: 30 --> en:adamantinoma
    n1=chondrosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  366. en:ameloblastic odontosarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:ameloblastic odontosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  367. en:cancerous growth --- r_associated #0: 30 --> en:adamantinoma
    n1=en:cancerous growth | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  368. en:cancerous tumor --- r_associated #0: 30 --> en:adamantinoma
    n1=en:cancerous tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  369. en:carcinomatosa --- r_associated #0: 30 --> en:adamantinoma
    n1=en:carcinomatosa | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  370. en:carcinomatosis --- r_associated #0: 30 --> en:adamantinoma
    n1=en:carcinomatosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  371. en:chondrosarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  372. en:clinical data interchange standards consortium terminology --- r_associated #0: 30 --> en:adamantinoma
    n1=en:clinical data interchange standards consortium terminology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  373. en:ectomesenchymoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:ectomesenchymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  374. en:esthesioneurocytoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:esthesioneurocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  375. en:follicular dendritic cell sarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:follicular dendritic cell sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  376. en:indolent systemic mastocytosis --- r_associated #0: 30 --> en:adamantinoma
    n1=en:indolent systemic mastocytosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  377. en:infiltrating duct mixed with other types of carcinoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:infiltrating duct mixed with other types of carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  378. en:malignant blood vessel neoplasm --- r_associated #0: 30 --> en:adamantinoma
    n1=en:malignant blood vessel neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  379. en:malignant extra-adrenal paraganglioma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:malignant extra-adrenal paraganglioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  380. en:malignant leydig cell tumor --- r_associated #0: 30 --> en:adamantinoma
    n1=en:malignant leydig cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  381. en:malignant mixed tumor, chondrosarcomatous type --- r_associated #0: 30 --> en:adamantinoma
    n1=en:malignant mixed tumor, chondrosarcomatous type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  382. en:malignant trophoblastic teratoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:malignant trophoblastic teratoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  383. en:mesenchymal chondrosarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:mesenchymal chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  384. en:metastasizing ameloblastoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:metastasizing ameloblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  385. en:mixed mesodermal (mullerian) tumor --- r_associated #0: 30 --> en:adamantinoma
    n1=en:mixed mesodermal (mullerian) tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  386. en:myeloliposarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:myeloliposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  387. en:neoplastic epithelial cell --- r_associated #0: 30 --> en:adamantinoma
    n1=en:neoplastic epithelial cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  388. en:neoplastic sex cord-stromal cell --- r_associated #0: 30 --> en:adamantinoma
    n1=en:neoplastic sex cord-stromal cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  389. en:non-hodgkin's lymphoma of bone --- r_associated #0: 30 --> en:adamantinoma
    n1=en:non-hodgkin's lymphoma of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  390. en:pancreatic acinar cell cystadenocarcinoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:pancreatic acinar cell cystadenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  391. en:pancreatoblastoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:pancreatoblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  392. en:papillary transitional cell carcinoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:papillary transitional cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  393. en:plasma cell myeloma/plasmacytoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:plasma cell myeloma/plasmacytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  394. en:pleomorphic rhabdomyosarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:pleomorphic rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  395. en:primary malignant adenomatous neoplasm --- r_associated #0: 30 --> en:adamantinoma
    n1=en:primary malignant adenomatous neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  396. en:primary malignant neoplasm of neck --- r_associated #0: 30 --> en:adamantinoma
    n1=en:primary malignant neoplasm of neck | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  397. en:refractory anemia --- r_associated #0: 30 --> en:adamantinoma
    n1=en:refractory anemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  398. en:refractory cytopenia with multilineage dysplasia and ring sideroblasts --- r_associated #0: 30 --> en:adamantinoma
    n1=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  399. en:sarcomatoid mesothelioma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:sarcomatoid mesothelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  400. en:sea-blue histiocyte disease --- r_associated #0: 30 --> en:adamantinoma
    n1=en:sea-blue histiocyte disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  401. en:skin adenoid basal cell carcinoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:skin adenoid basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  402. en:small cell carcinoma carcinomatosis --- r_associated #0: 30 --> en:adamantinoma
    n1=en:small cell carcinoma carcinomatosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  403. en:swelling --- r_associated #0: 30 --> en:adamantinoma
    n1=en:swelling | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  404. en:telangiectatic osteosarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:telangiectatic osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  405. en:testicular spermatocytic seminoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:testicular spermatocytic seminoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  406. en:thymoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  407. en:« osteogenic » sarcoma --- r_associated #0: 30 --> en:adamantinoma
    n1=en:« osteogenic » sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  408. enflé --- r_associated #0: 30 --> en:adamantinoma
    n1=enflé | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  409. gonflement --- r_associated #0: 30 --> en:adamantinoma
    n1=gonflement | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  410. intumescence --- r_associated #0: 30 --> en:adamantinoma
    n1=intumescence | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  411. leucose --- r_associated #0: 30 --> en:adamantinoma
    n1=leucose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  412. odontosarcome améloblastique --- r_associated #0: 30 --> en:adamantinoma
    n1=odontosarcome améloblastique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  413. ostéoporose-pseudogliome (syndrome) --- r_associated #0: 30 --> en:adamantinoma
    n1=ostéoporose-pseudogliome (syndrome) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  414. thymome --- r_associated #0: 30 --> en:adamantinoma
    n1=thymome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  415. tuméfaction --- r_associated #0: 30 --> en:adamantinoma
    n1=tuméfaction | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  416. tuméfié --- r_associated #0: 30 --> en:adamantinoma
    n1=tuméfié | n2=en:adamantinoma | rel=r_associated | relid=0 | w=30
  417. en:adamantinoma of long bones --- r_associated #0: 29 --> en:adamantinoma
    n1=en:adamantinoma of long bones | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  418. en:aspects of radionuclide imaging --- r_associated #0: 29 --> en:adamantinoma
    n1=en:aspects of radionuclide imaging | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  419. en:blood supply aspects --- r_associated #0: 29 --> en:adamantinoma
    n1=en:blood supply aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  420. en:bone cancer by ajcc v8 stage --- r_associated #0: 29 --> en:adamantinoma
    n1=en:bone cancer by ajcc v8 stage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  421. en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements --- r_associated #0: 29 --> en:adamantinoma
    n1=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  422. en:clear cell chondrosarcoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:clear cell chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  423. en:complication aspects --- r_associated #0: 29 --> en:adamantinoma
    n1=en:complication aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  424. en:corneal rodent ulcer --- r_associated #0: 29 --> en:adamantinoma
    n1=en:corneal rodent ulcer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  425. en:familial letterer-siwe disease --- r_associated #0: 29 --> en:adamantinoma
    n1=en:familial letterer-siwe disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  426. en:high grade serous carcinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:high grade serous carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  427. en:high risk gastrointestinal stromal tumor --- r_associated #0: 29 --> en:adamantinoma
    n1=en:high risk gastrointestinal stromal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  428. en:immunology aspects --- r_associated #0: 29 --> en:adamantinoma
    n1=en:immunology aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  429. en:interdigitating dendritic cell sarcoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:interdigitating dendritic cell sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  430. en:lentigo maligna melanoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:lentigo maligna melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  431. en:malignant bone marrow neoplasm --- r_associated #0: 29 --> en:adamantinoma
    n1=en:malignant bone marrow neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  432. en:malignant carotid body paraganglioma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:malignant carotid body paraganglioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  433. en:malignant cell --- r_associated #0: 29 --> en:adamantinoma
    n1=en:malignant cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  434. en:malignant mesothelioma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:malignant mesothelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  435. en:malignant odontogenic ghost cell tumor --- r_associated #0: 29 --> en:adamantinoma
    n1=en:malignant odontogenic ghost cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  436. en:mixed acinar-ductal carcinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:mixed acinar-ductal carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  437. en:mixed liposarcoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:mixed liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  438. en:myxoid chondrosarcoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:myxoid chondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  439. en:osteogenic/bone tumor, special type --- r_associated #0: 29 --> en:adamantinoma
    n1=en:osteogenic/bone tumor, special type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  440. en:periosteal osteosarcoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:periosteal osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  441. en:primary malignant neoplasm of bone --- r_associated #0: 29 --> en:adamantinoma
    n1=en:primary malignant neoplasm of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  442. en:primary malignant neoplasm of nervous system --- r_associated #0: 29 --> en:adamantinoma
    n1=en:primary malignant neoplasm of nervous system | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  443. en:psychology qualifier --- r_associated #0: 29 --> en:adamantinoma
    n1=en:psychology qualifier | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  444. en:skin metatypical carcinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:skin metatypical carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  445. en:solid pseudopapillary carcinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:solid pseudopapillary carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  446. en:thyroid gland diffuse sclerosing papillary carcinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:thyroid gland diffuse sclerosing papillary carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  447. en:tibial adamantinoma --- r_associated #0: 29 --> en:adamantinoma
    n1=en:tibial adamantinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  448. en:warthin tumor --- r_associated #0: 29 --> en:adamantinoma
    n1=en:warthin tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  449. maladie de vaquez --- r_associated #0: 29 --> en:adamantinoma
    n1=maladie de vaquez | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  450. séminome --- r_associated #0: 29 --> en:adamantinoma
    n1=séminome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=29
  451. adénocarcinome eccrine --- r_associated #0: 28 --> en:adamantinoma
    n1=adénocarcinome eccrine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  452. en:adenomyoepithelioma with carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:adenomyoepithelioma with carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  453. en:carcinoma of lip, oral cavity and pharynx --- r_associated #0: 28 --> en:adamantinoma
    n1=en:carcinoma of lip, oral cavity and pharynx | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  454. en:carcinoma with osteoclast-like giant cells --- r_associated #0: 28 --> en:adamantinoma
    n1=en:carcinoma with osteoclast-like giant cells | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  455. en:endocrine neoplasm --- r_associated #0: 28 --> en:adamantinoma
    n1=en:endocrine neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  456. en:extraskeletal osteosarcoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:extraskeletal osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  457. en:fibroma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:fibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  458. en:giant cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:giant cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  459. en:large cell neuroendocrine carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:large cell neuroendocrine carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  460. en:lobular breast carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:lobular breast carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  461. en:low grade serous carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:low grade serous carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  462. en:malignant ovarian brenner tumor --- r_associated #0: 28 --> en:adamantinoma
    n1=en:malignant ovarian brenner tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  463. en:malignant ovarian thecoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:malignant ovarian thecoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  464. en:malignant sacral teratoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:malignant sacral teratoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  465. en:malignant squamous cell neoplasm --- r_associated #0: 28 --> en:adamantinoma
    n1=en:malignant squamous cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  466. en:melanoma arising from blue nevus --- r_associated #0: 28 --> en:adamantinoma
    n1=en:melanoma arising from blue nevus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  467. en:microcystic adnexal carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:microcystic adnexal carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  468. en:neoplasm of bone of lower limb --- r_associated #0: 28 --> en:adamantinoma
    n1=en:neoplasm of bone of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  469. en:neoplasm of rib --- r_associated #0: 28 --> en:adamantinoma
    n1=en:neoplasm of rib | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  470. en:pancreatic intraepithelial neoplasia --- r_associated #0: 28 --> en:adamantinoma
    n1=en:pancreatic intraepithelial neoplasia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  471. en:pharmacotherapeutic --- r_associated #0: 28 --> en:adamantinoma
    n1=en:pharmacotherapeutic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  472. en:pilomatrical carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:pilomatrical carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  473. en:polygonal cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:polygonal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  474. en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  475. en:primary malignant neoplasm of ear, nose and/or throat --- r_associated #0: 28 --> en:adamantinoma
    n1=en:primary malignant neoplasm of ear, nose and/or throat | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  476. en:primary undifferentiated large cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:primary undifferentiated large cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  477. en:reactive immunoproliferative disease --- r_associated #0: 28 --> en:adamantinoma
    n1=en:reactive immunoproliferative disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  478. en:rhabdomyoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:rhabdomyoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  479. en:sertoli cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:sertoli cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  480. en:signet ring cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:signet ring cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  481. en:small cell intermediate cell carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:small cell intermediate cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  482. en:synovial sarcoma - category --- r_associated #0: 28 --> en:adamantinoma
    n1=en:synovial sarcoma - category | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  483. en:undifferentiated carcinoma --- r_associated #0: 28 --> en:adamantinoma
    n1=en:undifferentiated carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  484. en:undifferentiated sarcoma, not otherwise specified --- r_associated #0: 28 --> en:adamantinoma
    n1=en:undifferentiated sarcoma, not otherwise specified | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  485. ethnologique --- r_associated #0: 28 --> en:adamantinoma
    n1=ethnologique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=28
  486. en:bone epithelioid hemangioendothelioma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:bone epithelioid hemangioendothelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  487. en:cancerous tumour --- r_associated #0: 27 --> en:adamantinoma
    n1=en:cancerous tumour | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  488. en:chemically induced --- r_associated #0: 27 --> en:adamantinoma
    n1=en:chemically induced | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  489. en:chief cell adenocarcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:chief cell adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  490. en:chondroid chordoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:chondroid chordoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  491. en:cystic partially differentiated nephroblastoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:cystic partially differentiated nephroblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  492. en:desmoplastic melanoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:desmoplastic melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  493. en:ductal carcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:ductal carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  494. en:enchondrosarcoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:enchondrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  495. en:endometrial stromal sarcoma - category --- r_associated #0: 27 --> en:adamantinoma
    n1=en:endometrial stromal sarcoma - category | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  496. en:epithelial carcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:epithelial carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  497. en:epithelioid cell melanoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:epithelioid cell melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  498. en:etiology aspects --- r_associated #0: 27 --> en:adamantinoma
    n1=en:etiology aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  499. en:extramammary paget disease --- r_associated #0: 27 --> en:adamantinoma
    n1=en:extramammary paget disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  500. en:giant cell sarcoma (except of bone, m-92503) --- r_associated #0: 27 --> en:adamantinoma
    n1=en:giant cell sarcoma (except of bone, m-92503) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  501. en:low grade lesion --- r_associated #0: 27 --> en:adamantinoma
    n1=en:low grade lesion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  502. en:lymphosarcoma of lymph nodes of head, face and neck --- r_associated #0: 27 --> en:adamantinoma
    n1=en:lymphosarcoma of lymph nodes of head, face and neck | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  503. en:lytic bone lesion --- r_associated #0: 27 --> en:adamantinoma
    n1=en:lytic bone lesion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  504. en:malignant immunoproliferative neoplasm --- r_associated #0: 27 --> en:adamantinoma
    n1=en:malignant immunoproliferative neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  505. en:malignant ossifying fibromyxoid tumor --- r_associated #0: 27 --> en:adamantinoma
    n1=en:malignant ossifying fibromyxoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  506. en:malignant thymoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:malignant thymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  507. en:metastasis to lymph node from adenocarcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:metastasis to lymph node from adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  508. en:metastatic carcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:metastatic carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  509. en:minimal deviation malignant melanoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:minimal deviation malignant melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  510. en:myxoid liposarcoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:myxoid liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  511. en:neoplasm of clavicle --- r_associated #0: 27 --> en:adamantinoma
    n1=en:neoplasm of clavicle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  512. en:nodular melanoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:nodular melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  513. en:oligodendroglioma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:oligodendroglioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  514. en:osteoclastic giant cell-rich tumor of bone --- r_associated #0: 27 --> en:adamantinoma
    n1=en:osteoclastic giant cell-rich tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  515. en:primary malignant neoplasm of pelvic bone --- r_associated #0: 27 --> en:adamantinoma
    n1=en:primary malignant neoplasm of pelvic bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  516. en:primary malignant neoplasm of ribs and/or sternum and/or clavicle --- r_associated #0: 27 --> en:adamantinoma
    n1=en:primary malignant neoplasm of ribs and/or sternum and/or clavicle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  517. en:primary malignant neoplasm of sweat gland --- r_associated #0: 27 --> en:adamantinoma
    n1=en:primary malignant neoplasm of sweat gland | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  518. en:primary malignant neoplasm of vomer --- r_associated #0: 27 --> en:adamantinoma
    n1=en:primary malignant neoplasm of vomer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  519. en:refractory anemia with excess blasts in transformation --- r_associated #0: 27 --> en:adamantinoma
    n1=en:refractory anemia with excess blasts in transformation | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  520. en:secondary osteosarcoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:secondary osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  521. en:sertoli-leydig cell tumor, poorly differentiated --- r_associated #0: 27 --> en:adamantinoma
    n1=en:sertoli-leydig cell tumor, poorly differentiated | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  522. en:skin basal cell carcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:skin basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  523. en:skin fibroepithelial basal cell carcinoma --- r_associated #0: 27 --> en:adamantinoma
    n1=en:skin fibroepithelial basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  524. en:solid papillary carcinoma with invasion --- r_associated #0: 27 --> en:adamantinoma
    n1=en:solid papillary carcinoma with invasion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  525. lipomyxosarcome --- r_associated #0: 27 --> en:adamantinoma
    n1=lipomyxosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  526. mélanome desmoplastique --- r_associated #0: 27 --> en:adamantinoma
    n1=mélanome desmoplastique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  527. oligodendrogliome --- r_associated #0: 27 --> en:adamantinoma
    n1=oligodendrogliome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  528. ostéosarcome périosté --- r_associated #0: 27 --> en:adamantinoma
    n1=ostéosarcome périosté | n2=en:adamantinoma | rel=r_associated | relid=0 | w=27
  529. adamantinome des os longs --- r_associated #0: 26 --> en:adamantinoma
    n1=adamantinome des os longs | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  530. adénocarcinome sudoripare --- r_associated #0: 26 --> en:adamantinoma
    n1=adénocarcinome sudoripare | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  531. en:anaplastic (malignant) meningioma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:anaplastic (malignant) meningioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  532. en:askin tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:askin tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  533. en:dedifferentiated liposarcoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:dedifferentiated liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  534. en:duct carcinoma, desmoplastic type --- r_associated #0: 26 --> en:adamantinoma
    n1=en:duct carcinoma, desmoplastic type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  535. en:epithelial-myoepithelial carcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:epithelial-myoepithelial carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  536. en:epithelioid mesothelioma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:epithelioid mesothelioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  537. en:essential thrombocythemia --- r_associated #0: 26 --> en:adamantinoma
    n1=en:essential thrombocythemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  538. en:femoral neoplasms --- r_associated #0: 26 --> en:adamantinoma
    n1=en:femoral neoplasms | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  539. en:fibroid tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:fibroid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  540. en:gain of chromosome 7 --- r_associated #0: 26 --> en:adamantinoma
    n1=en:gain of chromosome 7 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  541. en:indolent clinical course --- r_associated #0: 26 --> en:adamantinoma
    n1=en:indolent clinical course | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  542. en:infantile fibrosarcoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:infantile fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  543. en:intraductal papillary adenocarcinoma with invasion --- r_associated #0: 26 --> en:adamantinoma
    n1=en:intraductal papillary adenocarcinoma with invasion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  544. en:kidney wilms tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:kidney wilms tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  545. en:low grade central osteosarcoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:low grade central osteosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  546. en:malignancy in giant cell tumor of bone --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignancy in giant cell tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  547. en:malignant melanoma in giant pigmented nevus --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignant melanoma in giant pigmented nevus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  548. en:malignant mesenchymoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignant mesenchymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  549. en:malignant neoplasm of scapula and long bones of upper arm --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignant neoplasm of scapula and long bones of upper arm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  550. en:malignant peripheral nerve sheath tumor with perineurial differentiation --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignant peripheral nerve sheath tumor with perineurial differentiation | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  551. en:malignant tenosynovial giant cell tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:malignant tenosynovial giant cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  552. en:mesonephric adenocarcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:mesonephric adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  553. en:microbiological --- r_associated #0: 26 --> en:adamantinoma
    n1=en:microbiological | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  554. en:mixed germ cell tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:mixed germ cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  555. en:mixed glioma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:mixed glioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  556. en:myelodysplastic syndrome, no icd-o subtype --- r_associated #0: 26 --> en:adamantinoma
    n1=en:myelodysplastic syndrome, no icd-o subtype | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  557. en:neoplasm of pelvic bone --- r_associated #0: 26 --> en:adamantinoma
    n1=en:neoplasm of pelvic bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  558. en:neoplasm of scapula --- r_associated #0: 26 --> en:adamantinoma
    n1=en:neoplasm of scapula | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  559. en:olfactory neurogenic tumor --- r_associated #0: 26 --> en:adamantinoma
    n1=en:olfactory neurogenic tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  560. en:osteoporosis-pseudoglioma syndrome --- r_associated #0: 26 --> en:adamantinoma
    n1=en:osteoporosis-pseudoglioma syndrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  561. en:overlapping malignant neoplasm of lip, oral cavity and pharynx --- r_associated #0: 26 --> en:adamantinoma
    n1=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  562. en:pain --- r_associated #0: 26 --> en:adamantinoma
    n1=en:pain | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  563. en:polymorphous low grade adenocarcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:polymorphous low grade adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  564. en:primary malignant neoplasm of articular cartilage --- r_associated #0: 26 --> en:adamantinoma
    n1=en:primary malignant neoplasm of articular cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  565. en:primary malignant neoplasm of independent multiple sites --- r_associated #0: 26 --> en:adamantinoma
    n1=en:primary malignant neoplasm of independent multiple sites | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  566. en:prolymphocytic lymphosarcoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:prolymphocytic lymphosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  567. en:refractory cytopenia with multilineage dysplasia --- r_associated #0: 26 --> en:adamantinoma
    n1=en:refractory cytopenia with multilineage dysplasia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  568. en:roentgenographic --- r_associated #0: 26 --> en:adamantinoma
    n1=en:roentgenographic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  569. en:secretory breast carcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:secretory breast carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  570. en:seromucinous carcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:seromucinous carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  571. en:sternal neoplasm --- r_associated #0: 26 --> en:adamantinoma
    n1=en:sternal neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  572. en:steroid cell tumor, malignant --- r_associated #0: 26 --> en:adamantinoma
    n1=en:steroid cell tumor, malignant | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  573. en:thymic carcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:thymic carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  574. en:thymoma type b3 --- r_associated #0: 26 --> en:adamantinoma
    n1=en:thymoma type b3 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  575. en:trichilemmocarcinoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:trichilemmocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  576. en:tumentia --- r_associated #0: 26 --> en:adamantinoma
    n1=en:tumentia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  577. en:well differentiated liposarcoma --- r_associated #0: 26 --> en:adamantinoma
    n1=en:well differentiated liposarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  578. microbiologique --- r_associated #0: 26 --> en:adamantinoma
    n1=microbiologique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  579. neuroépithéliomes --- r_associated #0: 26 --> en:adamantinoma
    n1=neuroépithéliomes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  580. tumeurs neuroectodermiques périphériques primitives --- r_associated #0: 26 --> en:adamantinoma
    n1=tumeurs neuroectodermiques périphériques primitives | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  581. épithélioma adamantin --- r_associated #0: 26 --> en:adamantinoma
    n1=épithélioma adamantin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=26
  582. TULV --- r_associated #0: 25 --> en:adamantinoma
    n1=TULV | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  583. en:Vaquez-Osler disease --- r_associated #0: 25 --> en:adamantinoma
    n1=en:Vaquez-Osler disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  584. en:adenoid tumor --- r_associated #0: 25 --> en:adamantinoma
    n1=en:adenoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  585. en:dermatofibroma --- r_associated #0: 25 --> en:adamantinoma
    n1=en:dermatofibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  586. en:germ cell tumor --- r_associated #0: 25 --> en:adamantinoma
    n1=en:germ cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  587. en:lipoblastoma --- r_associated #0: 25 --> en:adamantinoma
    n1=en:lipoblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  588. en:nursing therapy --- r_associated #0: 25 --> en:adamantinoma
    n1=en:nursing therapy | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  589. en:rodent ulcer --- r_associated #0: 25 --> en:adamantinoma
    n1=en:rodent ulcer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  590. en:tumefied --- r_associated #0: 25 --> en:adamantinoma
    n1=en:tumefied | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  591. médullo-épithéliome --- r_associated #0: 25 --> en:adamantinoma
    n1=médullo-épithéliome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  592. mélanisation (unité épidermique de) --- r_associated #0: 25 --> en:adamantinoma
    n1=mélanisation (unité épidermique de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  593. radiographique --- r_associated #0: 25 --> en:adamantinoma
    n1=radiographique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=25
  594. anémie réfractaire --- r_associated #0: 24 --> en:adamantinoma
    n1=anémie réfractaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  595. carcinome annexiel microkystique --- r_associated #0: 24 --> en:adamantinoma
    n1=carcinome annexiel microkystique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  596. en:Vaquez' disease --- r_associated #0: 24 --> en:adamantinoma
    n1=en:Vaquez' disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  597. en:desmocytoma --- r_associated #0: 24 --> en:adamantinoma
    n1=en:desmocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  598. en:mu chain disease --- r_associated #0: 24 --> en:adamantinoma
    n1=en:mu chain disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  599. en:oncosis --- r_associated #0: 24 --> en:adamantinoma
    n1=en:oncosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  600. en:ou muqueuse exceptionnelle --- r_associated #0: 24 --> en:adamantinoma
    n1=en:ou muqueuse exceptionnelle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=24
  601. carcinome intracanalaire --- r_associated #0: 23 --> en:adamantinoma
    n1=carcinome intracanalaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=23
  602. en:oncoma --- r_associated #0: 23 --> en:adamantinoma
    n1=en:oncoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=23
  603. en:epidemiological --- r_associated #0: 22 --> en:adamantinoma
    n1=en:epidemiological | n2=en:adamantinoma | rel=r_associated | relid=0 | w=22
  604. en:in situ carcinoma --- r_associated #0: 22 --> en:adamantinoma
    n1=en:in situ carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=22
  605. améloblastome à cellules granuleuses --- r_associated #0: 21 --> en:adamantinoma
    n1=améloblastome à cellules granuleuses | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  606. améloblastomes --- r_associated #0: 21 --> en:adamantinoma
    n1=améloblastomes | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  607. chondrosarcome mésenchymateux --- r_associated #0: 21 --> en:adamantinoma
    n1=chondrosarcome mésenchymateux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  608. en:Hodgkin lymphoma --- r_associated #0: 21 --> en:adamantinoma
    n1=en:Hodgkin lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  609. en:adamantinoma of long bone of lower limb --- r_associated #0: 21 --> en:adamantinoma
    n1=en:adamantinoma of long bone of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  610. en:adenomata --- r_associated #0: 21 --> en:adamantinoma
    n1=en:adenomata | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  611. en:malignant ameloblastoma --- r_associated #0: 21 --> en:adamantinoma
    n1=en:malignant ameloblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  612. en:ncit neoplasm core terminology --- r_associated #0: 21 --> en:adamantinoma
    n1=en:ncit neoplasm core terminology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  613. en:osteoid osteoma --- r_associated #0: 21 --> en:adamantinoma
    n1=en:osteoid osteoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  614. en:ulcerating basal cell carcinoma --- r_associated #0: 21 --> en:adamantinoma
    n1=en:ulcerating basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  615. en:ulcus exedens --- r_associated #0: 21 --> en:adamantinoma
    n1=en:ulcus exedens | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  616. ostéome --- r_associated #0: 21 --> en:adamantinoma
    n1=ostéome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  617. rhabdomyome --- r_associated #0: 21 --> en:adamantinoma
    n1=rhabdomyome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  618. thrombocytémie essentielle --- r_associated #0: 21 --> en:adamantinoma
    n1=thrombocytémie essentielle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=21
  619. Séminome --- r_associated #0: 20 --> en:adamantinoma
    n1=Séminome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  620. Thymome --- r_associated #0: 20 --> en:adamantinoma
    n1=Thymome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  621. améloblastome, sai --- r_associated #0: 20 --> en:adamantinoma
    n1=améloblastome, sai | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  622. cancer --- r_associated #0: 20 --> en:adamantinoma
    n1=cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  623. carcinome intra-canalaire --- r_associated #0: 20 --> en:adamantinoma
    n1=carcinome intra-canalaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  624. en:acinar cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:acinar cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  625. en:acute leukaemia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:acute leukaemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  626. en:acute leukemia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:acute leukemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  627. en:adenoma and/or adenocarcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:adenoma and/or adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  628. en:adenosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:adenosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  629. en:adenosquamous carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:adenosquamous carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  630. en:adnexal carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:adnexal carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  631. en:alpha heavy chain disease --- r_associated #0: 20 --> en:adamantinoma
    n1=en:alpha heavy chain disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  632. en:alveolar rhabdomyosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:alveolar rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  633. en:ameloblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ameloblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  634. en:anal canal cloacogenic carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:anal canal cloacogenic carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  635. en:benign muscle neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:benign muscle neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  636. en:bone glomus tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:bone glomus tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  637. en:carcinoid tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:carcinoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  638. en:carcinoma ex pleomorphic adenoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:carcinoma ex pleomorphic adenoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  639. en:carcinoma of bone, connective tissue, skin and breast --- r_associated #0: 20 --> en:adamantinoma
    n1=en:carcinoma of bone, connective tissue, skin and breast | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  640. en:carcinosarcoma, embryonal --- r_associated #0: 20 --> en:adamantinoma
    n1=en:carcinosarcoma, embryonal | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  641. en:cdisc send tumor findings results terminology --- r_associated #0: 20 --> en:adamantinoma
    n1=en:cdisc send tumor findings results terminology | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  642. en:cellular secretion --- r_associated #0: 20 --> en:adamantinoma
    n1=en:cellular secretion | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  643. en:chemical aspects --- r_associated #0: 20 --> en:adamantinoma
    n1=en:chemical aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  644. en:chronic myelomonocytic leukemia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:chronic myelomonocytic leukemia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  645. en:clear cell (mesonephroid) neoplasm - category --- r_associated #0: 20 --> en:adamantinoma
    n1=en:clear cell (mesonephroid) neoplasm - category | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  646. en:combined small cell lung carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:combined small cell lung carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  647. en:complex epithelial neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:complex epithelial neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  648. en:composite hodgkin and non-hodgkin lymphoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:composite hodgkin and non-hodgkin lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  649. en:congenital mesh qualifier --- r_associated #0: 20 --> en:adamantinoma
    n1=en:congenital mesh qualifier | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  650. en:desmoplastic small round cell tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:desmoplastic small round cell tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  651. en:diagnosis aspect --- r_associated #0: 20 --> en:adamantinoma
    n1=en:diagnosis aspect | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  652. en:embryologic --- r_associated #0: 20 --> en:adamantinoma
    n1=en:embryologic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  653. en:embryonal rhabdomyosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:embryonal rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  654. en:embryonal tumor with multilayered rosettes, c19mc-altered --- r_associated #0: 20 --> en:adamantinoma
    n1=en:embryonal tumor with multilayered rosettes, c19mc-altered | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  655. en:enostosis --- r_associated #0: 20 --> en:adamantinoma
    n1=en:enostosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  656. en:epithelial skin neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:epithelial skin neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  657. en:ewing sarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ewing sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  658. en:ewing sarcoma of bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ewing sarcoma of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  659. en:ewing sarcoma/peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  660. en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  661. en:fibrosarcoma of connective tissue --- r_associated #0: 20 --> en:adamantinoma
    n1=en:fibrosarcoma of connective tissue | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  662. en:fibrous dysplasia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:fibrous dysplasia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  663. en:gain of chromosome 12 --- r_associated #0: 20 --> en:adamantinoma
    n1=en:gain of chromosome 12 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  664. en:gain of chromosome 19 --- r_associated #0: 20 --> en:adamantinoma
    n1=en:gain of chromosome 19 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  665. en:ganglioneuroblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ganglioneuroblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  666. en:giant cell and spindle cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:giant cell and spindle cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  667. en:glandular cell neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:glandular cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  668. en:glioblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:glioblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  669. en:hepatoblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:hepatoblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  670. en:historical aspects qualifier --- r_associated #0: 20 --> en:adamantinoma
    n1=en:historical aspects qualifier | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  671. en:hypereosinophilic syndrome --- r_associated #0: 20 --> en:adamantinoma
    n1=en:hypereosinophilic syndrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  672. en:in blood --- r_associated #0: 20 --> en:adamantinoma
    n1=en:in blood | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  673. en:intermediate bone neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:intermediate bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  674. en:intraepithelial neoplasia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:intraepithelial neoplasia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  675. en:intraspinal neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:intraspinal neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  676. en:juvenile ossifying fibroma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:juvenile ossifying fibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  677. en:langerhans cell histiocytosis --- r_associated #0: 20 --> en:adamantinoma
    n1=en:langerhans cell histiocytosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  678. en:large cell lung carcinoma with rhabdoid phenotype --- r_associated #0: 20 --> en:adamantinoma
    n1=en:large cell lung carcinoma with rhabdoid phenotype | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  679. en:leiomyoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:leiomyoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  680. en:liposarcoma of connective tissue --- r_associated #0: 20 --> en:adamantinoma
    n1=en:liposarcoma of connective tissue | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  681. en:long bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:long bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  682. en:lymphoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  683. en:malignant adrenal gland pheochromocytoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant adrenal gland pheochromocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  684. en:malignant chest wall bone neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant chest wall bone neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  685. en:malignant epithelial neoplasm - category --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant epithelial neoplasm - category | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  686. en:malignant giant cell neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant giant cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  687. en:malignant glioma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant glioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  688. en:malignant glomus tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant glomus tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  689. en:malignant histiocytosis --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant histiocytosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  690. en:malignant melanoma in precancerous melanosis --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant melanoma in precancerous melanosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  691. en:malignant neoplasm of bone of lower limb --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of bone of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  692. en:malignant neoplasm of bones of skull and face --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of bones of skull and face | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  693. en:malignant neoplasm of carpal bones --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of carpal bones | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  694. en:malignant neoplasm of laryngeal cartilage --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of laryngeal cartilage | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  695. en:malignant neoplasm of nail apparatus --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of nail apparatus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  696. en:malignant neoplasm of pelvic bones, sacrum and coccyx --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of pelvic bones, sacrum and coccyx | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  697. en:malignant neoplasm of ribs, sternum and clavicle --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of ribs, sternum and clavicle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  698. en:malignant neoplasm of scapula and long bones of upper limb --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of scapula and long bones of upper limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  699. en:malignant neoplasm of short bones of lower limb --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of short bones of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  700. en:malignant neoplasm of short bones of upper limb --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant neoplasm of short bones of upper limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  701. en:malignant spindle cell neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant spindle cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  702. en:malignant tumor, small cell type --- r_associated #0: 20 --> en:adamantinoma
    n1=en:malignant tumor, small cell type | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  703. en:mast cell malignancy --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mast cell malignancy | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  704. en:maxillary neoplasms --- r_associated #0: 20 --> en:adamantinoma
    n1=en:maxillary neoplasms | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  705. en:medulloblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:medulloblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  706. en:mesenchymoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mesenchymoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  707. en:mesonephric neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mesonephric neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  708. en:metabolic aspects --- r_associated #0: 20 --> en:adamantinoma
    n1=en:metabolic aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  709. en:metastatic carcinoma in the bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:metastatic carcinoma in the bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  710. en:metastatic malignant neoplasm in the bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:metastatic malignant neoplasm in the bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  711. en:miscellaneous bone tumors --- r_associated #0: 20 --> en:adamantinoma
    n1=en:miscellaneous bone tumors | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  712. en:mixed type rhabdomyosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mixed type rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  713. en:mucin-producing adenocarcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mucin-producing adenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  714. en:mucoepidermoid carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:mucoepidermoid carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  715. en:myelodysplastic syndrome with isolated del(5q) --- r_associated #0: 20 --> en:adamantinoma
    n1=en:myelodysplastic syndrome with isolated del(5q) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  716. en:myosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:myosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  717. en:myxoid leiomyosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:myxoid leiomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  718. en:neoplasm of uncertain behavior of bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:neoplasm of uncertain behavior of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  719. en:neuroblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:neuroblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  720. en:non-hodgkin lymphoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:non-hodgkin lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  721. en:nutritional management --- r_associated #0: 20 --> en:adamantinoma
    n1=en:nutritional management | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  722. en:odontoameloblastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:odontoameloblastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  723. en:osteofibrous dysplasia --- r_associated #0: 20 --> en:adamantinoma
    n1=en:osteofibrous dysplasia | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  724. en:osteogenic/bone tumor, nos --- r_associated #0: 20 --> en:adamantinoma
    n1=en:osteogenic/bone tumor, nos | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  725. en:osteogenic/miscellaneous bone tumors (all subtypes) --- r_associated #0: 20 --> en:adamantinoma
    n1=en:osteogenic/miscellaneous bone tumors (all subtypes) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  726. en:osteosarcoma/malignant fibrous histiocytoma of bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:osteosarcoma/malignant fibrous histiocytoma of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  727. en:ovarian epithelial tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:ovarian epithelial tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  728. en:overlapping malignant neoplasm of bone and articular cartilage of limbs --- r_associated #0: 20 --> en:adamantinoma
    n1=en:overlapping malignant neoplasm of bone and articular cartilage of limbs | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  729. en:papillary epithelial neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:papillary epithelial neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  730. en:papilloma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:papilloma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  731. en:pathological aspects --- r_associated #0: 20 --> en:adamantinoma
    n1=en:pathological aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  732. en:peripheral primitive neuroectodermal tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:peripheral primitive neuroectodermal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  733. en:physiopathological --- r_associated #0: 20 --> en:adamantinoma
    n1=en:physiopathological | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  734. en:pleomorphic carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:pleomorphic carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  735. en:pleuropulmonary blastoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:pleuropulmonary blastoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  736. en:primary lymphoma of bone --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary lymphoma of bone | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  737. en:primary malignant neoplasm of bone of skull --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of bone of skull | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  738. en:primary malignant neoplasm of endocrine gland --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of endocrine gland | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  739. en:primary malignant neoplasm of lower limb --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of lower limb | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  740. en:primary malignant neoplasm of maxilla (disorder) --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of maxilla (disorder) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  741. en:primary malignant neoplasm of muscle --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of muscle | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  742. en:primary malignant neoplasm of respiratory tract --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of respiratory tract | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  743. en:primary malignant neoplasm of soft tissues --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of soft tissues | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  744. en:primary malignant neoplasm of trunk --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of trunk | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  745. en:primary malignant neoplasm of unknown site --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of unknown site | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  746. en:primary malignant neoplasm of upper limb (disorder) --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of upper limb (disorder) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  747. en:primary malignant neoplasm of vertebral column --- r_associated #0: 20 --> en:adamantinoma
    n1=en:primary malignant neoplasm of vertebral column | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  748. en:pseudoglandular squamous cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:pseudoglandular squamous cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  749. en:rehabilitation aspects --- r_associated #0: 20 --> en:adamantinoma
    n1=en:rehabilitation aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  750. en:rhabdoid tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:rhabdoid tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  751. en:sarcomatoid squamous cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:sarcomatoid squamous cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  752. en:skin basosquamous cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:skin basosquamous cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  753. en:skin nodular basal cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:skin nodular basal cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  754. en:skull neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:skull neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  755. en:small cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:small cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  756. en:spindle cell rhabdomyosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:spindle cell rhabdomyosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  757. en:spiradenocarcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:spiradenocarcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  758. en:stage i bone cancer --- r_associated #0: 20 --> en:adamantinoma
    n1=en:stage i bone cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  759. en:stage ii bone cancer --- r_associated #0: 20 --> en:adamantinoma
    n1=en:stage ii bone cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  760. en:stage iii bone cancer --- r_associated #0: 20 --> en:adamantinoma
    n1=en:stage iii bone cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  761. en:stage iv bone cancer --- r_associated #0: 20 --> en:adamantinoma
    n1=en:stage iv bone cancer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  762. en:surgical aspects --- r_associated #0: 20 --> en:adamantinoma
    n1=en:surgical aspects | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  763. en:t lymphoblastic leukemia/lymphoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:t lymphoblastic leukemia/lymphoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  764. en:thymus epithelial neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:thymus epithelial neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  765. en:tp53 gene inactivation --- r_associated #0: 20 --> en:adamantinoma
    n1=en:tp53 gene inactivation | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  766. en:transitional cell carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:transitional cell carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  767. en:transitional cell neoplasm --- r_associated #0: 20 --> en:adamantinoma
    n1=en:transitional cell neoplasm | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  768. en:tumorlet --- r_associated #0: 20 --> en:adamantinoma
    n1=en:tumorlet | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  769. en:undifferentiated (embryonal) sarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:undifferentiated (embryonal) sarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  770. en:use of ultrasonography --- r_associated #0: 20 --> en:adamantinoma
    n1=en:use of ultrasonography | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  771. en:vaccine-induced fibrosarcoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:vaccine-induced fibrosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  772. en:verrucous carcinoma --- r_associated #0: 20 --> en:adamantinoma
    n1=en:verrucous carcinoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  773. en:viruses --- r_associated #0: 20 --> en:adamantinoma
    n1=en:viruses | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  774. en:wolffian adnexal tumor --- r_associated #0: 20 --> en:adamantinoma
    n1=en:wolffian adnexal tumor | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  775. maladies --- r_associated #0: 20 --> en:adamantinoma
    n1=maladies | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  776. médecine
    (science)
     --- r_associated #0: 20 --> en:adamantinoma
    n1=médecine
    (science)
    | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  777. ostéo-fibrodysplasie de Campanacci --- r_associated #0: 20 --> en:adamantinoma
    n1=ostéo-fibrodysplasie de Campanacci | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  778. papillome --- r_associated #0: 20 --> en:adamantinoma
    n1=papillome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  779. pathologie du système ostéoarticulaire --- r_associated #0: 20 --> en:adamantinoma
    n1=pathologie du système ostéoarticulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  780. pathologie ostéo-articulaire --- r_associated #0: 20 --> en:adamantinoma
    n1=pathologie ostéo-articulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  781. processus pathologique --- r_associated #0: 20 --> en:adamantinoma
    n1=processus pathologique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=20
  782. améloblastome malin --- r_associated #0: 16 --> en:adamantinoma
    n1=améloblastome malin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=16
  783. Adamantiades (maladie d') --- r_associated #0: 15 --> en:adamantinoma
    n1=Adamantiades (maladie d') | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  784. Adénome --- r_associated #0: 15 --> en:adamantinoma
    n1=Adénome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  785. Cancer du sang --- r_associated #0: 15 --> en:adamantinoma
    n1=Cancer du sang | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  786. Chordome --- r_associated #0: 15 --> en:adamantinoma
    n1=Chordome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  787. Enzymologie --- r_associated #0: 15 --> en:adamantinoma
    n1=Enzymologie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  788. Leucose --- r_associated #0: 15 --> en:adamantinoma
    n1=Leucose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  789. Ostéosarcome --- r_associated #0: 15 --> en:adamantinoma
    n1=Ostéosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  790. Parasitologie --- r_associated #0: 15 --> en:adamantinoma
    n1=Parasitologie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  791. Tissu épithélial --- r_associated #0: 15 --> en:adamantinoma
    n1=Tissu épithélial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  792. adamantinome malin (à l'exception des os longs m-92613) --- r_associated #0: 15 --> en:adamantinoma
    n1=adamantinome malin (à l'exception des os longs m-92613) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  793. fibromyalgie (critères de l' American College of Rheumatology ) --- r_associated #0: 15 --> en:adamantinoma
    n1=fibromyalgie (critères de l' American College of Rheumatology ) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  794. germinale (tumeur) --- r_associated #0: 15 --> en:adamantinoma
    n1=germinale (tumeur) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  795. histiocyto-fibrosarcome --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocyto-fibrosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  796. histiocytofibrome cornéen --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytofibrome cornéen | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  797. histiocytome nodulaire progressif de Taunton --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytome nodulaire progressif de Taunton | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  798. histiocytome pigmenté --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytome pigmenté | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  799. histiocytome sidérifère hémosidérinique --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytome sidérifère hémosidérinique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  800. histiocytosarcome --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  801. histiocytose --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  802. histiocytose auto-involutive de Hashimoto-Pritzker --- r_associated #0: 15 --> en:adamantinoma
    n1=histiocytose auto-involutive de Hashimoto-Pritzker | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  803. kyste (et fistule) auriculo-branchial de la première fente --- r_associated #0: 15 --> en:adamantinoma
    n1=kyste (et fistule) auriculo-branchial de la première fente | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  804. ostéosarcome parostéal (ou parostal) --- r_associated #0: 15 --> en:adamantinoma
    n1=ostéosarcome parostéal (ou parostal) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  805. papilloma --- r_associated #0: 15 --> en:adamantinoma
    n1=papilloma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  806. pathologie du système ostéo-articulaire --- r_associated #0: 15 --> en:adamantinoma
    n1=pathologie du système ostéo-articulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
  807. liposarcome polymorphe --- r_associated #0: 11 --> en:adamantinoma
    n1=liposarcome polymorphe | n2=en:adamantinoma | rel=r_associated | relid=0 | w=11
  808. tibial --- r_associated #0: 11 --> en:adamantinoma
    n1=tibial | n2=en:adamantinoma | rel=r_associated | relid=0 | w=11
  809. Cancer des os --- r_associated #0: 10 --> en:adamantinoma
    n1=Cancer des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  810. Chopart (désarticulation de) --- r_associated #0: 10 --> en:adamantinoma
    n1=Chopart (désarticulation de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  811. Fibrome --- r_associated #0: 10 --> en:adamantinoma
    n1=Fibrome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  812. Leiner-Moussous (syndrome de) --- r_associated #0: 10 --> en:adamantinoma
    n1=Leiner-Moussous (syndrome de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  813. Leucémie --- r_associated #0: 10 --> en:adamantinoma
    n1=Leucémie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  814. Maladie de Vaquez --- r_associated #0: 10 --> en:adamantinoma
    n1=Maladie de Vaquez | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  815. Melanoma --- r_associated #0: 10 --> en:adamantinoma
    n1=Melanoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  816. Mélanome --- r_associated #0: 10 --> en:adamantinoma
    n1=Mélanome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  817. Paraquat ® (intoxication par le) --- r_associated #0: 10 --> en:adamantinoma
    n1=Paraquat ® (intoxication par le) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  818. Sarcome --- r_associated #0: 10 --> en:adamantinoma
    n1=Sarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  819. Thygeson (kératite ponctuée superficielle de) --- r_associated #0: 10 --> en:adamantinoma
    n1=Thygeson (kératite ponctuée superficielle de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  820. Tula (virus) --- r_associated #0: 10 --> en:adamantinoma
    n1=Tula (virus) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  821. Tumarkin (vertige de) --- r_associated #0: 10 --> en:adamantinoma
    n1=Tumarkin (vertige de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  822. Tumeur neuroectodermique primitive --- r_associated #0: 10 --> en:adamantinoma
    n1=Tumeur neuroectodermique primitive | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  823. Vaquez (maladie de) --- r_associated #0: 10 --> en:adamantinoma
    n1=Vaquez (maladie de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  824. carcinome adéno-squameux --- r_associated #0: 10 --> en:adamantinoma
    n1=carcinome adéno-squameux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  825. carcinome in situ --- r_associated #0: 10 --> en:adamantinoma
    n1=carcinome in situ | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  826. carcinome mixte glandulaire et épidermoïde --- r_associated #0: 10 --> en:adamantinoma
    n1=carcinome mixte glandulaire et épidermoïde | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  827. dysplasie fibreuse des os --- r_associated #0: 10 --> en:adamantinoma
    n1=dysplasie fibreuse des os | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  828. en:Vaquez's disease --- r_associated #0: 10 --> en:adamantinoma
    n1=en:Vaquez's disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  829. en:auriculobranchial cyst --- r_associated #0: 10 --> en:adamantinoma
    n1=en:auriculobranchial cyst | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  830. en:congenital self-healing Langerhans cell histiocytosis or Hashimoto-Pritzker disease --- r_associated #0: 10 --> en:adamantinoma
    n1=en:congenital self-healing Langerhans cell histiocytosis or Hashimoto-Pritzker disease | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  831. en:corneal histiocytofibroma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:corneal histiocytofibroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  832. en:enchondroma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:enchondroma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  833. en:epidermal melanisation unit --- r_associated #0: 10 --> en:adamantinoma
    n1=en:epidermal melanisation unit | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  834. en:ethnological --- r_associated #0: 10 --> en:adamantinoma
    n1=en:ethnological | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  835. en:histiocytosarcoma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:histiocytosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  836. en:histiocytosis --- r_associated #0: 10 --> en:adamantinoma
    n1=en:histiocytosis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  837. en:histiocytosis, langerhans-cell --- r_associated #0: 10 --> en:adamantinoma
    n1=en:histiocytosis, langerhans-cell | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  838. en:histiosarcoma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:histiosarcoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  839. en:radiographic --- r_associated #0: 10 --> en:adamantinoma
    n1=en:radiographic | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  840. en:seminoma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:seminoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  841. en:spermatocytoma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:spermatocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  842. en:spermocytoma --- r_associated #0: 10 --> en:adamantinoma
    n1=en:spermocytoma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  843. histiocytomatose gigantocellulaire --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytomatose gigantocellulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  844. histiocytome fibreux cholestérotique --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytome fibreux cholestérotique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  845. histiocytome fibreux inflammatoire --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytome fibreux inflammatoire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  846. histiocytome éruptif --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytome éruptif | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  847. histiocytome éruptif généralisé --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytome éruptif généralisé | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  848. histiocytose à cellules de langerhans --- r_associated #0: 10 --> en:adamantinoma
    n1=histiocytose à cellules de langerhans | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  849. hyperéosinophile sanguine (variante lymphocytique) --- r_associated #0: 10 --> en:adamantinoma
    n1=hyperéosinophile sanguine (variante lymphocytique) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  850. leucémie aiguë --- r_associated #0: 10 --> en:adamantinoma
    n1=leucémie aiguë | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  851. lymphome --- r_associated #0: 10 --> en:adamantinoma
    n1=lymphome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  852. lymphome malin non hodgkinien --- r_associated #0: 10 --> en:adamantinoma
    n1=lymphome malin non hodgkinien | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  853. lymphome malin à cellules à noyaux non encochés --- r_associated #0: 10 --> en:adamantinoma
    n1=lymphome malin à cellules à noyaux non encochés | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  854. lymphome non hodgkinien --- r_associated #0: 10 --> en:adamantinoma
    n1=lymphome non hodgkinien | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  855. lymphomes non hodgkiniens --- r_associated #0: 10 --> en:adamantinoma
    n1=lymphomes non hodgkiniens | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  856. maladie des histiocytes bleu de mer --- r_associated #0: 10 --> en:adamantinoma
    n1=maladie des histiocytes bleu de mer | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  857. ostéome ostéoïde --- r_associated #0: 10 --> en:adamantinoma
    n1=ostéome ostéoïde | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  858. ostéopoecilie --- r_associated #0: 10 --> en:adamantinoma
    n1=ostéopoecilie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  859. ostéopsathyrose --- r_associated #0: 10 --> en:adamantinoma
    n1=ostéopsathyrose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  860. ostéoradionécrose --- r_associated #0: 10 --> en:adamantinoma
    n1=ostéoradionécrose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  861. ostéosarcomatose --- r_associated #0: 10 --> en:adamantinoma
    n1=ostéosarcomatose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  862. sarcoïde de Spiegler-Fendt (sarcoïde de ) --- r_associated #0: 10 --> en:adamantinoma
    n1=sarcoïde de Spiegler-Fendt (sarcoïde de ) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  863. tumeur --- r_associated #0: 10 --> en:adamantinoma
    n1=tumeur | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  864. tumeur à cellules claires --- r_associated #0: 10 --> en:adamantinoma
    n1=tumeur à cellules claires | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  865. tumeur à cellules claires de l'ovaire --- r_associated #0: 10 --> en:adamantinoma
    n1=tumeur à cellules claires de l'ovaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  866. tumorlet --- r_associated #0: 10 --> en:adamantinoma
    n1=tumorlet | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  867. ulcère gastroduodénal (UGD) --- r_associated #0: 10 --> en:adamantinoma
    n1=ulcère gastroduodénal (UGD) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=10
  868. mélanoblastome --- r_associated #0: 6 --> en:adamantinoma
    n1=mélanoblastome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=6
  869. Letterer-Siwe (maladie de) --- r_associated #0: 5 --> en:adamantinoma
    n1=Letterer-Siwe (maladie de) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  870. Microbiologique --- r_associated #0: 5 --> en:adamantinoma
    n1=Microbiologique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  871. Médecine --- r_associated #0: 5 --> en:adamantinoma
    n1=Médecine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  872. Tuméfaction --- r_associated #0: 5 --> en:adamantinoma
    n1=Tuméfaction | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  873. adamantin --- r_associated #0: 5 --> en:adamantinoma
    n1=adamantin | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  874. carcinome acineux --- r_associated #0: 5 --> en:adamantinoma
    n1=carcinome acineux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  875. carcinome adénosquameux --- r_associated #0: 5 --> en:adamantinoma
    n1=carcinome adénosquameux | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  876. carcinome glandulaire et malpighien --- r_associated #0: 5 --> en:adamantinoma
    n1=carcinome glandulaire et malpighien | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  877. carcinome mixte glandulaire et spinocellulaire --- r_associated #0: 5 --> en:adamantinoma
    n1=carcinome mixte glandulaire et spinocellulaire | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  878. dysplasie fibreuse --- r_associated #0: 5 --> en:adamantinoma
    n1=dysplasie fibreuse | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  879. fibroplastique --- r_associated #0: 5 --> en:adamantinoma
    n1=fibroplastique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  880. germinatif --- r_associated #0: 5 --> en:adamantinoma
    n1=germinatif | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  881. histiocytome xanthomisé --- r_associated #0: 5 --> en:adamantinoma
    n1=histiocytome xanthomisé | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  882. histiocytose langerhansienne --- r_associated #0: 5 --> en:adamantinoma
    n1=histiocytose langerhansienne | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  883. histiocytose à cellules de Langerhans --- r_associated #0: 5 --> en:adamantinoma
    n1=histiocytose à cellules de Langerhans | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  884. hystiocytose à cellules de langerhans --- r_associated #0: 5 --> en:adamantinoma
    n1=hystiocytose à cellules de langerhans | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  885. lymphome malin diffus --- r_associated #0: 5 --> en:adamantinoma
    n1=lymphome malin diffus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  886. lymphome à cellules b --- r_associated #0: 5 --> en:adamantinoma
    n1=lymphome à cellules b | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  887. maladie d'Adamantiades --- r_associated #0: 5 --> en:adamantinoma
    n1=maladie d'Adamantiades | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  888. melanocortin receptor 4 --- r_associated #0: 5 --> en:adamantinoma
    n1=melanocortin receptor 4 | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  889. melanodontie infantile --- r_associated #0: 5 --> en:adamantinoma
    n1=melanodontie infantile | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  890. mélanoacanthome --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanoacanthome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  891. mélanoblaste --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanoblaste | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  892. mélanoblastose neuro-cutanée --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanoblastose neuro-cutanée | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  893. mélanocortine --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocortine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  894. mélanocyte --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocyte | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  895. mélanocytome de la papille --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocytome de la papille | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  896. mélanocytome scléral --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocytome scléral | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  897. mélanocytopénie --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocytopénie | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  898. mélanocytose --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanocytose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  899. mélanodermie des vagabonds --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermie des vagabonds | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  900. mélanodermie du sida --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermie du sida | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  901. mélanodermie en taches --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermie en taches | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  902. mélanodermie maculeuse acquise --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermie maculeuse acquise | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  903. mélanodermie urémique --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermie urémique | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  904. mélanodermite toxique d'Hoffmann-Habermann --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanodermite toxique d'Hoffmann-Habermann | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  905. mélanogénèse --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanogénèse | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  906. mélanokératose striée --- r_associated #0: 5 --> en:adamantinoma
    n1=mélanokératose striée | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  907. ostiofolliculite --- r_associated #0: 5 --> en:adamantinoma
    n1=ostiofolliculite | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  908. ostium abdominal de la trompe utérine --- r_associated #0: 5 --> en:adamantinoma
    n1=ostium abdominal de la trompe utérine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  909. ostium abdominale --- r_associated #0: 5 --> en:adamantinoma
    n1=ostium abdominale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  910. ostium commune --- r_associated #0: 5 --> en:adamantinoma
    n1=ostium commune | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  911. ostium introïtus --- r_associated #0: 5 --> en:adamantinoma
    n1=ostium introïtus | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  912. ostium éjaculateur --- r_associated #0: 5 --> en:adamantinoma
    n1=ostium éjaculateur | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  913. ostéopraticiens --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéopraticiens | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  914. ostéoprotégérine --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéoprotégérine | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  915. ostéosarcome des parties molles --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéosarcome des parties molles | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  916. ostéosclérose généralisée --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéosclérose généralisée | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  917. ostéose --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéose | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  918. ostéose condensante --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéose condensante | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  919. ostéose fibrogéodique rénale --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéose fibrogéodique rénale | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  920. ostéose iliaque condensante --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéose iliaque condensante | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  921. ostéose parathyroïdienne --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéose parathyroïdienne | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  922. ostéosynthèse --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéosynthèse | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  923. ostéotaxis --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéotaxis | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  924. ostéotome --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéotome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  925. ostéotomie de Chiari --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéotomie de Chiari | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  926. ostéotomie de Salter --- r_associated #0: 5 --> en:adamantinoma
    n1=ostéotomie de Salter | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  927. semialdéhyde succinique-déshydrogénase (déficit en) --- r_associated #0: 5 --> en:adamantinoma
    n1=semialdéhyde succinique-déshydrogénase (déficit en) | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  928. tumeur annexielle wolffienne --- r_associated #0: 5 --> en:adamantinoma
    n1=tumeur annexielle wolffienne | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  929. tumeur du cartilage laryngé --- r_associated #0: 5 --> en:adamantinoma
    n1=tumeur du cartilage laryngé | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
  930. épithélioma --- r_associated #0: 5 --> en:adamantinoma
    n1=épithélioma | n2=en:adamantinoma | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr